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Summary 
 
Exercising in hot and cold conditions poses one of the greatest challenges to human 
homeostasis. Popular belief is that cold exposure increases susceptibility to upper 
respiratory tract infections, however, evidence to support a link between cold exposure, 
impaired immune function and increased incidence of infection is not well defined. On 
the other hand, if heat production during exercise is not effectively dissipated, core body 
temperature can rise to dangerous levels, thereby placing the individual at risk of 
developing exertional heat-illness (EHI), or the more serious, and potentially fatal, 
condition of exertional heat stroke (EHS).  In addition to exercising in hot and humid 
environments, a number of risk factors for EHI/EHS have been identified. Other potential 
risk factors, which are less well supported, include the circulating inflammatory response 
that follows a muscle-damaging exercise bout. All together, these conditions might 
potentially affect athletes and military personnel, which are expected to perform arduous 
physical activity, often in extreme environments. 
Hypothermia is common in trauma victims and is associated with an increase in 
mortality. Its causes are still not well understood. We found (Chapter 4) that after mild-
hypothermia (Body rectal temperature (Tre) 35.17 ± 0.33 °C) vaccine-stimulated IFN-γ 
production significantly decreased by 44% suggesting temporary immune suppression. 
Moreover, despite rewarming and feeding, vaccine-stimulated IFN-γ production did not 
return to control values within 3-hour, suggesting more prolonged immune suppression, 
specifically, impaired antimicrobial capacity and increased risk of infection. This might 
partially explain the increased mortality reported after mild-hypothermia. 
During exercise heat stress (HS) (Chapter 5), ΔTre was significantly greater following 
EIMD than in CON (0.52 ºC). Therefore, HS was increased during endurance exercise in 
the heat conducted 30min trial after, and to a much lesser extent, 24h after muscle-
damaging exercise. These data indicate that EIMD is a likely risk factor for EHI 
particularly during exercise-heat stress. After a repeated bout of muscle-damaging 
exercise (EIMD trial 2) (Chapter 6), final Tre during HS was lower (39.25 ± 0.47 ºC) than 
in EIMD trial 1 (39.59 ± 0.49 ºC), whilst no differences between repeat trials were 
observed in control trials (CON). Thus, incorporating a muscle-damaging bout into 
training is a strategy to reduce the risk of EHI in individuals undertaking heavy exercise 
with an eccentric heat component.  
Further research is required clarify the role of thermo-genic activity on innate immune 
markers during cold exposure needs clarification. In addition, future studies would need 
to examine the supposed contribution of pyrogenic pathways after muscle damage upon 
exercise heat strain in more depth. 
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Thesis Format 
A literature review (Chapter 2) provides a brief background and proposes the broad 
aims of the research presented in the thesis. A general methods chapter follows that 
outlines the common procedures and analyses performed in the subsequent three 
independent experimental studies (Chapter 3). The first study principally investigates 
the effects of mild-hypothermia on immune system function (Chapter 4). The second 
experimental study is divided into two chapters: the first investigates whether exercise-
induced muscle damage (EIMD) increases heat strain during subsequent exercise heat 
stress, which in turn may increase the risk of exertional heat illness (Chapter 5). The 
second examines the influence of exercise-induced-muscle–damage repeated bout effect 
upon heat strain during subsequent exercise in the heat (Chapter 6). A general 
discussion (Chapter 7) contains a summary and critical analysis of the main findings of 
the research programme, highlighting limitations and potential areas for future research. 
Since all chapters are linked, at times there is necessary overlap between them. 
Throughout the thesis, abbreviations are defined at first use and for clarity a list of 
abbreviations, tables and figures appears prior in the Frontispiece.  
Bold type is used to refer to sections elsewhere within the thesis.
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Extreme temperature exposure or single-day, multiple strenuous exercise bouts (singly 
or in any combination) are common in active populations (e.g. military personnel, 
athletes, outdoor enthusiasts). As result, these individuals can have an increased 
susceptibility to Upper Respiratory Tract Infections (URTI) (Chapter 4) or be 
predisposed to exertional heat illness (EHI) and exertional heat stroke (EHS) (Chapters 
5 and 6). 
Popular belief points towards cold exposure increasing one’s susceptibility to infections. 
Evidence to support a link between cold exposure and an increased infection incidence is 
lacking in human studies (Castellani and Rhind, 2002). The few human studies to 
investigate the effect of cold exposure on immune function report conflicting information 
that is dependent on the degree of hypothermia, the health of the individual, and the 
immune parameters studied (Lackovic et al., 1988; Brenner et al., 1999; Wenisch et al., 
1996; Costa et al., 2010). Collectively, these studies suggest that lowering core 
temperature (core body temperature decrease > 1 °C) can disrupt circulating immune 
function, which may partly explain the increased URTI reported after cold exposure. 
Limitations of previous research are that they included unhealthy population (e.g. 
patients undergoing surgery) and they did not perform a thermoneutral control trial 
(Wenisch et al., 1996; Beilin et al., 1998). Therefore it is unclear whether surgery, 
anaesthesia, existing comorbidity and diurnal variation have independent effects for the 
altered immune function reported. Thus it remains to be shown in healthy humans 
whether immune function is impaired when core temperature is reduced (e.g. core 
temperature decrease of 1–2 °C).  
Oppositely, active populations such as athletes and soldiers taking part in heavy training 
are also expected to perform multiple bouts of strenuous exercise in hot environments, 
which may predispose them to EHI or the more severe form, and often incurable EHS. 
Conventionally classified risk factors for EHI and EHS include hot and humid 
environmental conditions, unsuitable clothing, sleep disruption, absence of heat 
acclimation, high exercise intensity, poor physical fitness levels (or obesity) and 
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underlying undiagnosed medical conditions (Armstrong et al., 2007;	  Epstein et al., 1999; 
Rav-Acha et al., 2004). These conventional risk factors do not however explain all EHI 
events, this begs the question: “Which lesser known risk factors or pathways might play 
important roles in many cases of EHI?” (Sawka et al., 2011) (Chapter 4). 
One further pathway was suggested for EHI progression; this relates to a systemic 
inflammatory reaction with an incremental increase in pyrogenic cytokines [e.g., 
interleukin (IL)-1β, IL-6, and tumour necrosis factor-α] (Bouchama, 1995; Lambert et 
al., 2001; Shephard and Shek, 1999). This may result in quicker progression toward EHI 
and/or EHS (Walsh et al., 2011). If firm evidence of a pyrogenic cytokine role in the 
development of EHI is uncovered, it would be of great interest to investigate, and 
develop strategies of avoiding or managing EHI.  Reducing the amount of muscle 
damage and inflammation would plausibly decrease heat strain. Indeed, evidence 
showed that over 80% of all EHI casualties reported during Marine recruits training 
occurred in the first 3 days of unaccustomed exercise in the heat (Kark et al., 1996). 
This is also supported by data collected during Operation TELIC in the summer of 2003 
where a heat illness rate of 50/1000 were recorded during the first 10-14 days of 
deployment among troops that were performing arduous physical activity in 
Afghanistan’s tactical scenarios (Bolton et al., 2006). One obvious, but as yet un-
investigated, avenue is the well-known repeated bout effect in muscle-damaging 
exercise, where a single session of eccentric exercise causes adaptations which in-turn 
result in decreased damage from subsequent training (Clarkson et al. 1992; Clarkson 
and Hubal 2002; McHugh et al. 1999) (Chapters 5 and 6). 
Consequently, the aims of this thesis were to investigate:  
1. The unknown effect of mild hypothermia and prolonged cold exposure on immune 
function in healthy humans. 
2. If exercise-induced muscle damage (EIMD) increases heat strain during 
subsequent exercise-heat-stress, which in-turn may increase the risk of 
exertional heat illness. 
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3. If the repeated-bout of EIMD blunts the increase in rectal temperature (Tre) 
during subsequent endurance exercise in the heat. 
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Introduction 
In the 1950's a Canadian physician, Hans Selye pioneered the scientific study of stress. 
He first defined the word “stressor” (Selye, 1956) as influences that put the human body 
out of homeostatic balance. This definition came from his research on the physiological 
responses to exhaustive exercise, prolonged exposure to extreme environments, and 
other damaging stimuli. 
Indeed, the human body tries to adapt to stressors by counteracting and re-establishing 
homeostasis (Elliot and Eisdorfer, 1982; Mausch and Rulkowska, 1993; Weiner, 1992); 
therefore, an adaptation represents improved body function (Baker, 1974; Cannon, 1929; 
Mrosovsky, 1990; Sherrington, 1941). This adaptation is also defined by its duration; 
short-term adaptations are classed as accommodations; intermediate-term adaptations 
as acclimation or acclimatization; and long-term adaptations as genetic adaptation 
(Armstrong, 2000; Fregly and Blatteis, 1996). 
The nervous, endocrine and immune systems have been classically seen as independent 
responders to stressors. However, recently findings has led to the idea that for some 
purposes these systems interact as a large single, system serving an integrated function 
rather than as three distinct systems (Berne and Levy, 1996; DeSouza and Appel, 1991; 
Dunn, 1989; Dunn and Berridge, 1990; Guyton and Hall, 1996; Mason, 1972) (Figure 
1.). 
Therefore, the next chapter will focus on the immune responses to external stressors, 
such as physical exercise (e.g. moderate and intense) and extreme environments (e.g. 
cold and heat). 
Each section will describe in detail the factors mentioned, providing a “picture” of the 
processes that the immune system uses to counteract stressors. 
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Fig. 1. The two pathways by which the CNS may communicate with the periphery include neuroendocrine 
outflow, via the hypothalamic–pituitary–target organ axis, and the automatic nervous system, through direct 
nerve fibre connections with cells or the organs of the immune system. ACTH, Adrenocorticotropic hormone; 
GH, Growth hormone (Adapted from Jonsdottir et al., 2000). 
 
Immune function and exercise 
From the early 20th century, exercise has been suggested by physicians as a cause of a 
decreased resistance to bacterial diseases (Bosch et al., 2002; Shephard, 1997; 
Shephard, 2010; Shephard and Shek, 1996; Walsh et al., 2011). These concerns were 
legitimised by an increased number of URTI reported after endurance competitions 
(Nieman et al., 1990; Peters, 1997; Peters and Bateman, 1983).  
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2.1. Effect of exercise on innate immune function 
Presently, research in understanding if exercise-induced changes in innate immune 
function alter infectious disease susceptibility or outcome is at an early stage. It remains 
unclear if the exercise-induced effects on innate immune cells, due to regular exercise, 
mediate any anti-inflammatory effect. Innate immunity, following skin, represents our 
second line of defence against pathogens and unlike adaptive immune responses it does 
not strengthen after exposure. Moreover, its ability to recognise pathogens is less 
specific.  
The innate immune system is based principally on cells and soluble factors. Soluble 
factors are a heterogeneous group of proteins, which include interferons that restrict 
viral infection, anti-microbial peptides which help to prevent bacterial growth, and 
complement proteins which control phagocytosis, inflammation and interact with 
antibodies (Woods et al., 1998). Taken together, Soluble factors help to activate other 
immune cells, such as macrophages.	  
Indeed, the main contributor of the innate immune response is the macrophage, 
followed by neutrophils, dendritic cells and monocytes. These versatile cells plays 
numerous roles but mainly perform phagocytic, antigen presentation, and regulation 
functions.  
It is really important to note that innate and adaptive immune responses, thanks to 
antigen presentation and regulation functions are inextricably linked together (Delves et 
al., 2011; Glaser and Kiecolt-Glaser, 2005; Janeway and Medzhitov, 2002; Kindt et al., 
2006; Murphy, 2011; Parham, 2009; Playfair and Bancroft, 2004; Shetty, 2010; Smith 
et al., 2012). Dendritic cells are the main envoys between the innate and adaptive 
immune system but dialogue between the innate and adaptive immune systems is not 
one sided. Elements of the adaptive response also support the function of the innate 
immune system. For example, antibodies secreted by B cells bind to macrophages and 
other phagocytes by interaction with Fc receptors on these cells. Phagocytes can 
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efficiently recognize, internalize, and destroy pathogens using these borrowed antibodies 
(Clark and Kupper, 2005). 
2.1.1. Macrophages 
Macrophage function appears to be dependent on exercise intensity, where moderate 
exercise enhances many macrophages functions (adherence, chemotaxis, phagocytosis 
and microbicidal activity), while acute exercise to exhaustion appears to have no effect 
on macrophage functions (Ortega, 2003). Stress hormones, such as cortisol seem to be 
involved in the regulation of this process (Baybutt and Holshner, 1990).  
Usually, macrophages, the tissue resident differentiation of monocytes, serve three main 
functions in the immune system. These are phagocytosis, antigen presentation, and 
cytokine production. Acute exercise reduces IL-6, IL-1β and TNF-α production from 
stimulated monocytes, perhaps due to a reduction in the number of Toll-like receptors 
(TLRs)	  (Lancaster et al., 2005). Due to maturation status and exercise-induced changes 
in monocyte function for example, this may not reflect actual tissue macrophage function, 
which is far more important.  
Moderate and intense physical activity affects the tissue macrophage, which has 
stimulatory effects on chemotaxis (Okutsu et al., 2008; Ortega et al., 1997), 
phagocytosis (Ortega et al., 1996) and production of reactive oxygen species (ROS) 
(Woods et al., 1993; Woods et al., 1994), reduced macrophage MHC class II expression 
(Woods et al., 1997) and antigen presentation (Ceddia et al., 1999; Ceddia and Woods, 
1999) especially by endurance exercise. It appears that the volume and intensity of 
exercise decreases tissue macrophage and disease outcome in animal studies; however, 
there is no evidence, at present, to expand this effect to humans.  
2.1.2. Neutrophils 
Neutrophils contribute about 50-60% of the circulating blood leukocyte cells. They are 
vital in innate immune responses as they are attracted to areas of infection (chemotaxis) 
and they ingest microbes (phagocytosis). This process is followed by enzymatic attack 
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and digestion within intracellular vacuoles, using granular hydrolytic enzymes and ROS 
in the oxidative burst; this process is called degranulation. 
Neutrophils exert their main function outside blood, via a process called diapedesis. Their 
ability to do this is based upon the ability of neutrophils to emigrate from the blood 
vessels into surrounding tissue. Acute or exhausting exercise does not seem to affect 
their ability to adhere to endothelium (Lewicki et al., 1987; Ortega et al., 1993).  
Typically, the pathogen is overwhelmed by the neutrophils (phagocytosis) by extending 
pseudopodia. When these extensions are fused together the pathogens is trapped within 
intracellular vacuoles and then the neutrophils begin their attack. This neutrophil ability 
has been used to assess neutrophil function in vitro. Most of the reports show that there 
is an increase in phagocytic activity of neutrophils during intense physical activity (Hack 
et al., 1992; Lewicki et al., 1987; Ortega et al., 1993; Rodriguez et al., 1991), however, 
this evidence is still under debate (Blannin et al., 1996; Gabriel et al., 1994; Nieman et 
al., 1998; Rodriguez et al., 1991). 
Even if neutrophil phagocytic activity is just one process that contributes to 
immunological integrity, it has been shown that long periods of heavy training may lead 
to a decrease in this activity at rest (Blannin et al., 1996), leading to an increased risk of 
getting opportunistic infections. Certainly, disorders of neutrophil function and 
neutropenia are associated with recurrent infections (Yang and Hill, 1991) and there is 
now convincing evidence to show that highly trained athletes are more susceptible to 
infection than their relatively sedentary counterparts (Brenner et al., 1994; Shephard et 
al., 1991). Indeed, exercise seems to induce degranulation by increasing the plasma 
levels of elastase and myeloperoxidase (Blannin et al., 1996; Robson et al., 1999; 
Suzuki et al., 2003), although this might merely reflect the simultaneous neutrophilia 
often observed (Suzuki et al., 1999). Unfortunately, during subsequent exercise, 
neutrophils can enter into a refractory activation period after exercise that may lead to a 
lower degranulation response to subsequent bacterial exposure (Bishop et al., 2002; 
Bishop et al., 2003; Blannin et al., 1997), supported by the observation that no changes 
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in total elastase content have been reported after physical exercise, which could mean 
there was no a depletion of neutrophil granules. 
An attenuated ROS production has been reported after high intensity exercise (Hack et 
al., 1992; Pyne, 1994). Indeed, it has been demonstrated that the generation of 
hydrogen peroxide (H2O2) by stimulated neutrophils is reduced during acute exercise by 
plasma borne inhibitors, such as nicotinamide adenine dinucleotide phosphate-oxidase 
inhibitors. Although other researchers have shown the converse, an increased production 
of hydrogen peroxide and hydrochlorous acid (HClO) after moderate intensity 
exercise(Smith et al., 1990). This ambiguity may be a consequence of a shift in 
neutrophil function that could be dependent on exercise intensity (Dziedziak, 1990; Pyne, 
1994; Suzuki et al., 2003). Furthermore, a decrease in respiratory burst has been 
reported in the hours (h) following a bout of intense physical activity (Pyne, 1994). In 
this case, the exercise-intensity seems to be the most important factor; shown in the 
decreased neutrophil oxidative burst during a marathon race (Suzuki et al., 2003). This 
process appears to be mediated by catecholamines, especially adrenaline, which 
decreases neutrophil respiratory burst in vitro elevating cycling adenosine 
monophosphate (Tintiger et al., 2001). Furthermore, pro-inflammatory cytokines, such 
as IL-6, appear to be involved in regulating this process, which would also be in-line with 
the different result found at moderate and high exercise intensities (Peake et al., 2005). 
Thus, the combined uses of the neutrophilic arsenal, creates a hostile environment for 
any foreign bodies, leading to their destruction. The ability of neutrophils to kill has been 
shown to be unaffected or enhanced by acute exercise, irrespectively of intensity 
(Lewicki et al., 1987; Ortega et al., 1993; Rodriguez et al., 1991). Resting neutrophil 
bactericidal activity was similar in trained and sedentary subjects (Lewicki et al., 1987). 
The contradictions in the effects of acute and chronic exercise on neutrophil functions 
are attributable to the differences in age, gender and initial fitness levels of the subject 
(Wolach et al., 2000). 
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2.1.3. Natural killer (NK) cells 
NK cells may serve as a “front line of defence” before a specific response can be 
mounted by the adaptive immune response, and do not require recognition of an 
antigen-MHC class II combination. The effects of intense exercise on NK-cell function 
appear to be biphasic, with an initial increase followed by delayed suppression (Kappel et 
al., 1991; Nieman et al., 1993; Pedersen, 1991). 
Exercise induces an increase in the absolute number and percentage of blood NK cells, 
which also results in an increased cytolytic activity (Gannon et al., 1995; Pedersen et al., 
1988; Roberts et al., 2004). The delayed suppression of NK cell function seems to be 
mediated via prostaglandins released from the relatively numerous monocytes observed 
after intense exercise (Kappel et al., 1991; Pedersen et al., 1988). 
2.1.4. Other contributors to innate immune function 
The stress hormones adrenaline and cortisol are involved in many of the changes in 
innate immunity outlined above. Indeed, they regulate innate immune cell function and 
the production of the leukocytosis by bone marrow release and demargination (Ortega, 
2003). Cortisol release and clearance is regulated by exercise intensity; moderately 
intense exercise, which is often associated with enhanced immune cell function, 
decreases cortisol levels. On the other hand, high intensity exercise, which can depress 
innate immune cell function, increases cortisol secretion. The similarities between acute 
exhaustive exercise and acute inflammatory response lead to the conclusion that other 
immunological mediators are involved (Camus et al., 1992). For example, IL-6 increases 
during endurance exercise and is released by exercising muscle (Steensberg et al., 
2000). A consequence of this event accounts for increases in cortisol secretion, and IL-
1ra and IL-10 expression (Steensberg, 2003). 
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2.2. Effects of exercise on acquired immune function 
Acquired immunity combats infections by not allowing colonisation of pathogens and by 
destroying invading microorganisms. It is initiated, in most cases, by antigen 
presentation to T helper lymphocytes, within the peptide-binding groove of major 
histocompatibility complex class II molecules on antigen-presenting cells. The 
subsequent cell-mediated immune response is mediated by inflammatory monocytes 
(CD4+) T-cells. 
According to the cytokines they produce, helper T-cell clones can be divided into two 
main phenotypes: Type-1 (Th1) and Type-2 (Th2). Th1 cells play an important role in 
the defence against intracellular pathogens and Th2 cells are involved in the protection 
against extracellular parasites and stimulation of B-cell antibody (AB) production. 
Cytotoxic T cells can also be classified into Type-1 (Th1) and Type-2 (Th2) cells 
according to their cytokine profiles. 
2.2.1. T-cells 
As outlined above, T cells play a fundamental role in the organization and regulation of 
the cell-mediated immune response to pathogens. To cope with the enormous variability 
of environmental antigens, T lymphocytes comprise a collection of cell clones, each 
featuring the ability to specifically recognize a given antigen (Von Boehmer, 1997). 
Specificity of recognition, memory of previous antigen encounter and lack of self-
reactivity are the physiological hallmarks of T lymphocytes. These features are acquired 
during the maturation of T cells, which takes place in the thymus and later on in 
secondary lymphoid organs (Von Boehmer, 1997). Antigen recognition leads to the 
clonal amplification of antigen-specific T cells, which will eventually acquire effector 
functions ranging from the ability to kill infected cells to the production of soluble 
paracrine factors required for cooperation among immune cells (Lanzavecchia and 
Sallusto, 2000). A defect of their function, such as inherited or acquired 
immunodeficiency syndromes, might lead to an increased incidence of infections (Fabbri 
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et al., 2003), so it is reasonable to think that the increased incidence of URTI recorded 
between sports enthusiasts may be due to exercise-induced decreases in T-cell function.  
The effect of acute exercise on cell-mediated immune function has been most commonly 
assessed measuring cytokine production and cell proliferation (Gleeson et al., 2013). It 
has been reported that exercise had little or no effect on the portion of circulating Th2 
cells, where conversely it had a decreasing effect on Th1 cell numbers. This might be 
due to changes in the distribution of the cell between circulation and tissues ,cell death, 
or that the increase in plasma epinephrine during exercise contributes to the suppression 
of IL-2-producing T cells and that high plasma IL-6 helps to maintain the IL-4-producing 
T cells in the circulation. Thus epinephrine and IL-6 may participate in the exercise-
induced shift toward a relative type 2 T-cell dominance. However, other physiological 
changes, such as local inflammation, may also play a role. In addition, the present study 
supports the idea that an exercise-induced increase in plasma IL-6 induces elevated 
levels of plasma cortisol (Steensberg et al., 2001). 
Athletes are prone to viral infections. Some researchers have argued this is due to an 
impaired Th1 cellular response, leading to a reduced host-defence reaction against 
intracellular pathogens. Indeed, there are no differences between sedentary people and 
athletes in circulating lymphocyte numbers during rest (Nieman, 2000). In contrast, 
decreases in circulating numbers of Type-1 T cells, reduced T cell proliferative responses, 
and falls in stimulated B cell immunoglobulin synthesis have been reported in athletes 
after long periods of intensive training, suggesting a decrease in T-cell functionality (Baj 
et al., 1994; Lancaster et al., 2004; Verde et al., 1992). However, there are many other 
processes that lead to lymphocyte proliferation and cytotoxicity, including cytokine 
production and pathways that require other co-stimulatory signals, including specific 
antigen encounters. 
Numerous studies report that lymphocyte proliferation decreases during and after 
exercise (Walsh et al., 2011). This exercise-induced decline could be, in part, due to 
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changes in B cell responses to mitogen stimulation. However, given the small number of 
circulating B cells, this contribution appears to be small. 
2.2.2. Monocytes (CD14, CD16) 
Monocytes can be divided in two populations, classical (CD14++) and inflammatory 
(CD14+ and CD16+) cells, with their difference residing in how they express cell-surface 
tool-receptor 4 (TLR4), with inflammatory monocytes having twice the number of 
receptors as classical monocytes (Skinner et al., 2005).  Even if they represent only ten 
per cent of total monocyte population, they are a significant inflammatory potential of 
the monocyte pool as a whole (Belge et al., 2002). 
There is evidence of a temporary increase of the inflammatory monocyte percentage 
after a single bout of intense exercise, with a quick return to baseline levels during 
recovery. Cortisol may be involved in reducing CD14+, CD16+ monocyte numbers with 
exercise training (Fingerle-Rowson et al., 1998). Studies have shown that high-intensity 
training results in increases in regulatory T-cell numbers and activation was also 
associated with reduced pro-inflammatory and increased anti-inflammatory cytokine 
expression (Wang et al., 2012). 
2.2.3. Immunoglobulin contribution to immune function 
An AB, also known as an immunoglobulin (Ig), is a protein produced by plasma cells that 
is used by the immune system to identify and neutralize pathogens (Kenneth, 2005). 
The largest immunoglobulin pool in the blood is Immunoglobulin (Ig)G, with a smaller 
quantity of Immunoglobulin (Ig)A and Immunoglobulin (Ig)M. The amount of 
Immunoglobulin (Ig)D and Immunoglobulin (Ig)E is almost insignificant. Therefore, most 
studies have focused on exercise-induced changes in serum IgA, IgG and IgM. 
Serum immunoglobulin concentrations appear to remain either unchanged or slightly 
increased in response to moderate physical activity. When athletes run 45 to 75 km at 
high intensities, serum immunoglobulin levels have been reported to be depressed for up 
to 2 days. Thus intense ultra marathon running may lead to greater and longer lasting 
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decreases in serum immunoglobulin levels than following exercise of shorter duration. 
IgA and IgG, immunoglobulins commonly found in airway and alveolar space secretions, 
may have diffused from the serum during recovery from prolonged endurance exercise 
non-specifically and/or in response to microbial agents and antigens introduced into the 
airways during the exercise bout (Nehlsen-Cannarella et al., 1991; Nieman et al., 1989; 
Potteiger et al., 2001). 
 
2.3. Cytokines contribution to immune function 
Cytokines are known as an important family of intercellular molecules that influence 
inflammatory and immune responses. Cytokines can be categorised as being pro- or 
anti-inflammatory. Pro-inflammatory cytokines include IL-6, IL-1α, and -1β, and TNF-α. 
Examples of anti-inflammatory cytokines include IL-10, the IL-1 receptor agonist (RA) as 
well as soluble TNF-receptor (sTNFr) 1 and 2 (Heled et al., 2013). Both pro- and anti-
inflammatory cytokines counter-regulate one another, in sequence. This maintains their 
levels in homeostasis (Pedersen and Hoffman-Goetz, 2000; Suzuki et al., 2002). 
Cytokine IL-6 (an inflammatory) causes pyrogenesis, together with IL-1 and TNFα. Both 
neutrophils and monocytes produce inflammatory cytokines in local inflammation 
responses and during healing. 
2.3.1. Interleukin (IL)-6: release and functions 
Studies have demonstrated that the release of Interleukin (IL)-6 is induced by exercise 
and that this release almost exclusively accounts for the elevated systemic IL-6 
concentration found (Steensberg et al., 2000). Indeed, by obtaining arterial-femoral 
venous differences from an exercising leg and a resting leg, it has been found that 
exercising muscles released the total amount of circulating IL-6 (Pedersen et al., 2001). 
This demonstrates that only muscle contraction induces IL-6 and that secreted factors 
(e.g. adrenaline) do not play an important role in the exercise-induced increase in the 
systemic IL-6 concentration. In addition, even if strong evidence has been provided to 
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support IL-6 induction by exercise, it has not been mentioned that other cellular sources 
within the muscle (e.g. macrophages, the endothelium of the muscle capillary bed, 
adipose tissue or bone) may be the source of the increased IL-6 release from the muscle 
during exercise. 
There is also evidence that the kinetics of IL-6 concentration/release during exercise is 
closely related to the duration of the exercise bout. A plausible explanation of this 
process could be that the depletion of muscle glycogen during prolonged endurance 
exercise increases the release of IL-6 in response to an energy crisis (Steensberg et al., 
2000). This augmented concentration of IL-6 may signal the liver to increase its glucose 
output to prevent a drastic fall in the blood glucose concentration the muscles are now 
using as their main energy source. Supporting this hypothesis, studies have showed that 
carbohydrate ingestion during exercise, which provides an exogenous energy source, 
attenuates the systemic IL-6 concentration (Nehlsen-Cannarella et al., 1997; Starkie et 
al., 2001). More evidence has been provided to confirm that the IL-6 response to 
exercise is mainly dependent on exercise duration with a minor role played by exercise 
intensity (Fischer, 2006). 
This is supported by recently presented data which revealed that the inflammatory 
cytokine IL-6 increases significantly in the plasma after a marathon run even after 
adjustment for leukocyte (Bernecker et al., 2013) and more modest increases are 
reported with shorter duration or intermittent exercise protocols or when carbohydrates 
are provided during exercise (Fischer, 2006; Meckel et al., 2009). Exercise-induced IL-6 
increase is temporary, returning to basal levels within one-hour post exercise 
(Steensberg et al., 2000). The major stimulus of IL-6 synthesis and release seems to be 
a decrease in muscle glycogen, which results in an exponential increase of IL-6 
concentration (Keller et al., 2005; Pedersen and Fischer, 2007). Indeed, muscle-derived 
IL-6 is released into the circulation in large amounts and is likely to work in a hormone-
like fashion, exerting its effect on the liver and adipose tissue, thereby contributing to 
the maintenance of glucose homeostasis during exercise.  
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In addition, it is likely that the great increase in IL-6 in response to long-duration 
exercise is independent of muscle damage, while muscle damage itself is followed by 
repair mechanisms including invasion of macrophages into the muscle leading to IL-6 
production. IL-6 production in relation to muscle damage occurs later and is of smaller 
magnitude than IL-6 production	   related	   to	   muscle	   contractions.	   Increases in intracellular 
calcium and ROS production could also activate transcription factors, such as NF-IL-6 
and p38/RK known to regulate IL-6 synthesis (Fischer, 2006). Using arterio-venous 
difference techniques or muscle biopsies does not provide definitive information on the 
actual cellular source of the exercise-induced increase in systemic IL-6 concentration.  
To determine the cellular source of the exercise-induced increase in IL-6, researchers 
obtained muscle biopsies at rest and following 2 h of cycling (Hiscock et al., 2004). The 
data provided from this study showed that IL-6 protein was mostly expressed by 
myocytes in the periphery of individual myofibres.  
Even if the physiological process that leads to an increased release of IL-6 is now better 
understood, the biological role of this increased concentration has been, until very 
recently, unknown. The hypothesis that IL-6 is released from the exercising muscles to 
signal to the liver the need for a increased glucose production has been recently tested.  
Evidences show that increased exercise-induced levels of plasma IL-6, act in hormone-
like manner to regulate fat metabolism increasing substrate mobilisation (Pedersen et al., 
2001). Indeed, it is well know that strenuous exercise increases plasma concentrations 
of stress hormones and catecholamines (Steensberg, 2003). Therefore, it should be 
considered that IL-6 may affect the hypothalamus, increasing the release of 
adrenocorticopic hormone (ACTH) from the anterior pituitary gland or directly acting on 
the adrenal gland itself, to stimulate cortisol synthesis; evidence has been provided for 
both mechanisms but further research is required to confirm these processes. Therefore, 
an acute increase in IL-6 could be important to mobilize substrates in times of need, for 
example during exercise, through different processes (Glund and Krook, 2008) 
(Chapters 5 and 6). 
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In addition, increased synthesis of IL-6 induction preceded a rise of two anti-
inflammatory cytokines, IL-1ra and IL-10 (Steensberg, 2003). It has been argued that if 
IL-6 was the initiator of this response, then IL-6 and IL-4 would stimulate monocytes 
and macrophages to produce IL-1ra, which inhibits the effect of IL-1. Monocytes, 
lymphocytes and B cells are known to have an important role in producing IL-10, which 
together with IL-4 can inhibit Type-1 T-cell cytokine production. Evidence for this has 
already been provided by a study which showed that strenuous exercise causes a 
decrease in the number of type-1 T-cells, whereas the population of Type-2 T-cells is 
unchanged. Both cortisol and adrenaline are shown to decrease production of Type-1 T-
cell cytokines, whereas Type-2 T cell cytokine production is stimulated by IL-6 
(Steensberg et al., 2001).  
The exercise-induced IL-6 release may decrease the production Type-1 T cells, which 
consequently may lead to lower virus protection in the host as Type-1 T cells drive the 
immune system reaction against intracellular pathogens. This process might ultimately 
end with an increased incidence of URTI for serious exercisers. Interestingly, tissues 
other than skeletal muscles appear to be involved in the exercise-induced increase in 
systemic IL-6 concentrations. Data has shown that IL-6 is also released by the brain 
during exercise (Nybo et al., 2002) and IL-6 gene expression is increased within adipose 
tissue in response to exercise (Keller et al., 2003).  
In conclusion, the stimulus for the increased IL-6 synthesis from tissue other than 
skeletal muscle is unclear, although glycogen depletion may be one possible explanation 
as it has been showed that low muscle glycogen is a stimulus for muscle-derived IL-6 
production.  This effect may be of interest for athletes or outdoor enthusiasts who 
appear to be more susceptible to exercise-acquired URTI. 
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2.3.2. Interleukin (IL)-4: release and functions 
IL-4, a multifunctional pleiotropic cytokine discovered in the mid-1980s, remains a focus 
of attention and continues to spur vigorous research efforts. This mediator is produced 
mainly by activated T cells but also by mast cells, basophils, and eosinophils (Nelms et 
al., 1999). A typical cytokine structurally, with molecular weight varying between 12 and 
20 kDa as a result of variable natural glycosylation, IL-4 shares sequence homology, cell 
surface receptors, intracellular signaling, and partial functional effects on cells with IL-13 
(Kelly Welch et al, 2005; Murata et al., 1998). Functionally, IL-4 is best known for 
defining the so-called Th2 phenotype of lymphocytes and for regulating cell proliferation, 
apoptosis, and expression of numerous genes in various cell types, including 
lymphocytes, macrophages, and fibroblasts, as well as epithelial and endothelial cells 
LaPorte et al., 2008; Chomarat et al., 1998). Considering the already staggering and still 
rapidly growing volume of information available about IL-4, it is hardly possible to 
provide a systematic review of this pivotal regulator alone, even without considering 
important relevant aspects, for example, recent advances concerning functionally related 
Th2 mediators, such as IL-10, IFN-ϒ and, IL-13 As the field of IL-4 research has 
expanded, it has become obvious that the initial broad-strokes picture of IL-4 function 
created in the 1980s and 1990s needs to be adjusted to reflect the numerous intricacies 
related to IL-4 generation, receptor use, and the effects on cells. Specifically, it has 
emerged that instead of linear scenarios, the field of IL-4 biology is full of alternative 
pathways. In addition to the well-appreciated—now described at the textbook level—role 
of IL-4 in determining the alternative fates of Th lymphocytes (Zhu et al., 2008), 
particularly in promoting Th2 and inhibiting Th1 (Constant et al., 1997) differentiation, 
new knowledge about other IL-4-related, alternative branchings has emerged. 
The effect of IL-4 following exercise is presented in more details in the following 
paragraph. 
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2.3.3. Effect of exercise on cytokines 
Exercise and environmental stressors induce an increase in the systemic concentration 
and muscle levels of numerous cytokines. It is interesting to note that the function of 
many of these cytokines is not completely understood. Additional research is needed to 
augment our knowledge about the biological role of exercise and environmental induced 
release of cytokines. 
The mRNA expression of a number of cytokines in response to prolonged exercise has 
been studied to understand if their exercise-induced patterns are similar to IL-6 (Chan et 
al., 2004; Nieman et al., 2003). The mRNA of many cytokines (e.g. IL-1β, IL-6, IL-8, IL-
15, TNF-α, IL-12p35 and IFN-ϒ) is detectable at rest in muscle. On the other hand, other 
cytokines, such as IL-1α, IL-2, IL-4, IL-5, IL-10 and IL-12p40 are not detectable. There 
is evidence of an increase of mRNA expression for IL-6 and IL-8 during prolonged 
exercise (Nieman et al., 2006); one study also reported an increase in IL-1β (Lysiak et 
al., 2004), but that observation could be attributable to differences in exercise protocols. 
For example, a study that did not cause any muscle damage did not induce IL-1β mRNA 
expression (Chan et al., 2004). There was no increase in mRNA expression for any other 
cytokine following exercise.  
A metabolic role for IL-6 and IL-8 is supported by the fact that exogenous carbohydrate 
ingestion decreases their mRNA expression. In contrast, no effect of carbohydrate 
ingestion was observed on IL-1β mRNA expression. Consequently, this evidence provides 
support for the notion that IL-8 may have a similar biological pattern to IL-6. However, it 
is important to mention that while an increase in the expression of both IL-6 and IL-8 
mRNA within the contracting muscle after exercise has been recorded, only IL-6 is 
synthetized and released.  
IL-1ra concentrations are increased in response to endurance exercise with a peak in 
magnitude that is similar to that of IL-6. Interestingly, the increase in IL-1ra 
concentration occurs later than that of IL-6. Knowing that IL-6 could induce IL-1ra, it is 
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plausible that the release of IL-6 from the contracting muscle during exercise elicits the 
release of IL-1ra from blood mononuclear cells. As IL-1ra is an anti-inflammatory 
cytokine, it seems reasonable that the increase in the IL-1ra concentration after a bout 
of exercise acts as a negative feedback mechanism, helping control the magnitude and 
duration of IL-6 mediated effects (Ostrowski et al., 1998).  
In addition, exercise induces an increase of many cytokines in the systemic circulation 
and muscles, but there is little understanding of their function. Two main mechanisms 
appear to be involved in the anti-inflammatory chronic effects of exercise. The first is an 
increased synthesis and release of anti-inflammatory cytokines from contracting skeletal 
muscle (Mathur and Pedersen, 2008). The second is attributable to a reduced expression 
of TLRs on monocytes and macrophages (Flynn and McFarlin, 2006), which inhibits the 
downstream responses, such as pro-inflammatory cytokine production, antigen 
presentation and co-stimulatory molecule expression (Gleeson et al., 2006). However, 
these two processes do not completely account for the anti-inflammatory effects of 
exercise.  
Other effects of exercise have been demonstrated, such as the inhibition of 
monocyte/macrophage infiltration into adipose tissue 	   (Kawanishi et al., 2010), a 
reduction of circulating numbers of pro-inflammatory monocytes (Timmerman et al., 
2008) and an increase the circulating numbers of IL-10 secreting regulatory T-cells 
(Wang et al., 2012).  
As stated above, IL-6 appears responsible for the subsequent rise in circulating levels of 
other anti-inflammatory cytokines (IL-10 and IL-1ra) and also stimulates the release of 
cortisol from the adrenal glands (Steensberg, 2003). IL-1ra, which is mainly secreted by 
monocytes and macrophages, decreases the pro-inflammatory actions of IL-1β. 
Regulatory T cells, monocytes, Th2 cells, macrophages, CD8+ T cells and Th1 cells are 
primarily involved in IL-10 production.  
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The main role of IL-10 is counteracting the inflammatory responses in order to down-
regulate adaptive immune effector responses and to minimise tissue damage in response 
to microbial challenges. This has been showed by a study conducted during Copenhagen 
marathon in May 1997 where they found that a dramatic increase in the inflammation 
responsive cytokine IL-6 was balanced by the release of the anti-inflammatory cytokine 
IL-10 (Ostrowski et al., 1999). In addition, several pro-inflammatory cytokines and other 
soluble mediators are inhibited by IL-10. Moreover, as insulin sensitivity is increased by 
IL-10, a protective effect against obesity, induced by macrophage infiltration in skeletal 
muscle, has been observed (Hong et al., 2009). 
TLRs together with the IL-1 receptors form a receptor family, and they are generally 
expressed by macrophages and dendritic cells. They mainly detect and recognise 
microbial pathogens. They are transmembrane proteins and can be activated by 
endogenous signals of tissue damage, such as heat shock proteins (Kaisho and Akira, 
2006). TLRs mainly produce pro-inflammatory cytokines after signalling of the antigen-
presenting cell, and thus TLR pathways are fundamental in mediating whole body 
inflammation (Takeda et al., 2003). Physically active people have shown lower 
inflammatory response by their blood monocytes to endotoxin stimulation in vitro and 
lower TLR4 expression (Gleeson et al., 2006). The physiological stimulus that triggers an 
exercise-induced decrease in cell surface TLR expression is not fully understood. 
However, anti-inflammatory cytokines, stress hormones and heat shock proteins have 
been implicated (Gleeson et al., 2006). 
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2.4. Influence of exercise on URTI incidence  
Exercise has been suggested by physicians as the cause of a decreased resistance to 
bacterial diseases (Bosch et al., 2002; Shephard, 1997; Shephard, 2010; Shephard and 
Shek, 1996; Walsh et al., 2011). As support to this, an increased number of URTI 
reported after endurance competitions has been showed (Nieman et al., 1990; Peters, 
1997; Peters and Bateman, 1983). 
2.4.1. Influence of exhaustive exercise on URTI incidence                                             
A temporary fall in the circulating number of natural killer (NK) cell number has been 
observed after an exhaustive bout of exercise (Shinkai et al., 1992). This observation 
provides a partial explanation for the recorded increase in URTI, as a drop of NK cells 
offers a period when infecting microorganisms have easier access. This transient period 
is called an “open window”. There is still debate around the length of this “open window”; 
some studies report that it could last for more than seven days (Shek et al., 1994), but 
most studies describe this reduction lasting just for a few hours.  Also, doubts have been 
raised as to whether the "window" is open sufficiently long enough to lead to increased 
susceptibility to infections. In addition, it has also been observed that NK cells do not get 
damaged by exercise, instead they are temporarily relocated to blood vessel walls 
because of the exercise-induced secretion of catecholamines (Shephard et al., 2000). A 
more plausible explanation could be a depression of front-line defences resulting in a 
subsequent lower secretory rate of antimicrobial peptides (AMPS) from the nasal and 
salivary glands (Mackinnon, 1997; McDowell et al., 1991; Tharp and Barnes, 1990). 
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2.4.2. Influence of moderate exercise on URTI incidence  
 
Fig. 2. The J-shaped model of the relationship between risk of Upper Respiratory Tract Infection (URTI) and 
exercise volume (Nieman et al., 1994). 
 
It has been also observed that regular moderate sessions of exercise have a beneficial 
effect on health and that excessive volumes of training have negative consequences. 
Thus suggesting a J shape relationship between physical activity and resistance to 
diseases (Figure 2.; Nieman et al., 1994); however, this observation is based on a 
limited amount of data (Nieman et al., 1990; Shephard et al., 1999). In the case of the 
immune system it would seem that a disproportionate inflammatory reaction leads to 
tissue damage after exagerated training (Shek and Shephard, 1998). 
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Most of the studies on this topic were survey-based epidemiological studies and 
presented limitations on data reliability and study design, particularly on inclusion 
criteria, food intake, memory recall effect limitations, and population specificity for 
symptoms of Upper Respiratory Tract Infection (URI) (Cramer et al., 1991; Hemila et al., 
2003; Kostka et al., 2000; Matthews et al., 2002; Nieman et al., 1990; Shephard and 
Shek, 1999). However, these results suggest that moderate physical activity was 
associated with a 20-30% reduction in annual risk of URTI when compared with 
sedentary subjects. In conclusion, the evidence from available studies show a decreased 
incidence, severity and duration of URTI in consequence of acute moderate (lasting   ̴ 30 
min) physical activity (Nieman et al., 1990; Weidner et al., 1998). 
The evidence mentioned above suggests that the human body can increase its ability to 
respond to bacterial challenges leading to the concept of “immunosurveillance”, thereby 
providing a plausible explanation for the apparent relationship between moderate 
exercise and incidence of infections (Nieman, 2000). Conversely, physical activity 
showed little effect on the immune system and there is a lack of evidence to support this 
theory.  
2.4.3. Influence of heavy exercise on URTI incidence 
Little research has been conducted in the area of intense physical activity and risk of 
URTI. Some elegant studies have looked at the incidence of URTI after marathon and 
ultra-marathon competitions and there is evidence of an increased risk of URTI during 
the 7-14 days following the race (Nieman et al., 1990; Peters and Bateman, 1983; 
Peters et al., 2010). Even stronger evidence supports the idea that there is a linear 
relationship between exercise intensity and post-race diseases (Nieman, 1994), 
suggesting that the more acute the exercise stress the higher the susceptibility to URTI. 
Scientific studies based on endurance competition and heavy volume training have 
investigated the relationship between high-intensity exercise and the immune system 
(Bury et al., 1998; Foster, 1998; Gleeson et al., 1999). Evidence suggests that 
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performing both a session of intense prolonged exercise and higher volumes of training 
is associated with increase susceptibility to URTI, thus supporting the J-shaped model. It 
is now well established that a depression of immune function can last for 72 hours 
following a bout of high intensity physical activity (Nieman, 2000), and it seems 
reasonable to relate this to the increased incidence of URTI, even if it has not been 
demonstrated definitively.  
In conclusion, a suppression of immune function, following high intensity exercise could 
lead to an “open window” during which bacteria and viruses may invade the body, and 
thus augment the risk of infections (Nieman, 2000). However, a direct link between 
impaired immune function in vivo and increased incidence of URTI has not yet been 
demonstrated. 
2.4.4. Effect of extreme environments on immune responses to exercise 
The hypothesis that extreme environments could affect immune function while exercising 
was firstly proposed in the late 90’s. Considering that exercise and environmental stress 
both affect the immune function it is easy to comprehend why Dr Shephard hypothesised 
that linking them together would cause greater disruption to immune function and host 
defence (Shephard, 1998).  
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Fig. 3. The co-ordinated hormonal responses, supervised by the central nervous system to contrast stressors. 
ACTH, Adrenocorticotropic hormone; GH, Growth hormone (Jonsdottir, 2000). 
 
Stressors are contrasted by co-ordinated hormonal responses supervised by the central 
nervous system (Figure 3.; Jonsdottir, 2000). The hypothalamic-pituitary-adrenal (HPA) 
axis and sympatho-adrenal medullary (SAM) axis provide the signals by which the brain 
modulates immune function to oppose stressors. Cortisol is produced by the HPA axis, 
and SAM axis regulates the production of catecholamines. Evidence supports an 
interaction between neuroendocrine responses and immune responses to exercise 
(Hoffman-Goetz and Pedersen, 1994). 
To provide an example, during fever, the body's temperature is increased by 
endogenous pyrogens through an increase in the hypothalamic temperature set point. 
On the other hand, the hypothalamic temperature set point does not change during 
vigorous physical activity (Byrne et al., 2006; Pugh et al., 1967). However, decreased 
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heat dissipation during exercise causes the body's temperature to rise, often exceeding 
levels associated with fever and hyperthermia. 
Exercise in hot conditions is often associated with an increase of catecholamines and 
cytokines, which amplify immune modifications, stress hormones, higher heart rate, and 
a decrease of endurance performance when compared with thermo-neutral conditions 
(Febbraio, 2001; Galloway and Maughan, 1997). Evidence shows that exercising in the 
heat poses a greater threat to immune function compared with thermo-neutral 
conditions (Rhind et al., 2004; Walsh et al., 2011; Walsh et al., 2011; Walsh and 
Whitham, 2006) (Chapters 5 and 6).  
2.4.5. Hyperthermia and heat stroke: a role for cytokines? 
Studies have reported an acute inflammatory response to heat strain, which involved 
hyperthermia-related pyrogens (IL-6, IL-1, and TNFα), of which IL-6 corresponded to 
the severity of the EHS, as well as their antagonist receptors (IL-6R, IL-1RA, and TNFr 
I&II), after being exposed to a mix of exertional components and heat. An uncontrolled 
anti-inflammatory response was related to poor prognosis in recovering patients 
(Bouchama et al., 1993; Hammami et al., 1997; Hashim et al., 1997). 
A more distinct effect of environmental heat has been observed in neutrophil activation, 
which serves as a link between the inflammation and coagulation responses (Heled et al., 
2013). Involvement of pyrogenic cytokines (IL-6, IL-8 and IL-1 RA) was also reported 
(Duque et al., 2014). Animal models reported similar results alongside increases in anti-
inflammatory cytokines, such as IL-10 and IL-1 RA (Zhang et al., 2007). Again the 
elevation in plasma IL-6 levels was related to the severity of the heat stroke. A 
dysregulation of the inflammatory response in non-surviving patients leads to the 
hypothesis that it may contribute to fatal tissue injury. Nevertheless, the anti-
inflammatory component is also heavily involved in heat stroke (Bouchama et al., 2005 
a; Bouchama et al., 2005 b). In EHS, a major role for the endotoxemic component is 
reflected by cytokines, especially by the IL-1 cytokine family (IL-1α, IL-1β, and IL-1 RA). 
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Cytokines are involved from the early stages, pointing to multi-factorial damage due to 
excessive heat and EIMD. Once again, IL-6 is correlated with the severity of the heat 
stroke (Chang, 1993; Lu et al., 2004). 
Following a bout of physically demanding exercise, plasma levels of both pro- and anti-
inflammatory cytokines increase, and that this increase is enhanced by previous illness 
or inflammation (Bouchama and Knochel, 2002; Lim and Mackinnon, 2006; Suzuki et al., 
2000). For example, performing physical activity in the heat contributes to and increases 
the level of complexity of the physiological processes mentioned above, providing a 
combination of stressors (Akimoto et al., 2000; Cox et al., 2007; Rhind et al., 2004; 
Walsh and Whitham, 2006). Indeed, submaximal exercise in a hot environment has been 
found to enhance the amount of pyrogenic cytokines following lipopolysaccharide (LPS) 
stimulation (Starkie et al., 2005). In addition, evidence demonstrates that 
skeletal muscle responds to heat stress with a distinct "stress-induced immune 
response," characterized by an early upregulation of IL-6, IL-10, and TLR-4 and 
suppression of IL-1β and TNF-α mRNA, a pattern discrete from classic innate 
immune cytokine responses (Leon et al., 2015; Welch et al, 1985). This effect is due to 
an increased amount of secreting cells such as like macrophages, B lymphocytes, 
and T lymphocytes (Janeway et al., 2001) (Chapters 5 and 6).  
Following exercise, an inhibition of cytokine production was expected due to the release 
of stress hormones, but this has not been confirmed in studies that showed cytokines 
plasma levels to rise in the combined stress situation. It has also been shown that 
acclimation has considerable influence on the ability to perform exercise bouts in the 
heat. Indeed, heat acclimation was found to lower the increase in pro- and anti-
inflammatory cytokines during exercise in the heat (Heled et al., 2013). Furthermore, 
thermoregulatory preconditioning has a considerable influence on the ability to perform 
exercise in the heat. In particular, heat acclimation was found to diminish the increase in 
IL-6 and IL-10 during exposure to exercise in the heat, while TNF-α remained unchanged. 
Supplementation with quercetin, a heat shock response inhibitor, abolished this effect, 
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suggesting that the mechanisms controlling the extent of the pro- and anti- 
inflammatory cytokine reaction to heat stress are enhanced by heat acclimation 
(Kuennen et al., 2013). 
Cytokines have been shown to contribute to thermoregulation and heat stroke 
development via fever, leucocytosis, leukocyte activation, and stimulation of the HPA 
axis (Heled et al., 2013; Rav-Acha et al., 2004). However, the role of cytokines in the 
pathophysiology of heat illnesses is complex (Figure 4.). Increases in the production of 
both anti- and pro-inflammatory cytokines and the activation of several pathways 
belonging to physiological and biochemical processes have been highlighted in 
hyperthermia (Heled, Fleischmann, and Epstein, 2013). Current knowledge is 
summarised in Fig. 4.  
 
     
Fig. 4. Proposed roles of cytokines in hyperthermia and heat stroke, (Heled et al., 2013). T core, core body 
temperature; BBB, Blood-brain-barrier; CVP, Central venous pressure. 
	  
	  
48	  
2.4.6. Considerations on the effect of exercise on innate and adaptive immune function 
With regard to exercise-induced changes in innate immune function and how this relates 
with EHI and EHS, there is evidence to show how febrile response to LPS injection was 
nullified in test-rodents previously dosed with anti-IL-6 antibodies (Rummel et al., 
2006). Furthermore rats injected with an IL-1 receptor antagonist had an increase rate 
of survival following experimentally induced heatstroke (Chiu et al., 1996). Another 
study clearly shows how exercise has a pyrogenic effect of similar magnitude to fever. 
For example, human plasma taken from subjects post-exercise induced fever in rodents, 
in contrast to pre-exercise plasma which did not. This indicates an exercise response, 
and not an allergic or immune response (Cannon and Kluger, 1983). A later study 
showed that doping human subjects with the cyclooxygenase (COX) inhibitor rofecoxib 
over a six day period, curtailed body temperature increase during prolonged exercise, 
which indicates that the prostaglandin-mediated inflammatory processes might 
exacerbate exercise-induced caused heat strain (Bradford et al., 2007). This prompted 
the proposition of an additional pathway in the development of EHI. This would involve a 
systemic inflammatory response (Bouchama, 1995; Lim and Mackinnon, 2006), with 
increased pyrogenic cytokines (e.g. IL-1β, IL-6 and TNF-α), which might in turn push the 
individual towards EHI and/or EHS (Walsh et al., 2011 a). Hence, it remains unclear 
whether EIMD increases heat strain during subsequent exercise heat stress, which in 
turn may increase the risk of EHI. As mentioned, it is well known that exercising muscle 
releases the inflammatory cytokine IL-6, and it has been demonstrated that EIMD elicits 
a greater circulating IL-6 response than non muscle-damaging concentric exercise. 
Therefore, it is plausible that EIMD and associated inflammation (increase in circulating 
pyrogenic cytokines) might increase heat strain at least in the short-term during 
subsequent exercise heat stress. 
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2.5. Heat Shock Proteins  
In consequence to exposure to physiological stressors a challenge to homeostasis at the 
cellular level is posed, and this stimulates an increase in the expression of Heat Shock 
Proteins (Hsp). Although many studies have focused on the function of intra-cellular 
Hsp72 after exposure to acute stressors, such as exercise or extreme environments, 
little is known about the potential function of endogenous extra-cellular Hsp72 (eHsp72). 
What is known is that although eHsp72 might be a not widely recognized feature of the 
stress response, it may function as an endogenous “danger signal” for the immune 
system. Therefore, this allows a reaction and an adaptation to the new challenge the 
body is facing.  
These molecules have a cytoprotective effect, indeed to maintain cellular homeostasis 
they act as molecular chaperones. In addition, they are also involved in the immune 
response modulating the inflammatory response following a stress (Horowitz et al. 
1996). There is also evidence that Hsp72 is a marker of heatstroke risk (Pavlik et al., 
2003; Westman and Sharma, 1998; Yang et al., 1998). Therefore it is of interest of the 
present thesis to investigate its role during exercise-heat stress and the subsequent 
effect on thermoregulation. Indeed, it could be suggested that Hsp might act as a link 
between the peripheral inflammatory response following eccentric-exercise and the CNS 
that regulate core body temperature. Hsps are characteristically divided into super-
families based on their function, structure and molecular weight (Feige and Polla, 1994; 
Park et al., 2000; Westman and Sharma, 1998).  
2.5.1. Heat Shock Protein 72 (Hsp 72) (Chapter 6) 
Heat shock protein 72 is an inducible isoform of 70kDa of molecular weight.  
Indeed, Hsp72 release depends on the Heat Shock Element (HSE) in the promoter region 
of the Hsp gene binding heat shock transcription factor-1 (Pirkkala et al., 2001). After 
Hsp72 mRNA transcription, Hsp72 protein synthesis starts (Kregel and Moseley, 1996). 
Expression of intracellular Hsp72 is the result of many signals such as ACTH (Blake et 
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al., 1991; Blake et al., 1994), corticosterone (Cvoro and Matic, 2002; Valen et al., 
2000), catecholamines (Heneka et al., 2003; Matz et al., 1996; Matz et al., 1996), 
glycogen depletion (Febbraio et al., 2002; Santoro, 2000), oxidative stress (Calabrese et 
al., 2001; Wallen et al., 1997) and heat/hyperthermia (Cvoro and Matic, 2002; King et 
al., 2002; Kregel and Moseley, 1996; Redaelli et al., 2001; Thomas et al., 2002) .  
 
Studies have shown that stressors of exercising muscle (e.g. acidosis, increased 
temperature, free radical formation, ischaemia and glucose deprivation) induce an 
increase in intracellular Hsp72 (Salo et al., 1991; Skidmore et al., 1995; Zhou et al., 
1997; Omatsky et al., 1995; Vesely et al., 1998; Martinez et al., 1999). Furthermore, 
exercise itself increases Hsp72 in many central and peripheral tissues (Walsh et al., 
2001). This evidence suggests that exercise might affect the extracellular expression of 
Hsp72 (Febbraio et al., 2002; Fleshner and Johnson, 2005; Walsh et al., 2001; Yamada 
et al., 2008), because Hsp72 had been demonstrated in vitro to have potential immuno-
stimulatory capabilities (Asea et al., 2000; Prohaszka et al., 2002; Wang et al., 2005).  
Hsp72 has been detected in the circulation of humans (Pockley et al., 1998). It has been 
hypothesized that an acute bout of exercise would increase Hsp72 protein expression in 
contracting skeletal muscle, which would then be released into the extracellular 
environment, increasing the concentration of serum Hsp72. A study by Walsh et al. 
(2001) showed that after an acute-exercise bout serum eHsp72 was elevated, but the 
increase preceded the increase in mRNA and protein Hsp72 synthesis within the muscle 
tissue. This led to the conclusion that muscle cells were not responsible for the 
extracellular release of eHsp72. Further studies have corroborated this using different 
protocols (Marshall et al., 2006; Johnson et al., 2006). Studies have demonstrated that 
eHsp72 responses were dependent on the intensity and duration of exercise (Fehrenbach 
et al., 2005); therefore, demonstrating that exercise results in an increase in 
extracellular Hsp72 in humans.  
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2.5.2. Mechanism, releasing signal and origin of extracellular Hsp72 
Many questions, however, have been raised about the possible mechanism, releasing 
signal and origin of extracellular Hsp72 release, and the biological significance of Hsp72 
in the extracellular environment. Given that eHsp72 has been measured in interstitial 
space and in body periphery, something (e.g. cell, organ) must release it. Two 
mechanisms might, potentially, be involved; (1) Hsp72 is passively released from an 
intra-cellular pool following cellular lysis, or death, and (2) a receptor-mediated 
exocytotic pathway actively releases Hsp72 (Asea, 2007; Fleshner and Johnson, 2005). 
A further plausible explanation for Hsp72 presence is that it is co-ordinating further 
molecules, which the cell excreted/secreted (Prohaszka and Fust, 2004). Other studies 
suggest that Hsps are only released under pathological circumstances (Gallucci et al., 
1999). Either way, this results in necrotic death rather than controlled apoptotic cell 
death (Kroemer et al., 2005). Some in vivo evidence links elevated eHsp72 with muscle 
damage markers.  
One study on runners showed that heavy/repeated footfall damages erythrocytes 
(Gromov and Celis, 1991), and this might help towards elevating eHsp72. Indeed, 
exercise duration and the consequent induced muscle-damage, seems a principle 
elevator of eHsp72 (Fehrenbach et al., 2005). However, a direct correlation between 
eHsp72 levels and markers of muscle damage has not been shown in literature. 
Moreover, downhill running and running on a level gradient reported similar Hsp72 levels 
(Peake et al., 2005).  
The fact that Hsp72 is released into the peripheral circulation within 10-30 minutes of 
stressor onset suggests that necrosis is not the only factor involved in such a big 
increase (Fleshner and Johnson, 2005). Indeed, 30 minutes is not enough time for the 
protein induction pathway, and moreover it is unlikely that such a large number of cells 
would simultaneously die through necrosis. Whilst a passive release through necrosis 
may be an important mechanism in pathological circumstances and trauma (da Rocha et 
al., 2005; Pittet et al., 2002), the fact that psychological stressors, such as predatory 
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fear and threat of electric shock, evoke a stress-induced eHsp72 release adds further 
evidence to the suggestion that a pathway other than necrosis is evident (Fleshner et 
al., 2004; Fleshner et al., 2003; Johnson et al., 2005). In particular, an active release 
mechanism for Hsps in the absence of lysis was demonstrated by stimulated cultured rat 
embryo cells that released a number of heat shock proteins. More recently, glia-like cells 
have been shown to actively release Hsp70 upon heat shock in vitro, prompting recent 
investigations into the mechanism of this selective exocytic release. It has been 
demonstrated that the presence of Hsp72 within plasma membrane detergent-resistant 
micro domains of epithelial cells increased significantly when exposed to heat shock. 
Recently, much interest has revolved around the role of exosomes in the selective 
release of Hsp72 (Clayton et al., 2001). Much of this interest is based on findings that 
exosomes contain many immuno-stimulatory molecules, such as major 
histocompatibility complex (MHC) I and II, co-stimulating molecules and adhesion 
molecules, suggesting that exosomes could provide an exocytic pathway for other 
potential immune-stimulatory molecules, such as Hsp72 (Johnson et al., 2006), and are 
small membrane-bound vesicles that are secreted by a number of eukaryocytes as the 
consequence of a fusion of multivesicular bodies with the plasma membrane (Denzer et 
al., 2000). Exosomes are released by many haemopoietic cells following changes in 
intracellular calcium levels (Savina et al., 2003). Hsp72 has been detected within 
exosomes in a variety of cell types, although it appears that cellular specificity exists 
with regard to exosomal Hsp72release/expression (Clayton et al., 2005). Whilst the 
supporting evidence to date suggests that the majority of Hsp72 is actively released via 
an exocytic pathway into the circulation from cells under times of stress, it is likely that 
exosomes/lysosomes are involved, although further research is needed to clarify the 
factors involved in Hsp72 release.  
Exercise is a stress that tends to disrupt homeostasis inducing a multitude of 
physiological changes.  In addition, these physiological changes are known to increase 
the concentration of intracellular Hsp72, providing a plausible answer to “What triggers 
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the specific release of eHsp72?”. The term heat shock protein clearly elicits heat as the 
main stimulator of the Hsp response. Indeed, using an isolated working heart model at 
different temperatures (Staib et al., 2007), it has been implied that elevated 
temperature was a requirement for myocardial Hsp72 expression and might be 
concluded that HSF-1, which regulate Hsp72 synthesis, is activated by temperature 
(Ruell et al., 2006). However, it is still unclear if heat stress increases Hsp72 into the 
extracellular environment.  
Whitham and Fortes, using an elegant model, which involved a thermal clamp protocol 
have studied the independent and combined effects of exercise and increased core 
temperature on eHsp72 (2008). The greatest eHsp72 increase was the result of 
combined exercise and increases in core temperature, although it must be mentioned 
that passive heating alone induced significant eHsp72 responses (Ruell et al., 2006). 
Therefore, the increases in eHsp72 during exercise are not just induced by increases in 
core temperature.  
2.5.3. Other factors involved in the eHsp72 response 
The eHsp72 response is clearly complex. Prolonged exercise decreases muscle glycogen 
and blood glucose. Inadequate refuelling directly leads to an increase in glycogenolysis 
within the liver and skeletal muscle which maintains blood glucose levels (Coyle et al., 
1986). The liver releases a great deal of acute phase proteins, and it was therefore 
postulated that Hsps may originate there. Evidence supporting the described process 
stems from studies which used arterial-venous difference cannulation techniques 
(Febbraio et al., 2002). These evidenced significant Hsp72 release during cycling, from 
the hepatosplanchic viscera (Febbraio et al., 2002). Furthermore, this release was 
diminished following recent glucose ingestion therefore, researchers concluded that 
glucose ingestion reduces hepatic production (Febbraio et al., 2004; Jeukendrup et al., 
1999). Further evidence that blood glucose may regulate eHsp72 production abounds in 
the literature (Krause et al., 2015; Keane et al., 2015).  
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Exercise challenges cellular integrity by releasing increased levels of ROS and reactive 
nitrogen species (RNS). ROS have been shown to induce Hsp expression in lymphocytes 
(Marini et al., 1996). The findings showed that heat, glucose availability and oxidative 
stress play significant roles in generating an eHsp72 exercise response (Fischer et al., 
2006). These studies failed, however, to demonstrate a clear cause and effect 
relationship. Any association might, therefore, be mediated by a different signal, 
particularly should an active exocytic pathway be the release mechanism from the cell. 
Campisi et al. (2003) suggested that eHsp72 could form part of the normal stress 
response. Hence it would seem plausible for eHsp72 release to be mediated by a signal 
associated with the HPA or the SAM axis, particularly since many stress-induced signals 
originate in the anterior pituitary.  Also, adrenal glands were shown to increase the 
intra-cellular concentration of Hsp72 (Matz et al., 1996). Studies that utilised 
adrenalectomy, hypophysectomy and adrenergic receptor blockade to induce eHsp72 in 
animal subjects, suggested a probable catecholamine connection.  
One hypothesis states that under times of stress, calcium flux within the cell is 
precipitated by increased noradrenaline acting on α-adrenergic receptors and, 
subsequently, Hsp72 is released in exosomes, since intra-cellular calcium affects them 
(Johnson and Fleshner, 2006). Furthermore, one mouse study measured the release of 
eHsp72 by noradrenaline stimulation of α-adrenergic receptors, but there is relatively 
little human research to date (Fleshner et al., 2003). Since catecholamines possibly 
stimulates eHsp72 release, it is also possible that any sympathetic nervous system 
stimulation could stimulate eHsp72. This could be shown by psychologically stimulating a 
subject during exercise to induce a greater cardiovascular response. Psychological stress 
has been proven to stimulate eHsp72 in animals (Fleshner et al., 2004), which would 
suggest that heightened mental stress during exercise might have an additive effect in 
inducing a greater eHsp72 response.  
Studies on post-operative anaesthesia and curarization, which essentially block or reduce 
peripheral tissue afferent feedback, suggest a central command contribution in 
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sympathetic activity (Kjaer et al., 1989; Pawelczyk et al., 1997). This would provide a 
potential mechanism by which central drive could stimulate eHsp72, independent of 
afferent feedback.  Further evidence shows that immune and epithelial cells can release 
Hsp72 into extracellular environments (Broquet et al., 2003). It would also be worth 
investigating whether there are any other tissue sources of eHsp72 during exercise. One 
concept skeletal muscle is highly active during exercise, and exercise-induced 
intracellular Hsp72 response has been widely demonstrated, which appears to present 
skeletal muscle cells as an additional generator of eHsp72. While this could be true, the 
appearance of eHsp72 preceded the increase in skeletal muscle Hsp72 mRNA and 
protein concentration in exercising humans, as already mentioned (Walsh et al., 2001). 
Further to this, eHsp72 was not detected after 4-5 hours of knee extensor exercise at 
40% maximal leg power output in a muscle glycogen depleted state (Febbraio et al., 
2002).  
In conclusion, it might be said that Hsp72 is partly released by muscle damage. 
Additionally, cannulation studies revealed a possible Hsp72 release in the brain after 180 
minutes of cycling at 60% VO2max, albeit the response demonstrated significant subject 
specificity. Considering the involvement of sympathetic activation in Hsp72 expression 
(Johnson et al., 2005), it can be plausibly suggested that Hsp72 could be released by 
any tissue served by the sympathetic nervous system. 
2.5.4. Potential functions of Hsp 72 
A deeper understanding of the signalling mechanisms behind intracellular and 
extracellular Hsp72 expression becomes more urgent when one considers the potential 
roles played by Hsp on immune system function, and vice versa (Srivastava et al., 
1986). Initiating an intracellular Hsp leads to stress tolerance and protection against 
otherwise potentially lethal stressors. It has been previously suggested that Hsp72 has a 
role to play in the protection of immune cells operating in stressful inflammation 
environments (Campisi et al., 2003; Breloer et al., 1999). 
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It has been also shown that Hsp72 demonstrates higher responses to heat shock in 
phagocytic leukocytes than in other immune cell types (Oehler et al., 2001), and this 
increase was attributed to the observation that phagocytes mainly produce reactive 
oxygen species. Pursuant to this, the resting and post exercise concentrations of eHsp72 
initially decrease during heat acclimation (Marshall et al., 2006) and that leads to the 
conclusion that there is an increased cellular uptake of eHsp72 which improves stress 
tolerance to any subsequent heat exposure. So Hsp72 may, in trying times, protect cells 
from external stressors and also from cytotoxicity of the immune system itself. It would 
be fascinating to understand whether eHsp72 could be taken up by distant cells that 
might be undergoing stress and/or are incapable of inducing Hsp72 by themselves. To 
present one idea; motor neurons contain basal Hsp72, but are incapable of synthesizing 
it following heat shock (Whitham and Fortes, 2008). One study administered an 
exogenous application of Hsp72 to a motor neuron cell culture and this enhanced post 
heat shock motor neuron survival (Robinson et al., 2005). Glial cells also release Hsp72, 
and since they are in close proximity to motor neurones their production could bolster 
the stress tolerance of their neighbours (Guzhova et al., 2001). This attribute of Hsp72 
could lead to innovative treatment for exertional heat illness, particularly heat stroke. 
Whilst many cell types are known to release Hsp72, eHsp72 must bind to a receptor, 
thereby precipitating an event cascade resulting in the initiation of an immune response. 
For example, leukocytes and NK cells have been shown to bind with eHsp72 (Asea et al., 
2000; Asea, 2006; Sondermann et al., 2000) and certain pattern recognition receptors 
(PRR’s) have been shown to exhibit cytokine-like eHsp72 of actions (Asea, 2006). Some 
argue that since Hsp72 could bind with the plasma membrane of human monocytes that 
this could cause intracellular calcium flux, that concordantly results in up-regulation of 
the inflammatory cytokines TNF-α, IL-1β, and IL-6. It has also been shown that Hsp72 
activates the complement cascade, independent of antibodies (Markievski et al., 2007). 
One molecule, the Cluster of Differentiation 14 (CD14), is a co-receptor for LPS detection 
expressed by macrophages, and has been shown to induce pro-inflammatory cytokines 
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via eHsp72. Consequentely, a bacterial activation of CD14 might lead to an eHsp72-
initiated up-regulation of innate immunity (Asea et al., 2000). Since Hsp72 binds to and 
then stimulates CD40+ cells (e.g., macrophages and B cells) this could be through a co-
stimulatory pathway which would consist of an interaction between CD40 on PAC and 
CD40L on T cells (Caux et al., 1994). Accordingly, Hsp72, it is postulated, could have a 
contributory role in the interphase between innate and adaptive immunity.  
 
2.6. The pathophysiology of heat stroke (Chapters 5 and 6) 
Humans maintain their body core temperature within a narrow range. Consequently, 
when body temperature becomes higher, clinical failure may quickly develop (Hales et 
al., 1996; Horowitz and Hales, 1998). Heat illness represents a family of disorders 
ranging in severity from temporary and mild to fatal, depending on a variety of factors 
and the presence of hyperthermia (Sawka et al., 2011). Together these factors affect the 
magnitude and rate in the rise of body temperature, by interfering with the homeostatic 
control systems that regulate temperature (Hales et al., 1996). Nevertheless, the 
cascade of pathophysiological consequences is similar in all cases, with the critical factor 
in the development of heat stroke being the inability to sustain circulatory function 
(Hales et al., 1996; Horowitz and Hales, 1998). Indeed, cardiovascular activity 
transports heat to the body surface, while perfusing all tissues at a rate adequate to 
meet their metabolic demand. For example, during mild heat stress, body surface blood 
flow is elevated, without impairing the blood supply to other tissues. As the heat load 
increases, skin blood flow is further augmented and profuse sweating occurs. This 
increases peripheral blood volume, concurrently, the enhanced evaporation decreases 
total blood volume and causes a depletion of central blood volume. In turn, this reduces 
central venous pressure, which diminishes skin blood flow and volume, as well as 
evaporative cooling via low-pressure baroreceptors. These factors in conjunction, may 
lead to hyperthermia as blood maintenance becomes difficult, as the thermoregulatory 
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demands conflict with blood pressure regulation requirements. This conflict may result in 
physiological breakdown and heat stroke syndrome development.  
Body temperature control is considered secondary compared to cardiovascular need. 
Severe body hyperthermia is supplemented by cellular/molecular changes resulting in a 
potentially fatal cascade of events, including cerebral hypoxia, neural dysfunction and 
hypotension 	  (Hales et al., 1996; Horowitz and Hales, 1998). Many studies have focused 
on experimental animal models, as well as case reports of humans suffering from heat 
stroke or post-mortem examinations. Substantiated causal relationships between 
elevated circulating plasma cytokines (Leon et al., 2006), brain cytokines and 
monoamines (Kao et al., 1994; Lin, 1999) have all been suggested in the 
pathophysiology of this syndrome (Bouchama, 2006; Bouchama and Knochel, 2002). 
2.6.1. Hsp 72 as marker for Heat Stroke risk (Chapter 6) 
The assertion that Hsp72 is a marker of heatstroke risk is based on studies 
demonstrating that a severe diffuse loss of Purkinje cells is associated with Hsp70 
expression in heat stroke victims (Bazille et al., 2005), and that a marked elevation in 
inducible Hsp70 is found in CNS tissues in response to heat stress and hyperthermia 
(Pavlik et al., 2003; Westman and Sharma, 1998; Yang et al., 1998). Animal studies 
have also shown increased Hsp70 in extracellular space during heat stroke (Dehbi et al. 
2010).  
This protein protects nascent and unfolded proteins and further protects against tissue 
damage (Hausenloy and Yellon, 2006; Reshef et al., 1996), therefore, this protein is 
considered to be a reliable biomarker for stress. Indeed, many studies evidence that 
thermal preconditioning (leading to the overexpression of Hsp70) delays heat stroke 
induced by cerebral ischaemia and hypotension (Yang et al., 1998). The neuroprotective 
role of Hsp70 has been tested in many stress conditions (Welch, 2001; Yenari, 2002). 
However, whether HSPs have additional functions beyond their chaperoning abilities or if 
they mediate physiological processes through cellular safeguarding is an important 
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unanswered research question. It is based on the observation that thermal 
preconditioning, in contrast to ischaemic preconditioning, induces the “Second Window of 
Protection” (SWOP) in cardio protection, suggesting that SWOP and heat stress have 
distinct protection mechanisms and that they might not be exclusive to Hsp72 
expression (Qian et al., 1999).  
There have been suggestions that Hsp70 potentiates the baroreflex response by acting 
on the Nucleus Tractus Solitarii (NTS) (Li et al., 2001), i.e. the baroreceptor afferent 
fibres. Li and colleagues (2001), demonstrated the Hsp70 levels in the NTS further 
enhanced the sensitivity of both the sympathetic and parasympathetic arms of the 
autonomic nervous system, and this mollified heat stroke induced cerebral ischaemia 
and hypotension. The opposite effect was seen when microinjections of anti-Hsp 
antibodies were applied to the NTS before thermal preconditioning.  The same authors 
observed a threshold level of Hsp expression in the NTS had to be overcome to activate 
the baroreflex response.  
These observations support the concept that thermal preconditioning and increased 
Hsp72 are fundamental to preserving synaptic transmission during thermal stress (Kelty 
et al., 2002). Since Hsp is absorbed by neurons it can control transmitter release by 
interacting with a variety of intracellular proteins (Jiang et al., 2000; Ohtsuka and 
Suzuki, 2000).  One might conclude that Hsp72 protects the organism by multiple 
functions and direct interaction with autonomic neuronal networks. The interaction is not 
completely understood, but molecular pathways associated with synaptic transmission 
have been mooted. It has been also hypothesized that cell integrity is important to this 
process (Chamber et al., 2013). 
2.6.2. Immune system and Heat stroke: Is there any link? 
Recently, the debate on whether or not the immune system is involved in the aetiology 
of EHS has gathered pace (Muldoon et al., 2004; Muldoon et al., 2008). Unlike milder 
EHI, EHS is a life-threatening acute heat illness characterised by hyperthermia and 
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neurological abnormalities that can develop after exposure to high ambient temperature 
and humidity (Figure 5.). 
 
 
 
Fig. 5. Summary of Exertional Heat Stroke (EHS) pathophysiological responses ending in multi-organ system 
failure. In exercise-induced heat stress, an increase is observed in cutaneous blood flow and decrease in 
splanchnic blood flow. Gut epithelial membrane ischemia induces oxidative and nitrosative stress and this 
increases tight junction permeability and allows endotoxins to leak into the systemic and portal circulation. 
Toll-like receptors (e.g., TLR4) meet pattern-associated molecular patterns (PAMPs) on the cell membrane and 
stimulate pro- and anti-inflammatory cytokine production. Heat is toxic to many organs and this stimulates 
heat shock proteins (HSPs) secretion. These interact with cytokines and other proteins to lessen the systemic 
inflammatory response syndrome. A shift in the cytokine populations from an anti-inflammatory (Th2) to a pro-
inflammatory (Th1) balance (i.e. anergy) is thought to mediate heat stroke symptoms that lead to multi-organ 
system failure and death (Sawka et al., 2011). 
 
 
There is evidence of the involvement of immune system in the aetiology of EHS (Sawka 
et al., 2011; Lim and Mackinnon, 2006; Shephard and Shek, 1999) (Figure 5.). Indeed, 
exercise heat stress can cause a redistribution of blood flow which can lead to 
gastrointestinal ischaemia. That in turn results in damage to the intestinal mucosa and 
leads to the unwelcome LPS in the portal circulation (Figure 5.). The LPS is neutralised 
by the liver and then by monocytes and macrophages. However, these may be 
insufficient, resulting in increased concentrations of LPS in peripheral circulation. This 
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process may be exacerbated by heavy training where immune function is impaired 
(Bosenberg et al., 1988; Camus et al., 1997). 
Many events are associated with LPS binding to protein; the transfer of LPS to its 
receptor complex (Toll-like receptor 4), subsequent nuclear factor-kappa B activation, 
and the translation and production of inflammatory mediators, including interleukins IL-
1β, TNF-α, IL-6 and inducible nitric oxide synthase (Selkirk et al., 2008). These events 
can lead to systemic inflammatory response syndrome, intravascular coagulation and 
eventually multi-organ failure. This is an attractive model, particularly for cases of EHS 
that are otherwise difficult to explain, because the pyrogenic cytokines can alter 
thermoregulation and cause cardiovascular instability resulting in collapse of the athlete 
or soldier (Bosenberg et al., 1988; Bouchama et al., 1991; Camus et al., 1997; Walsh 
and Whitham, 2006). 
It is likely that the more traditional predisposing factors for EHS, such as high heat load 
and underlying illness, alongside a possible muscle defect causing excessive endogenous 
heat production, play a more prominent role in EHS aetiology than immune 
dysregulation (Rav-Acha et al., 2004). Immune dysregulation might have a role to play 
in the aetiology of a small number of EHS cases that remain to be explained by more 
traditional predisposing factors (Rae et al., 2008). These considerations provide part of 
the rationale of the present thesis. Indeed, the effect of EIMD upon heat strain during 
subsequent exercise in the heat has been studied to clarify the role of inflammation on 
thermoregulation. 
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2.7. Cold stress and Immune function (Chapter 4) 
It is of interest for exercise immunologists to have a better understanding of the effects 
of cold exposure on immune function and URTI incidence (Castellani et al., 2006). There 
is still a debate on whether cold exposure with or without exercise increases 
susceptibility to URTI and leads to immune function depression. 
In a cold environment, any attempt by the body to maintain core temperature may be 
insufficient, consequently shivering thermogenesis and peripheral vasoconstriction begin 
(Castellani and Rhind, 2002). SAM and HPA axis lead these responses, which also have 
effects on the immune system; therefore, it conceivable to think that the immune 
system may also be affected. Evidence shows that peak infection and illness typically 
occur in the coldest times of the year and last longer. However, it must be noted that 
most of these epidemiological reports did not establish that cold exposure was the cause 
of URTI, as many other stressors were likely to have been present (Makinen et al., 2009; 
Shephard and Shek, 1998; Whitham et al., 2006). 
Makinen and colleagues (2009), has recently provided evidence for a link between low 
ambient temperature and increased URTI. Indeed, a study on 892 Finnish military 
conscripts indicates that URTI, including the common cold, were preceded by three days 
of declining ambient temperature and humidity (Makinen et al. 2009). More compelling 
evidence indicates that patients who become cold during surgery suffer greater surgical 
wound infection post operation (Kurz et al., 1996). Further, URTI symptoms were more 
than doubled in the 4-5 days after people had their feet immersed in cold water for 20 
minutes compared with non-chilled controls (Johnson and Eccles 2005). Consequently, 
decreased immune function with repeated cold exposure could be a mechanism which 
may partially explain for the increase in infection reported by athletes and soldiers 
during winter months. 
Hypothermia is defined as core body temperature of less than 35 °C, and it is 
uncommon in athletes due to the metabolic heat produced while exercising, nonetheless 
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it has been reported in cold-water swimmers or hill walkers (Pugh et al., 1967). Indeed, 
hypothermia is more frequent in some active occupational populations exposed to cold 
air and cold water during recreational or professional activities (e.g. military personnel, 
hikers and outdoor enthusiasts) (Beeley et al., 1993; Brannigan et al., 2009; Giesbrecht, 
2000; Keatinge et al., 2001; Nuckton et al., 2000). 
A limited number of investigations (Brenner et al., 1999; Costa et al., 2010) have 
studied the effect of modest core temperature reduction  (0.5-1 °C) on leukocyte cell 
trafficking and function in humans, and findings showed leukocytosis that lasted for two 
hours after cooling. In particular, an increase in neutrophils and a simultaneous decrease 
in lymphocytes were reported. This modest rise in neutrophils may be attributed to 
demargination of leukocytes from the blood vessel walls as a result of increased cardiac 
output and catecholamine action. Moreover, these studies reported that natural killer cell 
activity (NKCA) remained unaltered, but saliva secretory Immunoglobulin-A (SIgA) 
secretion rate, lymphocyte function and neutrophil function were all reduced (Beilin et al., 
1998; Brenner et al., 1999; Costa et al., 2010; Wenisch et al., 1996). Furthermore, it 
has been suggested that mild hypothermia can disrupt circulating immune function 
(LaVoy et al., 2011), which may partly explain the increased infection in cold exposed 
athletes and soldiers. A limitation of this research is that the studies were focused on 
patients undergoing surgery and might not be applicable to a healthy population, 
additionally a thermo-neutral control trial was not performed and therefore any effect of 
diurnal variation cannot be excluded. 
Because cold exposure causes an increased energy requirement, cold-induced diuresis 
and a blunted thirst response (Pugh et al., 1967), then a negative energy balance and 
dehydration, are more likely to affect those exercising and training in the cold. Physical 
activity in cold air versus thermo-neutral conditions has been shown to have minimal 
effect on mucosal immunity (Walsh et al., 2002). A limitation of this study, in the 
present context, is that data provided by Walsh and colleagues (2001) were collected 
after cold air exposure but core body temperature was not measured and it was also 
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unlikely to be decreased due to the metabolic heat produced whle exercising. However, 
there is limited evidence to support that exercising in cold air compared with thermo-
neutral conditions decreases mucosal immune function. Another plausible explanation for 
the increased URTI, is the decreased epithelial barrier function caused by upper airway 
drying from breathing cold air during exercise (Giesbrecht, 1995). Indeed, cold exposure 
leads to decreases in nasal respiratory epithelium temperature and reduces mucocilliary 
clearance of pathogens. Further evidence was provided by Tomasi and colleagues (1985) 
who studied secretory IgA levels in nationally ranked Nordic skiers before and after the 
national cross-country races held. Comparing the skiers with age-matched controls, 
there was significantly lower level of salivary IgA before the race. Concentrations of IgA 
decreased further following the competition to very low levels (Tomasi et al., 1985). 
Furthermore, low skin temperature and subsequent cold-induced peripheral 
vasoconstriction may impair whole body peripheral immune cell trafficking and function 
(Webb, 1992). This could be even greater with an existing open wound. Indeed, wound 
healing is slower and infection higher in patients that become hypothermic during 
surgical operations (Kurz et al., 1996). 
Another important factor that must be taken in account is the increased time spent in 
close contact with others during winter months that can increase pathogen exposure, 
and may therefore explain the increased reported URTI. This factor has been highlighted 
as a cause for increased infection for more than 80 years (Hill and Cobbold, 1929). 
Whether crowding is really greater in winter compared with summer has not been 
demonstrated yet. In summary, cold exposure is associated with a greater incidence of 
URTI in active populations. The mechanism responsible for the increased URTI, however, 
remains elusive and may not be related to a reduced immune function (Eccles, 2002).  
While the clinical significance of cold/exposure induced immune function impairment is 
yet to be clarified in healthy individuals, there are indications that decreases in 
neutrophil function, saliva IgA and other antimicrobial proteins have been have been 
linked to an increased incidence of infection in otherwise healthy and active subject, in a 
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wealth of clinical trials (Smitherman and Peacock, 1995; Fahlman and Engels, 2005; 
Gleeson et al., 1999; Gleeson et al., 2013; Gleeson et al., 2011). On numerous 
occasions the individual contributions of these agents have been conferred a high level 
of clinical relevance (Albers et al., 2005; Walsh et al., 2011). Associations between URTI 
and other blood and salivary immune agents are yet to be extensively examined. 
Additionally, dysregulation of interferon-gamma (IFN-γ) production (a cytokine which 
has important anti-viral and immunomodulatory roles) was found for illness prone 
athletes, with normal function in regularly robust athletes (Gleeson et al., 2011). These 
‘first line of defence’ chemicals form an innate part of immune system and a disruption 
by cold exposure could result in increased URTI. More research is required as to whether 
a decrease in innate immune function results from hypothermia or whether this is a 
consequence of extreme metabolic responses to the adverse/cold environment. These 
responses (or similar ones) could be attributed to moderate physical exercise. 
To date it is unknown whether the high incidence of infection cases in the studies above 
stem from a cold-induced immune-function suppression. As already mentioned, cold 
exposure responses (e.g. shivering thermogenesis or peripheral vasoconstriction) are 
regulated by the sympathetic nervous system (SNS) and hypothalamic-pituitary-adrenal 
(HPA) axis, which are also instrumental in modulating the immune system (Costa et al., 
2012). It would therefore follow that cold exposure might result in impaired immune 
function due to increased stress hormones (cortisol and catecholamines) which are 
released by the SNS and HPA axis during a thermoregulatory feedback process. 
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2.8. Exercise-Induced Muscle Damage (EIMD): mechanism, measures and 
consequences (Chapters 5 and 6) 
In 1902, Hough first suggested that delayed onset muscle soreness (DOMS) was a 
consequence of micro-lesions in the muscle (Hough, 1902). For the next 9 decades, the 
study of muscle damage and muscle soreness received little attention, with only a few 
studies published. However, the interest in exercise-induced muscle damage (EIMD) has 
risen, with more than 100 studies conducted on humans. Most of the studies used 
eccentric actions of isolated muscle groups or exercises that are biased toward eccentric 
action, because it is well documented that eccentric actions result in muscle damage. 
An additional EHI development pathway has been proposed which involves a systemic 
inflammatory response, with increased pyrogenic cytokines (e.g. IL-1β, IL-6 and TNF-α) 
that might accelerate progression towards EHI and/or EHS. It has been proven that 
exercise has a pyrogenic effect similar to fever. 
It remains unclear whether EIMD increases the heat strain experienced during 
subsequent exercise-heat-stress, which may in-turn increase the risk of EHI. 
2.8.1. Assessment of muscle damage 
Muscle biopsies or magnetic resonance imaging (MRI) are the only ways to directly 
assess muscle damage in human skeletal muscle. These techniques both present 
limitations, for example muscle biopsy uses a small sample to estimate damage in an 
entire muscle, and imaging techniques present images that are not stationary. Due to 
these limitations indirect measures to assess damage have been developed. The three 
most commonly used indirect damage markers on humans are; (1) a subjective 
determination of muscle soreness (63% of studies), (2) blood protein assessment (52% 
of studies), and (3) maximal voluntary contraction force (50% of studies) (Warren et al., 
1999). 
In 1981, some of the first evidence of muscle fibre damage in humans after exercise was 
provided using biopsies (Friden et al., 1981), and this was later confirmed by a follow-up 
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study (Friden et al., 1983). The percentages of damaged muscle corresponded to 1.6%, 
2.4%, and 0.6% of the fibre area, with disturbances predominantly occurring in Type II 
fibres. The greater damaged was observed immediately after exercise, compared with 
samples taken 24-48 hours after exercise cessation (Friden et al., 1983; Newham et al., 
1983). In contrast, the effect of multiple biopsies taken over a period of seven days in 
control subjects and subjects who performed eccentric exercise was measured, showed 
both conditions resulted in similar changes in infiltrating neutrophils and macrophages 
(Malm et al., 2000; Roth et al., 2000). Consequently, the biopsy procedure itself can 
produce some changes. There is evidence from human trials that the initial bump of the 
exercise creates a jolt to fibres, which results in damage to the extracellular matrix and, 
possibly, capillaries. This activates an inflammatory response, which may be part of the 
repair and regeneration process. 
Between indirect assessment methods, prolonged strength loss after eccentric exercise is 
considered to be one of the most valid and reliable measures of muscle damage in 
humans (Warren et al., 1999). Metabolic and neural fatigue strength losses (Edwards et 
al., 1977) immediately after exercise are restored quickly, with strength returning to 
baseline within hours after exercise (Jones et al., 1989; Newham et al., 1983). 
2.8.2. Differences between exercise protocols 
The main differences between concentric protocols and eccentric-biased downhill running 
protocols are a longer recovery period (up to 24 h post-exercise for eccentric exercise) 
with a comparable 10-30% force loss immediately after exercise (Eston et al., 1996; 
Eston et al., 2000; Mizrahi et al., 2001). Longer recovery time and higher degrees of 
strength loss are associated with high-force eccentric exercise (Clarkson and Newham, 
1995) that can often generate up to 50-65% loss of force-generating capacity (Newham 
et al., 1987; Nosaka et al., 1991; Saxton et al., 1995). Prolonged force loss in the days 
after eccentric exercise can typically last between 1 and 2 weeks (Armstrong, 1990; 
Lieber and Friden, 1993), as a result of the initial damage and additional damage during 
the regeneration process. 
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Mechanical muscle strain has been shown to be a principle causes of EIMD. Mechanical 
muscle strain is when a muscle is lengthened beyond 140% of its optimum length during 
eccentric contractions. This both decreases its force production capacity post exercise 
and increases subsequent muscle injury (Faulkner et al., 1993). Human studies have 
reported that greater produced force losses after the subject exercised with muscles 
initially set at a longer length (Child et al., 1998; Newham et al., 1988; Nosaka and 
Sakamoto, 2001; Saxton and Donnelly, 1996). These observations indicate that exercise 
at longer initial muscle lengths creates a larger amount of strain on muscle fibres. This 
should coincide with a linear deformation of sarcomeres within muscles that generate 
lower strength peak, which ultimately increases EIMD. 
The mechanism by which force is lost after eccentric exercise is yet to be established. 
One theory, the popping-sarcomere hypothesis, states that sarcomeres lengthen in a 
non-uniform manner during lengthening contractions (Morgan and Allen, 1999). If the 
muscle is lengthened slowly, sarcomere length uniformly stretches with increasing 
tension. If instead, sudden tension or of high force is applied, a non-uniform stretching 
takes place in the sarcomere resulting in excess stretching, generating cellular damage. 
The proposition: that when a muscle is lengthened, weak sarcomeres stretch to such a 
length that they are supported purely by passive elements; colloquially ‘popped’ (Morgan 
and Allen, 1999). 
2.8.3. Indirect methods of muscle damage assessment 
It has been often reported that the appearance of muscle proteins in the bloodstream 
following eccentric exercise provides an indirect indication of muscle damage. 
Assessments have been performed on the following muscle enzymes: lactate 
dehydrogenase, aspartate aminotransferase, carbonic anhydrase isoenzyme II, and 
creatine kinase (CK) (Sorichter et al., 1999). While all of these are now known to 
increase after damage-inducing exercise, CK has received the most attention. This is 
probably since it exhibits a high magnitude increase and the assay is relatively 
inexpensive. To date there has not been a systematic study of all of these markers in 
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combination. Another drawback is that the two types of exercise predominantly used in 
muscle damage studies (downhill running and high force muscular contractions) show 
different CK responses. It is problematic to use any of these muscle proteins from blood 
samples as muscle damage markers because blood concentration is a function of two 
individual processes: what the muscle produces, and what is cleared from the blood. 
Concentric exercise performed over several days after an eccentric exercise can result in 
increased levels of CK in the blood, but no evidence of damage has been found using 
direct measures. Therefore, it has been suggested that the increased CK levels was 
released from damaged muscle due a massaging action (Sorichter et al., 1995). 
However, exercising lightly in the days after a bout of high-force eccentric exercise 
resulted in lower increases in serum CK activity than performance of the eccentric 
exercise alone (Saxton and Donnelly, 1995). This effect could be due to a decrease in 
release from damaged muscle, but also faster clearance of CK from the blood. 
A second bout of eccentric exercise resulted in a lower CK increase; probably because 
blood CK levels were elevated from previous exercise and this had already activated 
clearance (Nosaka and Clarkson, 1994). CK is released by the muscle, enters the 
lymphatic system and finally is diffused into the blood stream (Havas et al., 1997; 
Sayers et al., 2000). One of the major drawbacks when using CK as a muscle damage 
marker is related to broad range of inter-subject response variability (236 to 25,244 UI/ 
Litre (Nosaka and Clarkson, 1996). MRI assessments show that individuals with the 
highest blood CK activity have generally undergone the greatest damage, but this 
relationship is not perfect. The great variability in CK response to exercise is not 
understood the roles of gender, muscle mass or subject activity level are not fully 
understood. The source of this variability remains to be determined (Gunst et al., 1998). 
The same study showed that serum CK activity might be related to serum glutathione 
activity, which ought to act as a CK preserving agent when in the circulation (Gunst et 
al., 1998). To summarise, blood CK activity clearly provides an indirect qualitative 
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marker of muscle damage and that it may be influenced by several factors besides 
exercise-induced muscle damage. 
2.8.4. Muscle soreness as a marker of muscle damage 
Muscle soreness peaks 24-48 hours after the performance of the damage-inducing 
exercise bout (Clarkson et al., 1992; Ebbeling and Clarkson, 1989; Newham et al., 
1983). The degree of soreness differs with mode and intensity of the exercise. The 
assessment of the amount of muscle damage is by a scale of 1 (no soreness) to 10 (very 
sore) and this correlates well with the increases in blood CK activity and force loss (Baird 
at el., 2012). 
Different exercise protocols have different degrees of soreness, but they are similar in 
time-course (Clarkson et al., 2002). Muscle soreness could be the result of swelling and 
augmented pressure in the muscle where, as consequence of the damage, muscle area 
increases proportionally (Friden et al., 1988). The larger the damage/area, the longer it 
takes for the tissue fluid pressure to return to normal. It is possible that swelling in the 
muscle fibres activates free nerve ending in muscles, contributing to the sensation of 
soreness (Shellock et al., 1991). In addition, through the synthesis and release of 
inflammatory mediators and interactions with neurotransmitters and their receptors, the 
immune cells, glia and neurons form an integrated network that coordinates immune 
responses and modulates the excitability of pain pathways (Ke Ren et al., 2010). The 
immune system also reduces sensitization by producing immune-derived analgesic and 
anti-inflammatory or pro resolution agents (Ke Ren et al., 2010). 
Chemicals (e.g. prostaglandins) are also implicated in producing the sensation of 
soreness (Ricciotti et al., 2012). Indeed, they activate Type III and Type IV nerve 
afferents, which send pain signals to the central nervous system (Buckworth et al., 
2013). There is evidence that the presence of chemical mediators is reflected by the 
time-course of soreness, but the physical stimulus for the sensation of pain should be 
given by the increased pressure (Howell et al., 1993). 
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Muscle damage is caused more by eccentric contractions than by concentric contractions 
due the mechanical strain from extreme muscle fibre lengthening (Teague and Schwane, 
1995). Eccentric contractions increase tension and a higher load is distributed across the 
same number of fibres (Enoka, 1996). This results in a higher ratio of load to fibre 
(Howell, 1995). However, since soreness peaks 24-48 hours after exercise and swelling 
is greatest several days after exercise, this suggests that damage is somehow 
exacerbated in the days following exercise. The inflammation after the initial insult is the 
most probable cause for continued damage and might contribute to the regeneration 
process. Enoka showed that reperfusion injury increases CK plasma activity and a biopsy 
showed histologic changes similar to those found after exercise-induced damage (Enoka, 
1996). Reperfusion injury was due to restricted blood flow and then an increase in blood 
flow. It has been suggested that muscle damage associated with reperfusion injury 
might stem from capillary damage (Jones and Round, 1997). 
Scientists have proposed that mechanical insult to muscle from eccentric contractions 
would most likely result in damage to the capillary endothelium. This is based on the 
similarities between reperfusion damage and exercise-induced muscle damage. 
Consequently, these burst capillaries could contribute to edema and compromised blood 
flow, causing further fibre damage (Jones and Round, 1997). Importantly, inflammation 
after muscle damage clears debris from the injury site to prepare for regeneration 
(MacIntyre et al., 1995). This is thought to be triggered by the initial mechanical insult 
and it is characterized by an infiltration of fluid and plasma proteins into the injured 
tissue and increased inflammatory cell populations (MacIntyre et al., 1995; Pedersen 
and Toft, 2000; Smith, 1991). This inflammatory cell increase is thought to amplify 
initial muscle injury by increased production of reactive oxygen species and an activation 
of phospholipases and proteases in injured tissue (MacIntyre et al., 1995). The 
development and duration of the inflammation can vary due to several factors, such as 
mode, intensity and duration of exercise (Brentano and Kruel, 2011; MacIntyre et al., 
1995; Pedersen and Toft, 2000; Smith, 1991). 
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2.8.5. The repeated bout effect (Chapter 6) 
A single bout of muscle-damaging eccentric produces an adaptation following there less 
damage is reported when the exercise bout is repeated after a week, or even up to 6 
months following the initial damage (Clarkson et al., 1992; McHugh et al., 1999). 
Significantly, CK activity is dramatically increased after the first bout but the second bout 
results in virtually no change (Balnave and Thompson, 1993; Clarkson and Tremblay, 
1988). When the second bout of muscle-damaging exercise occurred 2 to 6 days after 
the first bout, recovery time from the first bout did not differ and this did not result in a 
recovery setback (Nosaka and Clarkson, 1995; Paddon-Jones et al., 2000) .  
The process behind the repeated bout effect is not understood. One can assume that the 
first bout of damage produces an adaptation i.e. the muscle is less vulnerable to 
subsequent exercise damage (Clarkson and Tremblay, 1988). Moreover, this did not 
depend on the degree of damage in the first bout, which might suggest neural factor 
involvement (Kuhl et al., 2010). One plausible explanation is greater recruitment pattern 
efficiency during the second bout (Golden and Dudley, 1992; Nosaka and Clarkson, 
1995). For example, it was suggested that soreness was caused by muscle fibre rupture 
due to discrepancies in stimulating neurons activation (Hough, 1902; Hortobagyi et al., 
1998). Other reached the conclusion that neural factors were at least partly involved in 
the adaptation process. The limitations of neural factor models came originated in animal 
models where the repeated bout effect was found in electrically-stimulated muscular 
contractions, but fibre recruitment was not found to be different (McHugh et al., 1999). 
Armstrong (1990) first suggested that muscle damage observed after eccentric exercise 
could stem from irreversible damage to stress-susceptible fibres. One study (Foley et al., 
1999) may be taken to mean that the repeated bout effect is due to fragile fibre loss 
during the first bout of exercise. These findings suggest that stress-susceptible fibres 
develop over time quite naturally and are susceptible to eccentric exercise strain when 
they are irreversibly damaged or lost. When an exercise is repeated there follows further 
fibre damage, and these fibres would also be lost. If this continued a significant decline 
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in muscle mass would occur, which seems implausible.  A contrary explanation is that 
damaged fragile fibres are repaired over time and that these repaired fibres are 
enhanced and less susceptible to damage. Evidence, suggests a 6 months development 
period for fragile fibre areas due to muscle disuse (Clarkson et al., 2002).  
Immune responses to exercise-induced muscle damage are, it has been argued, 
diminished after repeated bouts of exercise. Evidence has shown decreases in the 
number of circulating neutrophils and lower levels of neutrophil and monocyte activation 
3 weeks after the first bout of exercise (Pizza et al., 1996). Neutrophils and monocytes, 
it has been suggested, induce more damage as they enter the fibre, therefore, their 
lessened activity could result in less damage sustained. Cytokines (e.g., IL-6) are 
released, it is believed, from exercise-damaged muscle due to acute inflammation. 
Plasma IL-6 increases were shown to show similar patterns following each bout of 
eccentric exercise (Croisier et al., 1999). It has therefore been argued that IL-6 is either 
not related to acute inflammation or that inflammation is not reduced by the repeated 
bout effect (Margaritelis et al., 2015). 
Animal studies show that the first bout of eccentric exercise could promote increased 
sarcomeres (Lynn and Morgan, 1994). Meanwhile human studies have shown sarcomere 
length may correlate to muscle injury (Clarkson et al., 2002). It has been further 
suggested that eccentric exercise produces an altered optimal angle for force production 
and that it was significantly greater in the leg that had been trained. This resulted in an 
increased muscle damage susceptibility (Whitehead et al., 1998). That in turn would 
suggest that concentric training reduces sarcomeres and leads to increased eccentric 
exercise-induced damage vulnerability. This evidence suggests that increasing 
sarcomeres may protect against injury (Ploutz-Snyder et al., 1998), which has particular 
implications for the repeated bout effect, and how it is taken under consideration in 
training plans. 
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2.9. Thesis objectives 
In conclusion, the aim in the present thesis was to assess the effect of mild hypothermia 
and prolonged cold exposure on relevant measures of immune function in healthy 
humans. As cold exposure is known to activate the SNS and HPA axes that have 
immunosuppressive effects, we hypothesised that mild hypothermia would impair 
immune function, as assessed by neutrophil degranulation, and whole-blood culture 
cytokine release (IFN-γ and IL4).  
In addition, it is of interest to investigate if prior EIMD increases heat strain during 
exercise-heat-stress conducted after muscle damage thus supporting the work of 
Montain et al. (2000). They showed that performing eccentric exercise might be an 
additional and novel risk factor for EHI due to the increased heat strain while exercising 
in the heat. Limitation of this study was to show a very small increase in core body 
temperature (0.2-0.3 °C) during exercise heat stress after muscle injury compared with 
control at 2 h and 7 h after injury. Evidently, it is of interest to investigate, and adopt 
actions that may reduce the risk of EHI.  It is logical that a reduction of the degree of 
muscle damage experienced will also lessen the amount of heat strain met.  One 
coherent, but unexplored pathway of research is the well-known repeated bout effect of 
muscle-damaging exercise. 
As stated above, there are numerous factors that could influence the immune response 
to exercise and extreme environments.  
With this in mind, the broad objectives of the following experiments were to investigate 
the influence of: 
  1. Mild hypothermia and prolonged cold exposure on measures of immune 
function in healthy humans.  
 2. Exercise-Induced Muscle Damage (EIMD) upon heat strain during subsequent 
exercise in heat. 
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 3. If the repeated-bout effect of EIMD lower the increase in rectal temperature 
(Tre) experienced during subsequent endurance exercise under determined heat 
conditions.  
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CHAPTER THREE 
 
 
 
 
General Methods 
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3.1. Ethical approval 
Approval for all studies was obtained from the local Ethics Committee (School of Sport, 
Health and Exercise Sciences, Bangor University, Bangor).  
The nature and purpose of each study was fully explained verbally and in writing to each 
volunteer (Appendix A). Each participant was made fully aware that they were free to 
withdraw from the study at any time and completed an informed consent form 
(Appendix B). To further confirm that participants were free from upper-respiratory 
tract infections, on each of the 14 days preceding both main trials, participants 
completed an illness-specific questionnaire (WURSS-44) (Barnett et al., 2002). 
Following personal meetings we could confirm that all participants were non–heat or cold 
acclimated, nor accustomed to downhill running or regular eccentric exercise. In addition, 
participants were non-smokers and free from any known immune, cardiovascular, or 
metabolic diseases and not taking any medication (e.g., anti-inflammatories). 
Participants were also asked to refrain from exercise 72 h before and from alcohol and 
caffeine 24 h before all exercise bouts. Prior to every trial, participants were provided 
fluids to consume (40 mL·kg-1·NBM·d-1) in the prior 24-hour period to ensure they began 
exercise bouts euhydrated.  
 
3.2. Anthropometry 
Prior to commencement of the first experimental trial, height was recorded using a wall 
stadio-meter (Bodycare Ltd, Warwickshire, UK) and Nude Body Mass (NBM) by digital 
platform scales accurate to the nearest 50 g (Model 705, Seca, Hamburg, Germany). To 
monitor NBM changes during exercise-induced dehydration (Chapter 4) or cold 
exposure participants removed clothing and were towel dried prior to being weighed. 
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3.3. Maximal oxygen uptake (VO2max) 
For the determination of VO2max and trial workloads, participants performed a continuous 
incremental exercise test to volitional exhaustion on a treadmill (Chapters 5, 6), (HP 
Cosmos Mercury 4.0, Nussdorf-Traunstein, Germany).  
Treadmill tests: on completion of a 5 min warm-up period at 9 km·h-1 participants began 
running at 10 km·h-1 at a 1.0% gradient with 2 km·h-1 increments every 3 min until 14 
km·h-1 was reached, after which the gradient was increased by 2.5% every 3 min 
increment until fatigue. During all VO2max tests expired gas was analysed continuously 
using an on-line breath-by-breath system (Cortex Metalyser 3B, Biophysik, Leipzig, 
Germany) to determine the volumes of expired gas, oxygen and carbon dioxide. Criteria 
for attaining VO2max included the participant reaching volitional exhaustion, a HR within 
10 beats·min-1 of age predicted HR max and a respiratory exchange ratio greater than or 
equal to 1.15 (Bird and Davison, 1997). 
 
3.4. Blood collection, handling and analysis 
Prior to commencement of every experimental trial, participants’ fasted condition was 
verified by a finger-prick blood sample analysed for glucose and ensuring that the 
reading was <6 mg·dl-1 (ACCU-CHECK Aviva, Roche, Basel, Switzerland).  
During experimental trials (Chapters 4, 5 and 6), blood samples were collected, without 
venestasis, by venepuncture from an antecubital vein, into separate vacutainers tubes 
(Becton Dickinson, Oxford, UK), containing the anticoagulants 
ethylenediaminetetraacetic acid (EDTA) and lithium heparin. Part of the blood collected 
was then immediately used to determine haematocrit. Haematocrit (heparinised blood) 
was determined in triplicate using the capillary method in accordance with Watson 
and Maughan (2014), and plasma volume changes were estimated (Dill and Costill, 
1974). Blood in the EDTA tube and blood in the lithium heparin tube was immediately 
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centrifuged (1500 g for 10 min at 5 °C: Hettich Rotina 35R, Bach, Germany), the plasma 
was aspirated and stored at -80 °C for further analysis. 
 
3.5. Urine collection, handling and analysis 
During experimental trials (Chapters 4, 5 and 6), all urine passed was collected into 2 L 
plastic containers. A 3 mL sample of each urine sample at collection times was aspirated 
into two eppendorfs and frozen at -80ºC for further analysis.  
Euhydration was verified by checking that urine-specific gravity (Atago Uricon-Ne 
refractometer, Atago Co., Ltd. Tokyo, Japan.) upon arrival at the laboratory was less 
than 1.028	   (Armstrong et al., 2010).  Urine colour was determined by a urine colour 
scale (Armstrong et al., 1994).  
 
3.6. Body temperatures 
Rectal core temperature was assessed using a standard flexible, sterile, disposable 
thermistor (Henleys Medical Supplies Ltd, Herts, UK) inserted 12 cm beyond the anal 
sphincter, with temperature recorded using a data logger (YSI model 4000A, YSI, 
Dayton, USA) (Chapters 4, 5 and 6).  In both repeated trials, participants used the 
same thermistor which was sterilized after every trial.  For skin temperature 
measurements (Tsk), insulated thermistors (Grant EUS-U, Cambridge, UK) were attached 
to the skin via surgical tape which conducted heat and allowed evaporation (Hypafix, 
BSN medical GmbH, Hamburg, Germany).  The amount of tape used to attach the 
thermistors was standardised both between and within participants.  Temperature data 
collected were registered using a portable data logger (Grant SQ2020, Cambridge, UK), 
then  mean Tsk was calculated using a weighted equation (Ramanathan, 1964).  
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3.7. Statistical Analysis 
Prior to commencement of each study, a sample size calculation was performed 
(G*Power, 3.1.9.2) using mean and SD data from previous studies (Costa et al., 2011; 
Montain et al., 2000; Fortes et al., 2013). For a two-tailed test with alpha level set at 
0.05, and power set at 0.8. 
All data were checked for normality and sphericity and analyzed using either paired t-
tests or fully repeated-measures ANOVA with the Greenhouse–Geisser correction applied 
to the degrees of freedom if necessary. All F values reported are for the time – trial 
interaction unless otherwise stated. Tukey's HSD or Bonferroni-adjusted paired t-test 
post hoc procedures were used to determine withinsubject differences where appropriate. 
All data were analyzed using SPSS version 14 software (IBM, NY) and Prism 6 (GraphPad 
Software Inc, La Jolla, CA, USA). Data are reported as mean (SD).  
Statistical significance was accepted as P < 0.05. 
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CHAPTER FOUR 
 
 
 
 
Influence of mild hypothermia and cold exposure on immune 
function as assessed by neutrophil degranulation and antigen-
stimulated cytokine production in whole blood culture 
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4.1. Abstract 
 
The aim was to assess the effect of mild hypothermia and prolonged cold exposure on 
relevant measures of immune function in healthy humans. As cold exposure is known to 
activate the SNS and HPA axes that have immunosuppressive effects, we hypothesised 
that mild hypothermia would impair immune function, as assessed by neutrophil 
degranulation, and whole-blood culture cytokine release (IFN-γ and IL4). In random 
order, nineteen men completed a thermal-neutral control trial and a cold trial. During 
the cold trial they were immersed in 13 °C water until rectal core temperature reached 
36 °C. Afterwards they completed a seated and semi-nude cold air exposure (0 °C) for 
up to 3 hours or until rectal core temperature reached 35 °C. Rectal core temperature 
was lowest (21 (31) (mean (SD)) minutes into the cold air exposure (35.17 (0.33) °C). 
Immediately after the lowest rectal core temperature total leukocytes were increased 
(30% P < 0.001), neutrophil degranulation and IL4 were unchanged, and IFN-γ 
production was decreased (44%, P = 0.04). In the fifteen participants that completed 
the 3-hour cold-air exposure, and were not removed from the chamber due to a 
decrease in rectal core temperature below 35 °C, immune function was similarly altered 
immediately afterwards. Despite rewarming and feeding, leukocytes (+30% P < 0.001) 
and IFN-γ production after cold-air exposure did not return to control values within the 
3-hour recovery period. This is the first study that reports that other stressors than 
exercise (e.g. cold) might affect interferon production even after recovery from 
hypothermic state. In conclusion, this study shows that mild hypothermia causes 
immune suppression in healthy young men that might, at least in part, explain the 
increased incidence of upper-respiratory infection reported after cold exposure. Further 
research is required to elucidate if the decrease in immune function observed is due to a 
lower core body temperature or to the metabolic responses to the adverse environment. 
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4.2. Introduction 
 
Cold exposure and mild hypothermia are commonplace in many active and clinical 
populations (e.g. military personnel, open-water swimmers, patients undergoing 
surgery).  Popular belief is that cold exposure increases susceptibility to infection, 
however, evidence to support a link between cold exposure and increased incidence of 
infection is not well defined in humans (Castellani and Rhind, 2002). Indeed, early 
research using viral inoculation before, or immediately after, cold exposure showed no 
increase in the frequency of colds in the six days after cold exposure (Dowling et al., 
1958). A recent study of 892 Finnish military conscripts indicates that URTI, including 
the common cold, were preceded by three days of declining ambient temperature and 
humidity (Makinen et al., 2009). More compelling evidence indicates that patients who 
become cold during surgery suffer greater surgical wound infection post operation (Kurz 
et al., 1996). Further, URTI symptoms were more than doubled in the 4-5 days after 
people that had their feet immersed in cold water for 20 minutes compared with non-
chilled controls (Johnson and Eccles, 2005). Whether the increased infection in these 
studies is related to a cold-induced suppression of immune function is not clear from 
these studies. Cold exposure responses, including peripheral vasoconstriction and 
shivering thermogenesis, are initiated by the SNS and HPA axis that are also potent 
modulators of the immune system (Costa et al., 2010). Therefore, it is plausible that 
cold exposure may lead to impaired immune function because of increases in stress 
hormones (cortisol and catecholamines) released by the SNS and HPA axis during 
thermoregulatory responses.  
The few human studies to investigate the effect of cold exposure on immune function 
report conflicting information that is dependent on the degree of hypothermia, the health 
of the individual, and the immune parameter studied. A very mild decrease in core 
temperature (<0.5 °C) has no effect, or may even be immune-stimulatory, increasing 
circulating leukocytes and natural killer cell activity (Lackovic et al., 1988; Brenner et al., 
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1999). In contrast, lymphocyte and neutrophil function are reduced when core 
temperature has been decreased by more than 1°C (Wenisch et al., 1996; Costa et al., 
2010; Beilin et al., 1998). Collectively, these studies suggest lowering core temperature 
(e.g. core temperature decrease > 1 °C) can disrupt circulating immune function, which 
may partly explain the increased URTI reported after cold exposure. Limitations of 
previous research is that they included patients undergoing surgery, which have 
questionable relevance to healthy persons, as surgery, anaesthesia and existing 
comorbidity have independent effects on inflammation and immune responses (Wenisch 
et al., 1996; Beilin et al., 1998). Moreover, the study with healthy participants did not 
include a thermoneutral control trial and therefore it is unclear whether diurnal variation 
is responsible for the altered immune function reported. Thus, it remains to be shown in 
healthy humans whether immune function is impaired when core temperature is reduced 
(e.g. core temperature decrease of 1–2 °C).  
In consequence, the purpose of this investigation was to determine, in healthy humans, 
the effect of cold exposure and mild hypothermia (rectal core temperature ~35 °C) on 
immune function. This was achieved by immersing participants in cold water until rectal 
core temperature reached 36 °C after which they were exposed to cold air for up to 3 
hours. 
Water immersion was chosen as water has many physical characteristics that 
differentiate it from air. It is reported that water has a thermal conductivity of 630.5 
mW/m2 per °K, whereas for air it is 26.2 mW/m2 per °K. This 24-fold greater capacity 
for thermal conductivity translates into a much greater capacity of heat transfer (Casa et 
al., 2007) Generally, the immersed body portion is nearly 100% in direct contact with 
water that surrounds it, therefore the conductive potential is far superior to air. This 
results in volume-specific heat capacity of water nearly 3500 times greater than that of 
air (Toner et al., 1996; Golden et al., 2002). Thus, a person cools four times faster in 
water than in air of the same temperature. Also, a water temperature of 13 °C during 
experimental trials was chosen to reflect typical water average temperatures in British 
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Isles during summer (Tipton et al., 1989).	   In addition, 3-hours air cold exposure was 
previously choosen to reflect the average time to rescue in practical context (MacGregor, 
1988; Grant et al., 2002). Indeed, even if the time for rescues varies greatly depending 
on weather conditions and location of the casualty it has been reported that the time 
taken for rescues is likely to be at least 2.25 hours, and non-helicopter evacuations 
could be in the region of 3.5 hours (MacGregor, 1988; Grant et al., 2002).  To control for 
time of day, results of immune function were obtained serially during a cold exposure 
trial and were compared to measures collected at the same time of day on a 
thermoneutral control trial. Immune function was assessed by neutrophil function, and 
antigen-stimulated IFN-γ and IL4 cytokine production, measures are considered relevant 
as they are part of the innate immune system and therefore the ‘first line of defence’ 
against pathogens, and thus disruption by cold exposure of any of these parameters 
could lead to increased URTI. Indeed, decreases in neutrophil function, and 
dysregulation of interferon-gamma (IFN-γ) production, a cytokine that has important 
anti-viral and immunomodulatory roles, is associated with increased infection in illness 
prone athletes compared with healthy counterparts  (Clancy et al., 2006; Fox et al., 
2003; Gleeson et al., 2012; Yang and Gordon, 2002; Fahlman and Engels, 2005). As 
cold exposure is known to activate the sympathetic nervous system and HPA axis, we 
hypothesised that cold exposure leading to mild hypothermia would impair immune 
function.  
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4.3. Methods 
4.3.1. Participants 
Nineteen healthy, recreationally active males volunteered to participate in the study 
(mean (SD): age 20.7 (2.2) years, height 178 (7) cm, nude body mass 68.7 (6.2) kg, 
body fat 11 (4) %). Participants gave written informed consent before the study, which 
received local ethics committee approval. Participants were free from medication or 
supplements and had not reported an infection on the daily health questionnaire in the 
two weeks before the first experimental trial (Barrett et al. 2005). 
4.3.2. Preliminary testing 
To ensure habituation to the laboratory, cold-water immersion and blood collections, 
participants visited the laboratory before their first experimental trial and performed 
each procedure. For the 24 hours before the first trial participants recorded their food 
intake. They were asked to repeat the same diet before each trial. The day before each 
trial participants consumed water equal to 35 ml·kg-1 of body mass throughout the day 
(Oliver et al., 2007). Participants were also asked to abstain from strenuous exercise 
and alcohol during this 24-hour period. 
4.3.3. Experimental trials 
In random order separated by one week participants completed a control trial and a cold 
trial. Participants awoke at 07:00 hours after an overnight fast and were transported to 
the laboratory. On arrival participants were requested to empty their bladder and bowels 
and a urine sample was collected to determine hydration status from the measurement 
of urine specific gravity (Atago Uricon-Ne, NSG Precision cells, New York, USA). After 
voiding, anthropometric measures of height and body mass were obtained. To measure 
rectal core temperature participants inserted a thermocouple 12 cm beyond the external 
anal sphincter (Grant REC soft insertion probe thermocouple; Grant 2020 Squirrel data 
logger, Shepreth, UK). Energy expenditure and metabolic heat production were 
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determined indirectly by analysis of expired gasses (Feurer and Mullen, 1986; ISO 8996, 
1989). 
Participants began each trial at 08:00 hours resting and clothed on a steel framed plastic 
laboratory chair in a 20.2 ± 1.7 °C environment. After 30-minutes of being seated, 
baseline blood samples were collected (08:30 hours). On the cold trial, whilst wearing 
swimming shorts only, participants were immersed up to the axilla in 13.0 (0.1) °C 
stirred water until rectal core temperature reached 36 °C. Once removed from the water 
participants were lightly towel dried and dressed in dry shorts, socks and gloves before 
entering an environmental chamber at approximately 09:00 hours. (0°C, 40% relative 
humidity and 0.2 m·s-1 wind velocity, Delta Environmental Systems, Chester, UK). 
During the cold-air exposure participants remained seated on a steel framed plastic 
laboratory chair in a polythene survival bag for 3 hours or until rectal core temperature 
reached 35 °C. Once seated, at 1 and 2 hours participants consumed water equal to 6 
ml·kg-1 body mass (412 (37) ml each serving (total 1236 (117) ml). The water was 
flavoured but had negligible nutritional value and was served at 36 °C in an insulated 
mug. 60-s expired gas samples were collected by Douglas bag method every 10 minutes 
and analysed for VO2, VCO2 and VE. No food was consumed during the cold air exposure. 
After the cold air exposure participants were immersed up to the axilla in 40 °C water 
until rectal core temperature reached 36 °C or for up to 1 hour. After participants were 
towelled dry, 1-hour recovery blood samples were obtained (~13:00 hours) and 
participants consumed a meal (5146 kJ; carbohydrate 58%, fat 28%; protein 14%). 
After a further 2 hours of seated rest, final blood samples were obtained (~15:00 hours). 
On the control trial, participants remained seated in the thermoneutral environment 
(20.2 ± 1.7 °C) and were asked to add and remove clothes to maintain thermal comfort 
(Hollies and Goldman, 1977). Participants consumed identical fluid and food as on the 
cold trial. An overview of the study design is depicted in Figure 6. 
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Fig. 6. Schematic of experimental procedures. Participants were removed from the environmental chamber if 
their rectal core temperature reached 35 °C. Participants were left in the Warm Bath until their rectal core 
temperature reached 36 °C or up to 1 hour. COLD, Cold trial; CON, thermo-neutral control trial; RH, relative 
humidity. 	  
 
4.3.4. Sample collection and analytical methods 
For both trials blood samples were collected at 08:30 hours (baseline), ~12:00 hours 
(immediately after the cold air exposure), ~13:00 hours (1 hour after the cold air 
exposure) and ~15:00 hours (3 hours after the cold exposure). On the cold trial only an 
additional blood sample was collected immediately after the lowest rectal temperature 
was recorded (~09:30 hours). Samples were obtained at 12:00, 13:00 and 15:00 hours 
after a baseline sample at 08:30 hours. These times of day were determined from 
average cold-water immersion times of pilot investigations. 
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Blood samples were collected, by venepuncture from an antecubital vein, into two 
K3EDTA and two lithium heparin vacutainer tubes (Becton Dickenson, Oxford, UK). 
Haematocrit was determined by capillary method in triplicate using lithium heparin blood 
and a micro-haematocrit reader (Hawksley & Sons Ltd., Lancing, UK). One K3EDTA 
vacutainer tube was placed on a roller and stored at room temperature before 
haematological analysis that included haemoglobin concentration, total and differential 
leukocyte counts (Gen-S, Beckman Coulter, High Wycombe, UK). All blood-borne 
parameters were corrected for changes in plasma volume, which was calculated from 
haematocrit and haemoglobin (Dill and Costill, 1974). 
4.3.6. Antigen stimulated whole blood culture IFN-γ  and IL-4 production 
Stimulated whole blood culture production of IFN-γ and IL-4 was determined as 
previously described (Gleeson et al., 2011). Within 10 minutes of collection, and after 
mixing, 0.25 mL of lithium heparin whole blood was added into a culture well with 0.75 
mL of medium (RPMI 1640, Sigma, Poole, UK) and 0.25 µL of vaccine stimulant 
(Pediacel Vaccine, Sanofi Pasteur, UK). The stimulant was a multi-antigen vaccine that 
contained diphtheria, tetanus, acellular pertussis, poliomyelitis and Haemophilus 
influenzae type b antigens, which was diluted in RPMI medium to a final concentration of 
1:100. The culture well was then placed for 24 hours in an incubator (5% CO2, 37 °C). 
After centrifugation at 5000 g for 4 minutes, supernatants were collected and stored 
frozen at -80 °C. After thawing ELISA was used to determine the cytokines IFN-γ (Cat. 
No. ab46045, Cambridge, United Kingdom) and IL-4 (Cat. No. ab46058 Abcam). Values 
that were below the detectable range on the normal sensitivity ELISA were re-assayed 
using high sensitivity ELISA (Cat. No. ab46063 (IFN-γ) and ab46050 (IL4), Abcam). The 
intra-assay coefficient of variation for IFN-γ and IL-4 concentration was 3.4 and 6.6% 
respectively. 
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4.3.7. Bacterially stimulated neutrophil degranulation 
Neutrophil degranulation was determined as previously described (Laing et al., 2008). 
Briefly, 1 mL of lithium heparin blood was added to a micro-centrifuge tube containing 
50 µL of bacterial stimulant solution (Sigma, Poole, UK). After a gentle vortex mix, this 
was incubated in a water bath at 37 °C for 1 hour. Samples were then centrifuged at 
5000 g for 2 minutes, and the supernatant was immediately aspirated into an eppendorf 
and stored at -80 °C for further analysis. Plasma elastase concentration, a marker of 
neutrophil degranulation, was measured in unstimulated and bacterially stimulated 
lithium heparin plasma by ELISA (Cat No. RM191021100 Biovendor, Heidelberg, 
Germany). The intra-assay coefficient of variation for elastase concentration was 2.8%. 
The remaining blood from lithium heparin and K3EDTA samples was centrifuged at 1500 
g for 10 minutes at 4 °C within 15 minutes of sample collection. The plasma was 
aspirated into eppendorfs and stored for further analysis. ELISA was used to determine 
cortisol concentration from lithium heparin plasma (Cat No. EIA1887, DRG Diagnostics, 
Marburg, Germany) and adrenaline and noradrenaline from K3EDTA plasma (Cat No. 
RE59242, IBL international, Hamburg, Germany). The intra-assay coefficient of variation 
was 1.9, 12.2, 16.2% for plasma cortisol, adrenaline and noradrenaline, respectively. 
4.3.8. Statistical analysis 
The required sample size for the main outcome measures (bacterially stimulated 
elastase release per neutrophil) was estimated to be between six and fourteen (G*Power, 
Version 3.1.2) using standard alpha (0.05) and beta (0.8) levels, and means and 
standard deviations from previous investigations in our laboratory that have examined 
the effect of cold exposure on immune function (Costa et al., 2011). All data analysis 
was completed using Prism 6 (GraphPad Software Inc, La Jolla, CA, USA). Data are 
reported as mean (SD). Paired t-tests were used to compare cold trial and control trial 
participant body mass, fat percentage, hydration status (urine specific gravity), rectal 
core temperature, energy expenditure and metabolic heat production. To determine the 
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effect of mild hypothermia on immune function each blood parameter obtained 
immediately after the lowest rectal core temperature was compared by paired t-test to 
the control trial sample collected at the nearest time of day (08:30 hours for bloods). To 
determine the effect of prolonged cold exposure and recovery from cold exposure, a 
fully-within groups factorial ANOVA was used to compare each immune parameter (two 
trials – Control and Cold x four to six measurements for time dependent on analysis of 
blood or saliva). Where data violated the assumption of normality it was log-transformed 
before completing the ANOVA. For post-hoc analysis of the fully-within groups factorial 
ANOVA we used Holm-Sidak-tests. Significance was accepted as P < 0.05. In addition to 
traditional hypothesis testing a standardised difference (Cohen’s d effect size) was 
calculated for each outcome measure to compare cold and control immune parameters 
at individual time points. In these calculations the numerator was the mean difference 
between trials. The denominator was the control standard deviation. Effect sizes were 
interpreted as ≥0.2 small, ≥0.5 moderate and ≥0.8 large (Cohen, 1988).  
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4.4. Results 
4.4.1. Pre trial body composition and hydration status  
Before each experimental trial, body mass and hydration status, as assessed by urine 
specific gravity, were similar (Body mass, Cold 68.65 (6.43) kg, Control 68.73 (6.23) kg, 
P = 0.73; Body fat, Cold 10.9 (3.7) %, Control 11.4 (3.7) %, P = 0.10; Urine specific 
gravity, Cold 1.022 (0.005) g·mL-1, Control 1.022 (0.004) g·mL-1, P = 0.81).  
4.4.2. Experimental trial thermoregulatory and plasma volume responses 
Rectal core temperature and metabolic heat production were similar during the 
thermoneutral rest at the beginning of each trial (rectal core temperature, Cold 36.80 
(0.29) °C, Control 36.78 (0.24) °C, P = 0.55; metabolic heat production, Cold 48 (11) 
W·m2, Control 47 (12) W·m2; P = 0.66). Immersing participants in cold water increased 
metabolic heat production (Cold 165 (58) W·m2, Control 45 (13) W·m2, P < 0.001) and 
reduced rectal core temperature to 36°C in 29 (14) minutes (Figure 7.).  
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Fig. 7. Rectal core temperature during a cold exposure trial and thermoneutral control trial. Interaction post 
hoc statistics indicate a difference between trials at the time of day compared, § P < 0.05, §§ P < 0.01. Note 
the cold stress only occurred during the cold trial. 
 
Rectal core temperature was lowest 21 (31) minutes into the cold air exposure (35.17 
(0.33) °C, which was lower than control trial rectal core temperature at this time (36.66 
(0.28) °C, P < 0.001). Rectal core temperature then rose slowly during the cold trial 
(cold air exposure 60 min 35.98 (0.52) °C, 120 min 36.06 (0.50) °C, 180 min 36.23 
(0.41) °C). However, at 180 minutes it was still lower than in the control trial (36.55 
(0.25) °C, P = 0.01). During the cold air exposure, metabolic heat production declined 
(60 min 120 (37) W·m2, 120 min 104 (36) W·m2, 180 min 100 (40) W·m2). However, at 
180 minutes it was still greater than in the control trial (60 (23) W·m2, P = 0.04). 
Consequently the energy expenditure during the cold stress was 180% greater during 
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the cold trial than during the control trial (Cold 2692 (1111) kJ, Control 966 (442) kJ, P 
< 0.001).  
Immediately after the lowest rectal core temperature, plasma volume was reduced by 12 
(5) % (P = 0.53). Immediately after the cold exposure plasma volume continued to be 
lower in the cold trial relative to the control trial (Cold -10 (5) %, Control -2 (5) %: 
Interaction F(3,39) = 8.5, P < 0.001). Plasma volume returned to within control values by 
1 hour after cold exposure (Cold -4 (5) %, Control -1 (4) %). 
4.4.3. Mild hypothermia, immune function and neurotransmitters 
Table 1 shows that mild hypothermia caused immune modulations that included 
increases in circulating leukocytes (30%), decreases in antigen-stimulated IFN-γ 
production (44%), and no change in  Neutrophil degranulation (bacterially stimulated 
elastase release per neutrophil), plasma elastase concentration and antigen-stimulated 
IL4. Additionally, Mild hypothermia increased plasma cortisol (39%), adrenaline (150%) 
and noradrenaline (357%).  
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Table 1. Mild hypothermia effect on blood immune and hormone responses for each blood parameter mean and (SD) is presented for the control (08:30 hours) and mild 
hypothermia (Tre < 36 °C). Absolute differences are presented as the mean difference of mild hypothermia minus control with 90% confidence intervals in brackets. Effect 
sizes are standardised differences (Cohen’s d) with a qualitative description in brackets. Effect sizes were interpreted as ≥0.2 (small), ≥0.5 (moderate) and ≥0.8 (large) 
(Cohen, 1988). Abbreviations: IFN-γ, interferon-gamma, IL-4, interleukin-4. 
 Number Control Mild hypothermia Absolute difference (90% 
confidence intervals) 
Effect size P value 
Leukocytes  (x109·L-1) 18 5.25 (0.93) 6.82 (1.81) 1.57 (0.90 to 2.23) 1.7 (large) <0.001 
Lymphocytes (x109·L-1) 18 1.70 (0.42) 2.07 (0.60) 0.37 (0.16 to 0.59) 0.9 (large) 0.008 
Monocytes (x109·L-1) 18 0.48 (0.13) 0.64 (0.19) 0.17 (0.10 to 0.24) 1.2 (large) <0.001 
Neutrophils (x109·L-1) 18 2.69 (0.74) 3.83 (1.43) 1.13 (0.59 to 1.67) 1.5 (large) 0.002 
Bacterially stimulated elastase 
release per neutrophil (fg·cell-1) 
17 591 (133) 566 (216) -25 (-117 to 67) -0.2 (small) 0.65 
Antigen stimulated IFN-γ (pg·mL-1) 12 27 (30) 15 (14) -12 (-22 to -3) -0.4 (small) 0.04 
Antigen stimulated IL-4 (pg·mL-1) 10 1.0 (1.0) 0.9 (0.7) -0.1 (-0.4 to 0.2) -0.1 (trivial) 0.46 
Plasma elastase (ng·mL-1) 17 42 (14) 49 (24) 7 (-1 to 15) 0.5 
(moderate) 
0.14 
Plasma cortisol (nmol·L-1) 18 358 (99) 498 (158) 140 (78 to 203) 1.4 (large) 0.001 
Plasma adrenaline (nmol·L-1) 18 0.4 (0.3) 1.0 (0.5) 0.6 (0.4 to 0.7) 1.5 (large) <0.001 
Plasma noradrenaline (nmol·L-1) 18 2.3 (1.0) 10.5 (5.1) 8.2 (6.1 to 10.2) 3.6 (large) <0.001 
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4.4.4. Three-hour cold air exposure effects on circulating immune responses 
Relative to baseline, circulating leukocytes were increased by 50% immediately after 
cold exposure and throughout recovery were higher than during the control trial 
(Interaction F(3,39) = 11.8, P < 0.001: Figure 8.A). This was attributable to a 93% 
increase in neutrophils (Interaction F(3,39) = 14.7, P < 0.001: Figure 8.B), which 
contrasted a smaller 13% decrease in lymphocytes (Interaction F(3,39) = 3.9, P = 0.02: 
Figure 8.C). This decline in lymphocytes was in contrast to the initial increase reported 
during mild hypothermia (Table 1). Lymphocytes returned to within control values 3 
hours after cold air exposure. Monocytes were not altered from control values after the 3 
hour cold exposure (Interaction F(3,39) = 1.2, P = 0.32), which differed from the initial 
increase observed with mild hypothermia (Table 1).   
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Fig. 8. Circulating leukocytes (A), neutrophils (B) and lymphocytes (C) during a cold exposure trial and 
thermoneutral control trial. Data are for the participants that completed the whole cold trial only (n = 14). 
Interaction post hoc statistics indicate a difference between trials at the time of day compared, §§ P < 0.01. 
Note the cold stress and warm bath only occurred on the cold trial. 
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Neutrophil function, as assessed by bacterially stimulated neutrophil degranulation, was 
increased at 13:00 from 08:30 hours (Main effect of time F = 9.4, P < 0.001). However, 
there was no difference between the trials (Interaction F = 1.8, P = 0.33; Figure 9.), 
which was consistent with observations during mild hypothermia (Table 1). Immediately 
after cold exposure, plasma elastase concentration was greater than in the control trial 
(Interaction F = 3.1, P = 0.04: Table 2).  
 
Fig. 9. Neutrophil degranulation during a cold exposure trial and a thermoneutral control trial. Data are for the 
participants that completed the whole cold trial only (n = 13). Main effect of time (P < 0.01): Post hoc 
statistics: * indicates that 13:00 hours was greater than all other times of day (P < 0.01). Note the cold stress 
and warm bath only occurred on the cold trial. 
 
Antigen-stimulated IFN-γ production decreased immediately after cold exposure, being 
69% lower than for the control trial throughout recovery (Interaction F(3,21) = 2.9,  P = 
0.06: Table 2). In contrast, antigen-stimulated IL-4 production was not altered by cold 
exposure (Interaction F(3,27) = 1.7,  P = 0.19: Table 2), which was consistent during 
mild hypothermia (Table 1). 
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Table 2. Prolonged cold exposure effect on antigen-stimulated production interferon-gamma, plasma elastase and interleukin-four cytokines. Data are for the participants 
that completed the whole cold trial only (n = 8 for IFN-γ, plasma elastase and IL-4). Interaction post hoc statistics indicating a difference between trials at the time of day 
compared, § P < 0.05 and §§ P < 0.01. Effect sizes are standardised differences (Cohen’s d) with a qualitative description in brackets. Effect sizes were interpreted as ≥0.2 
(small), ≥0.5 (moderate) and ≥0.8 (large) (Cohen, 1988). 
 08:30 hours 
Baseline 
12:00 hours 
Post cold air 
13:00 hours 
1 h post cold air  
15:00 hours 
3 h post cold air 
Antigen-stimulated IFN-γ (pg·mL-1)     
Cold 27 (23) 10 (9)§§ 9 (10)§ 11 (10)§§ 
Control 34 (34) 33 (37) 26 (32) 41 (45) 
Effect size -0.2 (small) -0.6 (moderate) -0.5 (moderate) -0.7 (moderate) 
Antigen-stimulated IL-4 (pg·mL-1)     
Cold  1.1 (0.9) 0.7 (0.7) 0.9 (0.7) 0.9 (0.8) 
Control 1.0 (1.0) 0.9 (0.9) 1.1 (1.0) 1.0 (1.0) 
Effect size 
Plasma Elastase (pg·mL-1) 
Cold 
Control 
<0.1 (trivial) 
 
582 (14) 
661 (24) 
0.2 (small) 
 
759 (39) 
577 (39) 
0.2 (small) 
 
798 (31) 
714 (30) 
-0.1 (trivial) 
 
688 (31) 
721 (68) 
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4.4.5. Three-hour cold air exposure effects on neurotransmitter 
Plasma cortisol was greater during the cold trial than for the control trial (main effect of 
condition F(1,13) = 5.0, P = 0.05, interaction F(3,39) = 3.2, P = 0.03: Table 3). Differences 
were evident at baseline (Table 3:  post hoc: P = 0.03, d = 0.8). However, differences 
between trials greatest at the lowest rectal core temperature (Table 1: P < 0.001, d = 
1.4). Plasma cortisol returned to within control values during the cold trial after the cold 
exposure (Table 3). Plasma adrenaline and noradrenaline were greater in the cold than 
the control trial (adrenaline, main effect of condition F(1,13) = 5.0, P = 0.04, interaction 
F(3,39) = 3.5, P = 0.02; noradrenaline, main effect of condition F(1,13) = 63.5, P < 0.001, 
Interaction F(3,39) = 26.4, P < 0.001: Table 3). Differences were evident immediately 
after the cold exposure (Table 3:  Post hoc: P < 0.01) and were similar to those at the 
lowest rectal core temperature (Table 1, d < 0.8, large effect size). Plasma adrenaline 
returned to within control values by 1 hour after the cold exposure (Table 3). There was, 
however a trend for noradrenaline to remain elevated during recovery 1 hour after the 
cold exposure (P = 0.09, d = 0.6), although this difference between trials was reduced 
after 3 hours recovery.  
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Table 3. Prolonged cold exposure effect on plasma adrenaline, noradrenaline and cortisol. Data are presented as mean (SD) and are for participants that completed the 
whole cold trial (n = 14). † Main effect of condition. Interaction post hoc statistics indicating a difference between trials at the time of day compared, § P < 0.05 and §§ P < 
0.01. Effect sizes are standardised differences (Cohen’s d). Effect sizes were interpreted as ≥0.2 (small), ≥0.5 (moderate) and ≥0.8 (large) (Cohen, 1988).
 08:30 hours 
Baseline 
12:00 hours 
Post cold air 
13:00 hours 
1 h post cold air  
15:00 hours 
3 h post cold air 
Plasma cortisol (nmol· L-1)†     
Cold 441 (122)§ 348 (165) 265 (209) 308 (112) 
Control 353 (105) 282 (174) 301 (189) 304 (102) 
Effect size 0.8 (large) 0.4 (small) -0.2 (small) <0.1 (trivial) 
Plasma adrenaline (nmol· L-1)†     
Cold 0.5 (0.4) 0.9 (0.7)§§ 0.7 (0.4) 0.5 (0.3) 
Control 0.5 (0.3) 0.4 (0.5) 0.5 (0.6) 0.6 (0.8) 
Effect size <0.1 (trivial) 1.0 (large) 0.3 (small) -0.1 (trivial) 
Plasma noradrenaline (nmol· L-1)†     
Cold 2.4 (0.8) 6.6 (2.1)§§ 3.5 (0.7) 3.6 (1.2) 
Control 2.2 (0.9) 2.5 (1.1) 2.7 (1.4) 3.2 (1.1) 
Effect size 0.2 (small) 3.7 (large) 0.6 (moderate) 0.4 (small) 
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4.5. Discussion 
The aim of the current study was to test the hypothesis that cold exposure, leading to 
mild hypothermia (rectal temperature ~35 °C) would impair immune function as 
assessed by neutrophil degranulation and antigen-stimulated cytokine production by 
whole blood culture (IFN-γ and IL-4 cytokine production) in healthy humans.  
Hypothermia is frequent in some occupational populations exposed to cold air and cold 
water during activities (e.g. military personnel, hikers and outdoor enthusiasts) (Beeley 
et al., 1993; Brannigan et al., 2009; Giesbrecht, 2000; Keatinge et al., 2001; Nuckton et 
al., 2000) and there is evidence of an increase of URTI incidence after cold exposure. In 
addition, trauma victims often suffer from hypothermia on arrival at hospital which is 
associated with a poorer prognosis and an increase in mortality rate (Lapostolle et al., 
2012; Luna et al., 1987). 
In the current study, cold-water immersion and cold-air exposure under controlled 
laboratory conditions were successful in inducing mild-hypothermia in healthy young 
males. In contrast to our hypothesis, immune indices such as neutrophil degranulation 
(bacterially stimulated elastase release per neutrophil), plasma elastase concentration 
and antigen stimulated IL-4 production were not compromised compared with a thermo-
neutral control trial. However, in support of our hypothesis, whole-body cooling to mild 
hypothermia and cold exposure decreased antigen-stimulated IFN-ϒ production 
compared to a thermoneutral control trial. The decrease in antigen-stimulated IFN-ϒ 
production was evident from immediately after onset of mild hypothermia, and remained 
below thermoneutral control values even after rewarming restored normal body 
temperature and individuals had received approximately two-thirds of their daily energy 
requirements (Nieman, 2011). Moreover, an increase in circulating leukocytes, cortisol, 
adrenaline and noradrenaline was observed during mild hypothermia. These data 
suggest that mild-hypothermia might decrease immunity leading to an “open window” 
where immune function is suppressed. This window of opportunity may allow for an 
increase in susceptibility to URTI. 
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Compared with previous studies (Lackovic et al., 1998; Brenner et al., 1999; Wenisch et 
al., 1996; Costa et al., 2010; Beilin et al., 1998), a strength of the present research is 
that experimental procedures were carried out under controlled laboratory conditions 
and were specifically designed to enable us to be more specific regarding the influence of 
cold exposure and mild hypothermia on immune function. Indeed, the main limitation of 
the studies in the literature was the lack of a thermo-neutral control trial and therefore 
the effect of diurnal variation on outcomes could not be excluded. Moreover, other 
limitations such as multi-stressor experimental designs and the study of patient 
populations with existing comorbidities or undergoing surgery mean that prior to this 
study it was difficult to interpret the possible interaction between cold exposure and the 
immune system.  
Additional strength to the present study design comes from protocol followed; removing 
participants from water immersion and cold-air exposure at pre-defined body 
temperature (water immersion Tre 36 °C, cold-air exposure Tre 35 °C), rather than a pre-
defined time period, allowed for a more accurate assessment of the influence of cold 
exposure and mild hypothermia on immune indices. Furthermore, a cut off time of 3 
hours of cold-air exposure was previously agreed to reflect the average time to rescue in 
practical context. Indeed, even if the time for rescues varies depending on weather 
conditions and location of the casualty, it has been reported that the time taken for 
rescues is likely to be at least 2.25 hours, and non-helicopter evacuations could be in the 
region of 3.5 hours (MacGregor, 1988; Grant et al., 2002). Lastly, even if participants 
did not reach a rectal core temperature of 35 °C in this time they were removed from 
the chamber.  
A limitation of the present study is that mild hypothermia does not generally apply to the 
general population but affects those involved in outdoor activities during winter months 
(e.g. soldiers, climbers, athletes). In this respect, the data presented have to be seen as 
the first attempt to clarify if cold exposure and the subsequent mild-hypothermia is a 
potential factor in the increase of URTI reported during winter months. 
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During cold exposure, the body attempts to maintain a normal body temperature by 
increasing heat production and minimizing heat loss. This is accomplished through 
involuntary tonic muscular activity, rhythmic muscular activity (shivering), and 
peripheral vasoconstriction. Although primarily thermoregulatory, these mechanisms 
induce metabolic and hormonal changes such as SAM axis stimulation, which can 
subsequently affect immune function (Brenner et al., 1999; Castellani et al., 2002). 
The relatively modest leucocytosis immediately after cold exposure is likely to be 
explained by demargination of neutrophils from the vascular endothelium. Although 
raised circulating noradrenaline after cold exposure might play a role in demargination of 
neutrophils from the vascular endothelium (Brenner et al., 1998), other mechanisms 
such as shear effect and adrenaline intervention results could be involved (Zhang et al., 
2011; Bote, Giraldo and Peake, 2008, Laing et al., 2008, Ortega et al., 2005; Ramel and 
Peake, 2004; Ramel, 2003; Malpica et al., 2002).  In this context, catecholamines are 
the most likely cause for the observed rise in circulating neutrophils because they are 
rapidly released in the blood, causing an immediate response in immune cells. On the 
contrary, the small increase in plasma cortisol (~12%) during cold exposure is unlikely 
to account for the changes observed in leukocyte trafficking due to the time required for 
cortisol itself to produce any immune responses (Goldstein-Golaire et al., 1970, Jefferies, 
1991). This is supported by that a second delayed increase of blood leukocytes count 
due to cortisol-induced release of neutrophil from the bone marrow has not been 
observed a few hours after cold exposure (Gagnon et al., 2014). There is evidence that 
the second increase in leukocyte trafficking elicited by cortisol is dependent upon 
intensity and duration of the exercise (Fragala et al., 2011), and that only high-intensity 
exercise results in significant elevation of cortisol (200%) (Jacks et al., 2002), which is 
unlikely to be the case of present study. In addition, substantial biological effects of 
cortisol tend to be reported only when the plasma cortisol concentration exceeds the 
capacity of the corticosteroid-binding globulin (550 nmol l-1) and free cortisol 
concentration increases (Costa et al., 2011). 
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Cold exposure and mild hypothermia did not compromise neutrophil function, as 
assessed by bacterially stimulated neutrophil degranulation. These results conflict with 
previous findings where modest whole body cooling (Tre 35.9 °C) was observed to 
decrease neutrophil degranulation (Costa et al., 2011). The decrease reported previously 
was explained by the demargination of more naïve intravascular neutrophils that 
responded less to the bacterial challenge. The discrepancy in the results might be 
explained by additional stressors in Costa et al.’s (2011) study before the cold exposure, 
which included two days of sleep and energy restriction with daily maximal exercise. The 
significant neutrophilia reported in our study is in line with evidence in the literature 
(Fedor and Fisher, 1959, Villalobos et al., 1955; Blair et al., 1969). An increase in 
circulating neutrophils was reported in septic patients who were cooled to 34 °C by Blair 
and colleagues (1969). To the contrary, in another study on animals, Biggar and 
colleagues (1983) found that hypothermia was associated with a marked reduction in the 
release of mature and immature neutrophils from the bone marrow into the circulation. 
Once again it is underlined that the mediators of the neutrophilia and decrease in 
neutrophil degranulation in response to stress (e.g. exercise) are not as clear as 
previously thought and require further research. 
Lymphocytosis is observed during and after cold exposure, with the number of cells 
falling below pre-exercise levels during recovery. It has been previously reported that 
changes in T cell populations, and to a lesser extent B cell populations, are proportional 
to stress intensity and duration, although the effect of intensity is more marked (Gleeson 
et al., 2005). Research showed a 50% decrease in T cell population after a 2.5 h 
treadmill run at 75% VO2Max compared with resting values (Gleeson et al., 2005). Due to 
the prolonged nature of that exercise bout present data can be compared. We 
acknowledge the limitation that we did not assessed maximal oxygen uptake before 
trials and therefore we are not able to determine the workload imposed by 
thermoregulatory responses. In addition, indirect assessment of the cost of thermogenic 
activity can be perform using the Metabolic Equivalent of Tasks (MET) providing us with 
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the information that the increased thermoregulatory demand during the three hours cold 
exposure can be equated with prolonged-moderate exercise (5.6 (2.0) MET) (Ainsworth 
et al., 2011). 
Lymphocyte count acted in a similar fashion to that measured in response to prolonged 
exercise even if the percentage decrease observed during trials was smaller. In addition, 
T cell number returned to baseline levels after 3 h, similarly to the response to prolonged 
exercise (Robson et al., 1999). Raised circulating adrenaline might account for the 
lymphopenia during recovery after cold exposure possibly via alterations in adhesion 
molecules and surface receptors on lymphocytes (Costa et al., 2011; Kruger and Mooren, 
2007). Adrenaline is thought to have a key role in governing lymphocyte trafficking 
during environmental stress (Costa et al., 2010). Moreover, adrenaline and 
noradrenaline indirectly mediate symphatetic influences on cardiac output, with the 
subsequent increase in shear stress associated with enhanced blood flow. T cells play a 
fundamental role in the orchestration and regulation of the cell-mediated immune 
response to pathogens (Shephard and Shek, 1999). One important consequence of a 
defect in T cell function is an increased incidence of viral infections (Fabbri et al., 2003).  
Cold air exposure did not alter monocyte count after the initial increase with mild 
hypothermia. A plausible explanation of this increase could be that shivering and 
involuntary tonic contractions count as acute physical exercise which has been reported 
to result in a transient monocytosis and which most likely represents the shifting of 
monocytes from the marginated to the circualtion pool (Young et al., 2000). This could 
occur as a result of haemodynamic and/or cortisol or catecholamine-induced release 
from the vascular endothelium (Walsh et al., 2011). This explanation is supported by 
research which showed that administering the beta-blocker propranolol reduced 
exercise-induced monocytosis (Walsh et al., 2011). Moreover, reports showed that 
stressors can affect monocyte phenotype, cell surface protein, and cytokine expression. 
For example, in response to acute exercise, there is  a preferred use of inflammatory 
monocytes (CD4+/CD16+) (Freidenreich and Volek, 2012). It is therefore conceivable 
107	  
	  
that these marginated cells have a more mature inflammatory function for entry into 
tissues and are knocked off the endothelium in response to exercise. Interestingly, the 
percentage of these CD14+/CD16+ cells is reduced during recovery, maybe indicating 
remarginalization or tissue recruitment. Acute exercise also reduces expression of TLRs 
1,2 and 4 on inflammatory monocytes (Gleeson et al., 2011). However it remains to be 
elucidated the extent to which these changes reflect a true decrease versus monocyte 
population shift.  
Some of the changes reported on innate immune markers are similar to the ones 
effected by exercise and this might partially be explained by the raised concentration of 
catecholamines observed in both scenarios. Indeed, under these conditions exercise 
could be seen as the thermogenic activity through which the body counteracts the cold 
environment (Walsh et al., 2006). Through involuntary tonic muscular activity and 
rhythmic muscular activity (shivering) up to 30% of aerobic capacity could be involved 
making reasonable expecting immune markers mimics the response to exercise (Young 
et al., 2000). It was previously been reported (Golden and Dudley, 1992) that shivering 
corresponded to 46% VO2Max in 12 °C water immersion which is close to the water 
temperature used in this study (13 °C). In addition, metabolic rate during cold exposure 
was also found to be comparable to the ~40% VO2Max observed results presented by 
Young et al. (2000) in participants who had a Tre of 35 °C and was.  
A direct comparison between the rise in adrenaline and noradrenaline recorded in the 
present study and the raise induced by exercise can be performed using data provided 
by Galbo et al. (1975). The increase in catecholamines observed is similar to the one 
observed in response of a short bout of running (10 mins) at 75% VO2Max intensity or 
repeated bouts of running performed at 75% VO2Max intensity for prolonged periods of 
time. Therefore, this suggests that the changes observed on innate immunity might be 
partially explained by the thermoregulatory activity initiated by the body to counteract 
mild-hypothermia. In addition, it also helps to describe why neutrophil function was not 
affected by cold exposure even if neutrophilia has occurred. Furthermore, 
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catecholamines have a direct effect on cardiac output and the shear effect derived. This 
additionally contributes to justification of the observed changes in white blood cell count.  
Antigen-stimulated IFN-ϒ production was lower compared with thermoneutral control 
trial values throughout cold exposure and did not recover to baseline levels after 3 hours 
despite participants having been fed and rewarmed. Similar results were found following 
a 2.5 h of cycling exercise at 65% VO2Max (Lancaster et al., 2005). The release of 
cytokines such as interferon is mediated by Th1 cells which play an important role in 
defence against intracellular pathogens (e.g. viruses) (D’Elios et al., 2007) and they 
have been found to decrease in response to prolonged moderate-intensity exercise 
(Gleeson et al., 2005), this might explain the decreased production of IFN-ϒ. They are 
part of the acquired immunity which is designed to combat infections by preventing 
colonisation of pathogens and destroying invading micro-organisms (Gleeson et al., 
2005). A disregulation of IFN-ϒ production has been reported in illness prone athletes 
compared with healthy counterparts (Clancy et al., 2006). This is the first study that 
reports that other stressors (e.g. cold) might affect interferon production. Present results 
suggest that the decreased capability of the adaptive immunity induced by cold exposure 
may increase the possibility of being affected by pathogens even during the recovery 
period. This is explained by the fact that the adaptive immunity response is initiated by 
the presentation of antigens to T helper lymphocytes within the peptide binding groove 
of major histocompatibility complex class II molecules on antigen presenting cells CD4+ 
T cells. This forms a key part of the cell-mediated immune response, since they 
orchestrate and direct the subsequent adaptive immune response to bacteria and viruses. 
A decreased production of IFN- ϒ might result in a suppressed response of the immune 
system to invading micro-organisms as they act with immunostimulatory and 
immunomodulatory effects or by directly inhibiting viral replication.  This might, in part, 
explain of the increased number of URTI reported by athletes and outdoor enthusiasts 
during winter months. 
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IL-4 production was not altered by cold exposure. This finding is in line with evidence in 
the literature regarding IL-4 production in response to prolonged exercise at moderate 
intensity (Gleeson et al., 2005). The role played in a hypothermic scenario by this 
cytokine is not well established, but it is known to activate B cells and T cell proliferation 
and regulate adaptive immunity responses (Paul et al., 1997). It is usually coupled with 
another anti-inflammatory cytokine, IL-10. There is evidence that IL-10 production from 
microglia, decreases with mild-hypothermic state and that this decrease is proportional 
to the decrease in body core temperature (Matsui et al., 2004). This decrease is 
beneficial as excessively high levels of IL-10 are detrimental for the central nervous 
system. 
In conclusion, cold exposure and mild-hypothermia did not alter neutrophil degranulation, 
or antigen-stimulated IL-4 production but did lower antigen-stimulated IFN-ϒ production. 
Despite rewarming and feeding, IFN-γ production did not return to control values within 
the 3-hour recovery period. These findings might therefore, at least in part, explain the 
increased susceptibility to upper respiratory tract infections reported after cold exposure. 
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CHAPTER FIVE 
 
 
 
 
Muscle-damaging exercise increases heat strain during 
subsequent exercise heat stress 
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5.1. Abstract 
 
It is still unclear if exercise-induced muscle damage (EIMD) increases heat strain during 
subsequent exercise heat stress, which in turn may increase the risk of exertional heat 
illness. We investigated heat strain during exercise heat stress 30 min after EIMD to 
coincide with the maximal increment in circulating pyrogens [e.g. interleukin (IL)-6] and 
24 h after EIMD to correspond with the late muscle inflammatory response when a 
greater rate of metabolic energy expenditure (Ṁ) and thus diminished economy might 
also increase heat strain.  
Thirteen non–heat-acclimated males (mean(SD), age 20(2) years) completed exercise 
heat stress tests (running for 40 min at 65% VO2max in 33 °C, 50% humidity) 30 min 
(HS1) and 24 h (HS2) after treatment, involving running for 60 min at 65% VO2max on 
either -10% gradient (EIMD) or +1% gradient (CON) in a crossover design. Rectal (Tre) 
and skin (Tsk) temperature, local sweating rate, and Ṁ were measured throughout HS 
tests.  
Compared with CON, EIMD elicited higher circulating IL-6 pre-HS1 (P < 0.01) and 
greater plasma creatine kinase and muscle soreness pre-HS2 (P < 0.01). The ∆Tre was 
greater after EIMD than CON during HS1 (0.35 °C, 95% confidence interval = 0.11 °C –
0.58 °C, P < 0.01) and HS2 (0.17 °C, 95% confidence interval = 0.07 °C –0.28 °C, P < 
0.01). Ṁ was higher following EIMD throughout HS1 and HS2 (P < 0.001). Thermo-
effector responses (Tsk, sweating rate) were not modified by EIMD. Thermal sensation 
and RPE were greater on EIMD after 25 min during HS1 (P < 0.05). The final Tre during 
HS1 correlated with the pre-HS1 circulating IL-6 concentration in EIMD trial (r = 0.67).  
Heat strain was higher during endurance exercise in the heat conducted 30 min after and, 
to a lower degree, 24 h after muscle-damaging exercise. These data show that EIMD is a 
probable risk factor for exertional heat illness especially during exercise heat stress when 
behavioural thermoregulation clues, they might suggest to stop exercising, are neglected.  
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5.2. Introduction 
 
Athletes and soldiers taking part in heavy training often have to perform repeated bouts 
of strenuous exercise on the same day, in hot environments, which may predispose 
them to EHI or the more severe form, and often incurable, EHS. Numerous conventional 
risk factors have been classified for EHI and EHS such as hot and humid environmental 
conditions, incongruous clothing, absence of heat acclimation, sleep disruption, high 
exercise intensity, obesity, poor physical fitness levels, and hidden medical conditions 
(Armstrong et al., 2007;	  Epstein et al., 1999; Rav-Acha et al., 2004). However, these 
conventional risk factors do not account for all EHI events, implying that other lesser 
known risk factors and pathways may play a role in many cases of EHI (Sawka et al., 
2011). An additional pathway for the development of EHI has been suggested that 
includes a systemic inflammatory reaction (Bouchama, 1995; Lambert et al., 2001; 
Shephard and Shek, 1999), with an increment in pyrogenic cytokines [e.g., interleukin 
(IL)-1β, IL-6, and tumor necrosis factor-α], which may accelerate the progression of the 
person toward EHI and/or EHS (Walsh et al., 2011). In support of this assumption, the 
fever response to LPS injection was abolished in rodents pre-treated with anti-IL-6 
antibodies (Cartmell et al., 2000; Rummel et al., 2006), and rodents injected with IL-1 
receptor antagonist showed increased survival after experimental heatstroke (Chiu et al., 
1996). Evidence also exists that exercise itself has a pyrogenic effect similar to that of 
fever. For example, post-exercise plasma taken from humans caused fever in rodents, 
opposite to pre-exercise plasma that did not cause the same effect (Pedersen et al., 
2002). Furthermore, 6 days of integration with the cycloxygenase (COX) inhibitor 
rofecoxib attenuated the increase in body core temperature during prolonged exercise in 
humans, implying that a prostaglandin-mediated inflammatory process may also 
reinforce to increased heat strain during exercise (Bradford et al., 2007). 
BASIC SCIENCES 
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It still needs to be established whether exercise-induced muscle damage (EIMD) boosts 
heat strain during successive bouts of exercise heat stress, which consecutively may 
increase the risk of EHI. 
Exercising muscle releases the pyrogenic cytokine IL-6 (Febbraio et al., 2002), and it has 
been showed that EIMD evokes a greater circulating IL-6 response than non–muscle-
damaging concentric exercise (Braun and Dutto, 2003). Accordingly, it is possible that 
EIMD and correlated inflammation (increase in circulating pyrogenic cytokines) might 
increase heat strain at least in the short-term during consecutive exercise heat stress. 
The muscle soreness that commonly peaks 24–48 h after EIMD might also augment heat 
strain during walking and running by increasing the rate of metabolic energy expenditure 
(decreased economy) as a result of alterations in gait and motor unit recruitment 
because of muscle stiffness (Montain et al., 2000). To the best of our knowledge, only 
one published study has tried to elucidate these possibilities, althought if the 
experimental design of this investigation elicited only relatively modest heat strain 
(Montain et al., 2000). Core body temperature was 0.2–0.3 °C higher at 2 and 7 h but 
was not altered 26 h after lower body muscle-damaging exercise (eccentric component 
of leg press and leg curl) (Montain et al., 2000). The authors credit a large proportion of 
the EIMD-evoked increase in core body temperature during exercise heat stress to 
diminished economy but admitted that other elements such as the inflammatory 
response probably play a role. Regrettably, the muscle-damaging protocol did not evoke 
a significant increase in circulating inflammatory markers (e.g. the pyrogen IL-6) prior 
tothe exercise heat challenge 2 h after muscle injury and only a small increase 7 h after 
injury. Fundamentally, it is still unclear whether the acute circulating inflammatory 
response that follows EIMD exarcebates to greater heat strain during subsequent 
exercise heat stress. In addition, from a practical viewpoint, participants in the preceding 
study were heat acclimated (Montain et al., 2000), so the effect of EIMD on exercise 
heat strain in non–heat-acclimated individuals, in whom EHI is more common 
(Armstrong et al., 2007) remains unknown. 
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The aim of this study was to examine the effect of EIMD upon heat strain during 
successive exercise bouts in the heat. Therefore, we had non–heat-acclimated 
participants 
perform muscle-damaging exercise on a downhill running model (10% gradient) and 
then assessed heat strain during two subsequent exercise heat stress running bouts. The 
first exercise heat stress bout was performed 30 min post-EIMD to coincide with the 
early inflammatory phase and expected increases in circulating pyrogens (e.g. IL-6). The 
second exercise heat stress bout was performed 24 h post-EIMD to coincide with the 
delayed muscle inflammatory response, i.e. when circulating creatine kinase (CK) values 
peak after downhill running (Clarkson and Hubal, 2002) and when lower economy might 
be expected to change heat strain. The EIMD responses to the two exercise heat stress 
bouts were compared with an energy-expenditure equivalent control, trial (treadmill 
running on a +1% gradient). We hypothesized that EIMD would increase core rectal 
temperature (Tre) during subsequent exercise heat stress compared with control and that 
the increase in Tre would be correlated with increases in circulating pyrogen 30 min post-
EIMD. 
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5.3. Methods 
5.3.1. Participants 
Thirteen healthy, active males volunteered to participate in the study and provided fully 
informed written consent. The study received local ethical approval and was conducted 
within the standards required by the Declaration of Helsinki. Participant characteristics 
were as follows (mean (SD)): age, 20 (2) years; nude body mass (NBM), 70.5 (7.5) kg; 
height, 176 (5) cm; body mass index, 22.8 (2.0) kg·m-2; body surface area,1.86 (0.11) 
m2; and maximal oxygen uptake (VO2max), 60 (5) mL·kg-1·min-1. All participants were 
non–heat acclimated nor accustomed to downhill running or regular eccentric exercise. 
Participants were non-smokers and free from any known immune, cardiovascular, or 
metabolic diseases and not taking any medication (e.g., anti-inflammatories). 
Participants were asked to refrain from exercise 72 h before and from alcohol and 
caffeine 24 h before all exercise bouts. All data were collected between February and 
December 2011. 
5.3.2. Study Design 
A counterbalanced experimental design in which the order of presentation of trials was 
randomized was used to test the hypothesis that previous muscle damage would 
increase rectal core temperature (Tre) during subsequent exercise heat stress tests. 
To assess this, participants completed exercise heat stress tests, 30 min (HS1) and 24 h 
(HS2) after both muscle-damaging exercise (EIMD: running downhill on -10% gradient) 
and energy-expenditure equivalent exercise (CON: running at +1% gradient). The two 
trials were separated by 14 days, and an overview of the study design is depicted in 
Figure 10. 
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Fig. 10. Schematic of experimental procedures. EIMD, exercise-induced muscle damage; CON, energy-
expenditure equivalent control exercise; RH, relative humidity.† Blood sampling time points. 
 
5.3.3. Fitness and familiarization  
Participant’s VO2max was determined by a continuous maximal incremental exercise test 
performed on a motorized treadmill (HP Cosmos Mercury 4.0, Nussdorf-Traunstein, 
Germany) to volitional exhaustion. Expired gas was analysed by an online breath by- 
breath system (Cortex Metalyser 3B; Biophysik, Leipzig, Germany). From this, the 
treadmill running speed which elicited 65% VO2max running at +1% gradient was 
calculated by interpolation of the running speed–VO2 relationship. 
This running speed was subsequently verified and used as the running speed for the 
treatment on CON and for both heat stress tests in both trials. Participants were also 
asked to run downhill on a -10% gradient with expired gas analysed continuously, with 
the running speed adjusted accordingly until 65%VO2max had been verified. This running 
speed was used for the treatment phase to elicit muscle damage on the EIMD trial. 
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Participants were also familiarized with all instrumentation and procedures used in the 
experimental trials. They were given diet diaries to record all food consumed during the 
24 h before and during the first experimental trial and instructed to replicate this diet 
before and during the second trial. 
5.3.4. Experimental Trials 
On the day of the experimental trial, participants arrived at the laboratory [20 °C 
ambient temperature and 40% relative humidity (RH)] at 07:10 h fasted. Participants 
were provided fluids to consume (40 mL·kg-1 NBM·d-1) in the previous 24 h period to 
ensure they began exercise euhydrated, and this was verified by assessing urine specific 
gravity upon arrival (Atago Uricon-Ne refractometer; NSG Precision Cells, Farmingdale, 
NY). Participants were then weighed nude (NBM) on a digital platform scale accurate to 
the nearest 50 g (Model 705; Seca, Hamburg, Germany). On the basis of this body mass, 
participants were then provided with a small breakfast consisting of a cereal bar 
equivalent to 8.4 kJ·kg-1 NBM and water (5 mL·kg-1 NBM). At 08:15 h, baseline 
NBM was again measured, and a rested blood sample was taken before the participant 
fitted a rectal thermistor probe and an HR monitor (Polar Electro, Kempele, Finland). The 
participant also rated their perceived muscle soreness at this point. 
5.3.5. Exercise Trial Treatment 
The exercise trial treatment (EIMD or CON) started at 08:30 h, with participants wearing 
standardized clothing, i.e. running shorts, socks, and shoes. Participants ran for 60 min 
at the predetermined speed that reflected 65% VO2max on either +1% gradient (CON) or 
-10% gradient (EIMD). Rectal core temperature (Tre) and HR were measured every 10 
min, and 60-s expired gas samples were collected by Douglas bag method at 20 and 40 
min of exercise and analyzed for VO2. Water (2 mL·kg-1 NBM) was provided every 15 min 
throughout treatment. 
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5.3.6. Exercise Heat Stress 1 
Immediately after treatment, participants rested for 30 min during which skin 
thermistors were applied. A standardized amount of water (2.5 mL·kg-1 NBM) was also 
provided during this period. Pre heat stress 1 (pre-HS1) NBM was assessed, and a blood 
sample was collected just before the participant entered the environmental chamber 
(Delta Environmental Systems, Chester, UK), which was maintained at a dry bulb 
temperature of 33 °C, 50% RH, and 0.2 m·s-1 face-on wind velocity. Immediately upon 
entering the chamber, a ventilated capsule was attached to the forearm (for local 
sweating rate), and participants then began exercise heat stress (HS1) by 
running ,without fluids, on a motorized treadmill at +1% gradient for 40 min at the 
predetermined running speed that reflected 65% VO2max. Throughout HS1, 
measurements taken were: local forearm sweating rate, HR, Tre, skin temperature (Tsk), 
RPE (Borg 6–20 scale (Borg, 1982)), thermal sensation (McGinnis 0–13 point (Hollies et 
al., 1977)), and 60-s expired gas samples by Douglas bag method VO2. Immediately 
after HS1, participants were removed from the chamber, seated, and a blood sample 
was drawn (post-HS1). Post-HS1, NBM (after towel drying) was re-assessed. Fluids were 
provided to replace sweat losses during HS1, and participants were provided with a 
standardized meal and fluids to consume until they returned to the laboratory the 
following morning for the second heat stress test (HS2). Participants refrained from any 
exercise, caffeine or alcohol in the intervening period between the two HS bouts. 
5.3.7. Exercise Heat Stress 2 
HS2 was performed 24 h after the beginning of HS1. Participants reported to the 
laboratory and were provided with a standardized breakfast and fluids identical to the 
previous day. Participants rated their perceived muscle soreness just before HS2. For 
HS2, participants ran in the same environmental conditions and running speed as that 
during HS1. Before (pre-HS2) and after (post-HS2) exercise heat stress blood samples 
were drawn, and NBM was also assessed. All measures collected during HS2 were 
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identical to HS1. The participant left the laboratory and returned 14 days later to 
complete the remaining trial. 
5.3.8. Measurements and Instrumentation 
Body temperatures. Tre was measured using a flexible, sterile, disposable thermistor 
(Henleys Medical Supplies Ltd., Herts, UK) inserted 12 cm beyond the anal sphincter, 
with temperature recorded using a data logger (YSI model 4000A; YSI, Dayton, OH). 
Participants used the same thermistor in both trials. Tsk was measured at four sites on 
the left side of the body (on the chest at a point midway between the acromion process 
and the nipple, the anterior mid-bicep, the anterior mid-thigh, and the lateral calf) using 
insulated thermistors (Grant EUS-U, Cambridge, UK) fixed to the skin using surgical tape. 
Temperature data were registered using a portable data logger (Grant SQ2020, 
Cambridge, UK). Mean Tsk was calculated using a four-site–weighted equation 
(Ramanathan, 1964). Because of individual skin thermistors becoming detached during 
HS in three participants, Tsk mean data are presented for those with a complete data set 
(n = 10). 
5.3.9. Sweating responses  
Whole-body sweating rate was estimated from NBM losses during HS1 and HS2. Local 
forearm sweating rate was measured by dew point hygrometry. 
Anhydrous compressed nitrogen was passed through a 5 cm2 capsule placed on the 
lower arm ventral surface (halfway between the antecubital fossa and carpus) and 
connected to a hygrometry system (DS2000; Alpha Moisture Systems, UK). Local 
forearm sweating rate was calculated using the difference in water content between 
effluent and influent air and the flow rate (1 L·min-1) and normalized for the skin surface 
area under the capsule (expressed in milligrams per square centimetre per minute). 
Sweating threshold and sensitivity were calculated by plotting individual relationships 
between local forearm sweating rate and Tre values. A simple linear regression equation 
for the initial 4 min of exercise was calculated, with the threshold Tre for active 
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thermoregulatory sweating defined as the Tre at which local forearm sweating rate = 
0.06 mg·cm-2·min-1. Sweating sensitivity was calculated as the slope of the linear 
regression line for both (a) the exercise transient phase (when the rapid increase in 
sweating rate occurred during the initial 4 min of exercise) and (b) the plateau sweating 
phase (when sweating rate plateaued from 6 to 40 min of exercise). 
5.3.10. Rate of metabolic energy expenditure (Ṁ)  
Oxygen consumption (VO2) was calculated for 60 s expired air samples collected into a 
Douglas bag and analyzed for O2 and CO2 concentrations (Servomex, Crowborough, UK) 
and volume (Harvard Apparatus,  Edenbridge, UK). Ṁ was calculated using VO2 (L·min-1) 
and RER in the following equation (Nishi, 1981):  Ṁ (W) = VO2 {21,166[0.23(RER) 
+0.77]} /60. 
5.3.11. Perceived leg muscle soreness 
Perceived leg muscle soreness was self-rated using two scales. First, participants 
rated leg muscle soreness using a 100-mm visual analog scale anchored on the left with 
the phrase ‘‘My leg muscles don’t feel sore at all’’ and anchored on the right with the 
phrase ‘‘My leg muscles feel so sore I don’t want to move them.’’ Participants gave their 
rating while performing a wall sit with their legs bent 90°. Participants also rated 
their leg muscle soreness using a seven-point validated Likert scale (Vickers, 2001) 
while walking up and down the laboratory. 
5.3.12. Blood collection, handling, and analysis  
Whole blood samples were collected, without venestasis, by venepuncture from an 
antecubital vein, and collected into one K2EDTA and one lithium heparin vacutainer tube 
(BD, Oxford, UK). 
Haematocrit (capillary method) using a micro-haematocrit reader (Hawksley & Sons Ltd., 
Lancing, UK) and haemoglobin concentration using a photometer (Hemocue, Sheffield, 
UK) were both analysed immediately on whole blood, in triplicate, with plasma volume 
change calculated (Dill and Costill, 1974). The remaining whole blood was spun in a 
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refrigerated centrifuged at 1500 g for 10 min, with the plasma aspirated, aliquoted into 
eppendorf tubes, and frozen at -80 °C for later analysis. CK activity pre-treatment and 
24 h post-treatment was assessed as an indirect measure of muscle damage. Plasma CK 
activity was measured in duplicate, on lithium heparin-treated plasma using an enzyme 
reaction kit (EnzyChromi CK assay kit; BioAssay Systems, Hayward, CA). The intra-
assay coefficient of variation for CK was 3.8%. Plasma IL-6 concentrations were 
determined at baseline and before and after HS1 and HS2 on EDTA-derived plasma in 
duplicate using a commercially available high sensitivity ELISA (Quantikine_ HS IL-6, 
HS600B; R&D Systems Europe, Abingdon, UK). Intra-assay coefficient of variation for 
plasma IL-6 concentration was 5.3%.  
For all biochemical analyses, the participant’s samples were always assayed on the same 
plate. 
5.3.13. Statistical Analysis 
A sample size calculation was performed (G*Power, 3.1.2) using mean and SD core 
temperature data from Montain et al. (Montain et al., 2000). For a two-tailed test with 
alpha level set at 0.05, and power set at 0.8, recruiting 12 participants was deemed 
appropriate to detect a significant difference in core rectal temperature between the 
conditions during subsequent exercise in the heat. All data were checked for normality 
and sphericity and analysed using either paired t-tests or fully repeated-measures 
ANOVA with the Greenhouse–Geisser correction applied to the degrees of freedom if 
necessary. All F values reported are for the time – trial interaction unless otherwise 
stated. Tukey’s HSD or Bonferroni-adjusted paired t-test post hoc procedures were used 
to determine within-subject differences where appropriate. To assess the contribution of 
acute circulating inflammation (IL-6) after muscle damage on altered heat strain during 
subsequent exercise heat stress, Pearson correlations were performed by correlating the 
pre-HS IL-6 concentration with the final Tre attained during HS. All data were analysed 
using SPSS version 14 software (IBM, NY). Statistical significance was accepted as P < 
0.05. 
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5.4. Results 
5.4.1. Treatment Responses 
 Both treatments [-10% (EIMD) and +1% gradient running (CON)] were conducted at 
the same exercise intensity with no between-trial differences in Ṁ (EIMD = 939 (111), 
CON = 941 (106) W, P = 0.90) or RER (EIMD = 0.92 (0.05), CON = 0.94 (0.05), P = 
0.25). Despite being conducted at the same exercise intensity, ∆Tre was greater during 
60 min -10% downhill running [EIMD = 1.88 °C (0.33) °C] than 60 min +1% gradient 
running [CON = 1.25 °C (0.27) °C; P < 0.001]. However, 30 min post-treatment and 
just before HS1, Tre was not different between trials (P = 0.52). 
Sixty minutes of downhill running was successful in inflicting muscle damage because 
indirect markers of muscle damage, assessed by plasma CK and perceived muscle 
soreness (VAS and Likert scale), were all significantly greater on EIMD than CON 24 h 
post-treatment (P < 0.001, Table 4).  
 
 
Table 4. Markers of muscle damage before and 24 h after either 60 min EIMD (-10% gradient running at 65% 
VO2max) or 60 min of energy-expenditure equivalent control exercise (+1% gradient running at 65% VO2max). 
Values are presented as mean ± SD; n = 13. aEIMD significantly higher than CON (P < 0.001); bLikert scale   
(0 – 6); VAS [visual analog scale (0 – 100 mm)]. 
 
   Before 24 h After 
Plasma CK activity (U·L-1)  EIMD 82 ± 82 253 ± 76a 
  CON 83 ± 60 133 ± 70 
Perceived muscle soreness (VAS)  EIMD 11 ± 10 52 ± 15a 
  CON 6 ± 6 17 ± 9 
Perceived muscle soreness 
(Likert scale)b 
 EIMD 1 ± 0.3 3.4 ± 1.4a 
  CON 2 ± 0.4 7 ± 0.7 
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Furthermore, all participants on EIMD had increases in plasma CK and perceived muscle 
soreness (VAS and Likert scale), and these responses were greater on EIMD compared 
with CON 24 h post-treatment for all participants. There were no baseline differences for 
any of these variables. 
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5.4.2. Exercise Heat Stress Responses 
Rectal core and skin temperature.  
Mean ∆Tre, Tre, and Tsk responses to HS1 and HS2 are presented in Figure 11. 
 
Fig. 11. Change in rectal temperature  (∆Tre, A and B), absolute temperature (Tre, C and D), and mean skin 
temperature (Tsk, E and F) responses during exercise heat stress tests, which involved running for 40 min at 65% 
VO2max in 33 °C, 50 % RH conducted 30 min (HS1) and 24 h (HS2) after treatment, which involved either EIMD 
(-10% gradient running, EIMD, filled bar and circles) or energy equivalent controlexercise (+1% gradient 
running, CON empty bar and circles). EIMD was significantly greater than CON (# P < 0.05, ## P < 0.01). 
Significantly greater than time 0 on both trials (* P < 0.05, ** P < 0.01).†† Main effect of time, significantly 
greater than time 0 (P < 0.01). Data are presented as mean ± SD, n = 13 for Tre and n = 10 for Tsk. 
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Tre demonstrated an interaction during both HS1 (F = 8.8, P < 0.01) and HS2 (F = 6.3, P 
< 0.01). There was no significant difference in starting Tre between trials before HS1 
or HS2. The ∆Tre during HS1 was greater after EIMD than CON (P < 0.01; Fig. 11A). 
During HS1, Tre was significantly higher after EIMD than CON from 16 min onward, 
resulting in a higher final Tre after 40 min of the same exercise heat stress (EIMD = 
39.53 °C (0.42) °C, CON = 39.01 °C (0.38) °C, P < 0.01; Fig. 11C). Furthermore, five 
participants showed evidence of mild hyperthermia with a Tre 39.5 on EIMD compared 
with only one participant on CON. During HS2, ∆Tre was also significantly greater after 
EIMD than CON (P < 0.05; Fig. 11B). Although post hoc testing failed to show any 
significant differences between trials in actual Tre throughout HS2, there was a trend for 
a 0.13 °C higher final Tre on EIMD than CON (P = 0.08; Fig. 11D). Mean Tsk was not 
altered by previous muscle-damaging exercise during HS1 (F = 2.1, P = 0.17; Fig. 11E) 
or HS2 (F = 0.44, P = 0.56; Fig. 11F). 
5.4.3. Sweating rate and plasma volume change  
Whole body sweating rate was not different between trials during HS1 [EIMD = 23.1 
(8.2), CON = 23.2 (5.0) mL·min-1, P = 0.98) or HS2 [EIMD = 21.4 (9.0), CON = 22.6 
(5.0) mL·min-1, P = 0.62]. There was a small interaction for local forearm sweating rate 
during HS1 (F = 2.9, P < 0.05; Fig. 12A), with sweating rate only higher after 2 min of 
exercise on EIMD than CON (P < 0.05). Despite the threshold temperature for initiation 
of sweating visually appearing to occur at a higher Tre on EIMD than CON during HS1 
(Fig. 12C), this was not significant (P = 0.36). There was no difference in sweating 
sensitivity between trials during the initial transient exercise phase (P = 0.50) nor later 
during exercise in HS1 (6–40min, P = 0.19). Throughout HS2, there was no effect of 
sweating threshold temperature (P = 0.95), sweating sensitivity during the initial 
transient phase of exercise (P = 0.69), or sweating sensitivity during the plateau 
sweating phase from 6 to 40 min of exercise (P = 0.17; Fig. 12D).  
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Fig. 12. Local forearm sweating rate reported as a function of time (A and B) and as a function of rectal 
temperature (Tre, C and D) during exercise heat stress tests, which involved running for 40 min at 65 % VO2max 
in 33 °C, 50 % RH conducted 30 min (HS1) and 24 h (HS2) after treatment, which involved either EIMD (-10% 
gradient running, EIMD, filled circle) or energy equivalent control exercise (+1% gradient running, CON, empty 
circle). EIMD was significantly greater than CON (# P < 0.05). ** Significantly greater than time 0 on both trial 
(P < 0.01). †† Main effect of time, significantly greater than time 0 (P < 0.01). Data are presented as mean ± 
SD, n = 11. 
 
There was no effect of muscle damage on plasma volume change during HS1 and HS2 
(no interaction, F = 1.7, P = 0.15, or main effect of trial, F = 0.1, P = 0.75). 
 
Rate of metabolic energy expenditure, RER, and HR.  
Mean Ṁ was significantly higher after EIMD than CON throughout both HS1 and HS2 
[HS1: EIMD = 1040 (115) W, CON = 970 (102) W, P < 0.001; HS2: EIMD = 986 (131) 
W, CON = 920  (113) W, P <0.001]. These metabolic rates equated to 71 (6)% and 66 
(6)% VO2max for EIMD and CON, respectively, during HS1, and 67 (6)% and 62 (6)% 
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VO2max for EIMD and CON, respectively, during HS2. There was no difference in mean 
RER between EIMD and CON throughout either HS1 [EIMD = 0.94 (0.05), CON = 0.92 
(0.04), P = 0.35] or HS2 [EIMD = 0.94 (0.03), CON = 0.96 (0.07), P = 0.19]. Mean HR 
throughout both HS1 and HS2 was significantly greater on EIMD than CON [HS1: EIMD 
= 177 (12) beats·min-1, CON = 168 (14) beats·min-1, P < 0.01; HS2: EIMD = 164 (12) 
beats·min-1, CON = 159 (11) beats·min-1, P < 0.05]. 
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5.4.4. Thermal sensation and RPE  
Thermal sensation and RPE data are presented in Figure 13. Participants rated their 
thermal sensation significantly hotter on EIMD from 25 min onward than CON throughout 
HS1 (F = 5.7, P < 0.01; Fig. 13A). Throughout HS2, there was a trend for a higher 
thermal sensation during EIMD than CON (main effect of trial, F = 4.4, P = 0.06; Fig. 
13B). Participant’s RPE was higher from 25 min onward on EIMD during HS1 (F = 4.1, P 
< 0.05, main effect of trial F = 7.4, P < 0.01; Fig. 13C). Participants RPE was 
considerably higher on EIMD than CON 24 h post-treatment throughout HS2 (main effect 
of trial, F = 11.4, P < 0.01; Fig. 13D). 
 
 
 
Fig. 13. Thermal sensation (A and B) and RPE (C and D) during exercise heat stress tests, which involved 
running for 40 min at 65% VO2max in 33 °C, 50% RH conducted 30 min (HS1) and 24 h (HS2) after treatment, 
which involved either EIMD (-10% gradient running, EIMD, filled circle) or energy equivalent control exercise 
(+1% gradient running, CON, empty circle). EIMD was significantly greater than CON (# P < 0.05, ## P < 
0.01). §§ Main effect of trial (P < 0.01). Data are presented as mean ± SD, n = 13. 
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5.4.5. Plasma IL-6  
Plasma IL-6 concentration was measured as a circulating marker of inflammation. 
Plasma IL-6 concentration was not different between trials at baseline but responded 
differently to the treatment and heat stress tests (F = 18.1, P < 0.001; Fig. 14). Thirty 
minutes after treatment and immediately before HS1, plasma IL-6 concentration was 
significantly elevated above baseline on EIMD (P < 0.001) and CON (P < 0.01). 
Importantly, participants began HS1 on EIMD with a significantly higher plasma IL-6 
concentration than CON (P < 0.01). In addition, the plasma IL-6 exercise response to 
HS1 was significantly greater on EIMD versus CON (P < 0.01). The acute circulating 
inflammatory response after treatment, measured as the pre-HS1 plasma IL-6 
concentration, correlated with the final Tre attained after HS1 in EIMD trial (r = 0.67, P < 
0.01). On day 2, immediately pre-HS2, plasma IL-6 concentrations on both trials had 
returned to baseline values with no difference between trials. As such, the preceding IL-
6 response was not strongly associated with final Tre during HS2 (r = -0.33, P = 0.10). 
Plasma IL-6 concentration increased after HS2 on both EIMD and CON (P < 0.01) with 
no between-trial differences. 
 
Fig. 14. Plasma IL-6 concentrations at baseline and before and after exercise heat stress tests, which involved 
running for 40 min at 65 % VO2max in 33 °C, 50% RH conducted 30 min (HS1) and 24 h (HS2) after treatment, 
which involved either EIMD (-10% gradient running, EIMD, filled circle) or energy equivalent control exercise 
(+1% gradient running, CON, empty circle). ## EIMD significantly greater than CON (P < 0.01). ** 
Significantly greater than baseline (P < 0.01). Data are presented as mean ± SD, n = 13. 
130	  
	  
 
5.5. Discussion 
In agreement with our hypothesis, in non–heat-acclimated males, ∆Tre is increased 
during exercise heat stress performed 30 min after moderate muscle-damaging exercise 
timed to coincide with the early inflammatory phase. This ended in a ~0.5 °C greater 
final Tre during HS1 in muscle damaged participants (final Tre ~39.5 °C) after just 40 min 
of moderate exercise heat stress, which under hot environmental conditions could 
perhaps expedite the progression toward EHI. 
We have also shown that the preceding EIMD-evoked increase in plasma IL-6 
concentration was associated (r = 0.67) with increased heat strain during HS1 conducted 
30 min after exercise heat stress tests, (running for 40 min at 65% VO2max in 33 °C, 50% 
RH) conducted 30 min (HS1) and 24 h (HS2) after EIMD (-10% gradient running) 
relative to energy equivalent control exercise (+1% gradient running).  
When exercise heat stress was timed to coincide with the deferred muscle inflammatory 
phase 24 h after moderate muscle-damaging exercise, we also observed a meaningful, 
even if small, increase in ∆Tre. These results have realistic applicability, particularly for 
non–heat-acclimated athletes and soldiers who undertake repeated, and/or prolonged 
heavy training bouts, with an eccentric component, in hot environmental conditions. 
Thus actions that can decrease EIMD associated inflammation may mitigate the risk of 
EHI. 
Downhill running is often used in studies to evoke muscle damage (Braun and Dutto, 
2003; Paulsen et al., 2012; Peake et al., 2005), and the aim of the model used here was 
to evoke moderate, realistic muscle damage that would not impair the participants ability 
to complete the subsequent exercise heat stress bouts. All participants were able to 
complete the HS bouts, and the degree of muscle damage was equivalent to 
experiencing ‘‘a light pain when walking’’ (Vickers, 2001). As anticipated, EIMD resulted 
in greater increases in plasma CK concentration than CON. Although we acknowledge 
that we did not assess muscle strength as an indicator of muscle damage and the 
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limitations of plasma CK and delayed onset of muscle soreness as markers of EIMD 
(Paulsen et al., 2012), the mode of EIMD (downhill running) and severity of soreness 
perceived may mirror that encountered by soldiers and athletes performing 
unaccustomed exercise. Despite not being a central focus of the current study, an 
important finding in the context of EHI risk is the greater increase in Tre (+0.63 °C) 
during the EIMD treatment in thermo-neutral conditions. This took place even exercise 
intensity was carefully matched in CON and EIMD and is likely interpreted by altered 
muscle fibre recruitment and efficiency during eccentric exercise (Abbott and Wilkie, 
1952). With our primary aim in mind, it is important that Tre was not significantly 
different between trials before commencement of HS1, 30 min later, or HS2, 24 h later. 
To the best of our knowledge, there is only one published study that has examined heat 
strain during exercise heat stress after muscle injury, which showed a 0.2 °C – 0.3 °C 
greater core body temperature than control at 2 h and 7 h, but no effect 26 h after 
injury (Montain et al., 2000). In line with our two phase approach, we noticed a 0.35 °C 
greater increment in Tre during exercise heat stress conducted 30 min post-EIMD timed 
to correspond with the early inflammatory phase, where participants exhibit evidence of 
mild hyperthermia (mean final Tre: EIMD = 39.5 °C, CON = 39.0 °C). The 0.17 °C 
greater increase in Tre during exercise heat stress conducted 24 h post-EIMD indicates a 
minor effect of the delayed muscle inflammatory phase on exercise heat strain. These 
considerations happened without any significant differences between trials in thermo-
effector response measures (e.g., skin temperature, whole body and local sweating rate, 
and sweating sensitivity) or hydration (plasma volume change). We recognize the 
limitations with measuring local sweating rate at only one site, and using Tre to calculate 
sweating sensitivity as opposed to oesophageal temperature, which responds more 
quickly during exercise-induced hyperthermia (Gagnon et al., 2010). We felt that these 
were necessary compromises because of the practical constraints of the running mode of 
exercise and for participant comfort. 
We also acknowledge that additional testing at later time-points post-exercise (48 h-120 
h post) has not been performed. Indeed, many of the criterion measures may peak 48-
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72 h post exercise. Therefore, assessment at these timepoints would have confirmed 
whether or not the criterion measures continued to rise and if muscle function was 
altered. Again we felt this was another necessary compromise to reflect real life 
situations where non–heat-acclimated athletes and soldiers undertake repeated, and/or 
prolonged heavy training bouts, in hot environmental conditions over short periods of 
time. 
Eccentric exercise has been demonstrated to inhibit glycogen resynthesizes (Costill et al., 
1990; O’Reilly et al., 1987), consequently one might hypothesize that modified substrate 
availability may have changed metabolism and contributed to increased heat strain, 
particularly during HS2. However, this is unlikely because we did not notice any 
differences between trials in RER during HS1 or HS2. On the basis of previous evidences 
(Montain et al., 2000), one might also assume a meaningful involvement of reduced 
economy in the increased heat strain after EIMD, possibly due to modified gait, greater 
motor unit recruitment, and/or muscle weakness due to the muscle-damaging protocol 
(Montain et al., 2000). In support of this assertion, Ṁ, HR, and RPE were greater during 
HS1 and HS2 after EIMD. Muscle-damaging exercise in humans has been shown to 
reduce economy, with steady-state exercise VO2 elevated 3% – 7% in the 3 d after 
downhill running (Braun and Dutto, 2003; Chen, Nosaka and Tu, 2007). Furthermore, 
rodent models have provided evidence that damaged muscle fibres also demonstrate 
diminished contraction economy (Warren et al., 1996). 
We assessed circulating IL-6 concentration as a marker of acute inflammation and 
hypothesized that EIMD-evoked increases in circulating IL-6 would be associated with 
increased heat strain during consecutive exercise heat stress 30 min after muscle-
damaging exercise. As expected, EIMD generated a significantly greater elevation in 
circulating IL-6 response than CON before HS1, although it is important that the 
circulating level of IL-6 after EIMD was relatively modest compared with the level usually 
observed after more prolonged, metabolically demanding endurance exercise (Nieman et 
al., 2001).  
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Nevertheless, it has been observed a moderate correlation between the previous 
circulating IL-6 concentration and the final Tre during HS1 in EIMD trial (r = 0.67). It is 
noteworthy to stress the sequential nature of this relationship, that is, it was the 
preceding, perhaps modest, early inflammatory response that was associated with 
subsequent increases in Tre during exercise heat stress. Additionally, these associations 
were not evident during HS2 when pre-HS2 IL-6 concentrations had returned to baseline 
values, with no difference between trials. Because IL-6 is a known pyrogen (Dinarello et 
al., 1991), it is plausible that acute increases in circulating IL-6 after muscle damage 
may act upon the cycloxygenase 2–mediated PGE2 pathway, ending-up in an increment 
in the thermoregulatory set point  (Bradford et al., 2007; Rummel et al., 2006) and heat 
strain during exercise heat stress. However, we recognize the relatively moderate 
augmentation in the circulating IL-6 response after EIMD and that the concept of a 
thermoregulatory set point remains controversial (Romanovsky, 2007). 
Future studies should examine the supposed contribution of pyrogenic pathways after 
muscle damage upon exercise heat strain. Because the exercise intensities on the two 
treatments were carefully matched, with no differences in RER, it is unlikely that 
modified metabolic demands or fuel utilization during treatment could account for the 
greater plasma IL-6 after EIMD. Whether the greater circulating IL-6 response after 
EIMD come from muscle cells, leukocytes, or other cells remains a topic of debate 
(Braun and Dutto, 2003; Montain et al., 2000; Paulsen et al., 2012). 
Soldiers and athletes undergoing heavy training are generally expected to perform 
repeated bouts of arduous physical activity on the same day, often in hot environments 
that might predispose them to EHI. Irrespective of the underlying mechanisms, based on 
the evidences of the present study, it is expected that the non–heat-acclimated soldier 
or athlete may experience greater heat strain during a subsequent exercise heat stress 
bout performed shortly after, and to a much lesser extent, the following day after 
unaccustomed muscle-damaging exercise. It has been also noticed a greater increase in 
Tre during the -10% gradient downhill running treatment than the energy-expenditure 
matched +1% gradient running exercise. Taking this into account, individuals 
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undertaking a prolonged bout of exercise in the heat that includes an eccentric 
component, such as running or walking across mountainous terrain, might also 
experience greater heat strain. Given the increase in thermal sensation during HS1 and 
increase in RPE during HS1 and HS2 after EIMD, the effects of EIMD may be somewhat 
self-limiting; that is, we anticipate that in many cases, the exercising individual would 
lower their exercise intensity while exercising in the heat after EIMD. However, it is a 
common observation in military and athletic scenarios that very motivated and highly 
experienced individuals choose to ignore some of the normal behavioural 
thermoregulation cues (Sawka et al., 2011) so they would be at increased risk of EHI as 
a consequence of EIMD. Likewise, it might be predicted EIMD-associated increased heat 
strain during exercise in the heat when the exercise intensity is externally regulated, for 
example, during group exercises in military scenarios. 
EIMD has not been proposed as a risk factor for EHI in recent reports (Armstrong et al., 
2007; Casa et al., 2012), but our data show that EIMD should be given due 
consideration as a risk factor for EHI, specifically for exercise in hot environments. 
Because it has been shown an association, perhaps moderate, between previous acute 
circulating inflammation and subsequent exercise heat strain, a logical line of exploration 
is to identify strategies that can diminish inflammation, which in turn may mitigate the 
rise in Tre and diminish the risk of EHI during exercise heat stress. It remains to 
bedemonstrated, for example, whether the well known repeated bout effect for muscle-
damaging exercise (Clarkson et al., 1992) or a period of heat acclimatization provides 
protection from the observed increase in heat strain during exercise heat stress after 
EIMD. Nonsteroidal anti-inflammatory drugs (e.g., Ibuprofen) are an unsuitable 
possibility because nonsteroidal anti-inflammatory drugs augment the plasma IL-6 
response in ultramarathon runners (Nieman et al., 2006) and increase gastrointestinal 
permeability, which in turn might increase the risk of EHI through the immune sequelea 
that results from gastrointestinal endotoxin leakage (Lambert et al., 2001; Lim et al., 
2006). Whether actions that dampen inflammation also curtail some of the important cell 
135	  
	  
signalling and associated physiological adaptations with training remains a debatable 
point. 
It is quite credible that strategies to diminish inflammation may decrease the risk of EHI 
for athletes and soldiers performing in hot environments in the short term but 
paradoxically decrease some of the training adaptations in the long term (e.g., anti-
inflammatory supplementation using antioxidants (Peternelj and Coombes, 2011; Ristow 
et al., 2009). Clearly, more evidence is required before we will know whether this is an 
ill-conceived concept. 
In conclusion, these data show that a bout of EIMD, brought about by downhill running, 
increases heat strain during successive endurance exercise in the heat conducted 30 min 
after and, to a much lesser extent, 24 h after muscle damage. EIMD evoked increases in 
the circulating pyrogen IL-6 were associated with increased heat strain during exercise 
heat stress conducted 30 min after EIMD. These results have practical relevance, 
particularly for non–heat-acclimated athletes and soldiers undertaking either multiple, or 
prolonged bouts of heavy exercise with an eccentric component in the heat. 
Consequently, it would be of interest to investigate, and adopt strategies that may 
reduce the risk of EHI following EIMD.  Reducing the degree of muscle damage 
encountered might be a countermeasure to lessen the degree of heat strain encountered.  
One unexplored avenue of investigation is the well-known repeated bout effect of 
muscle-damaging exercise, where a single session of eccentric exercise induces 
adaptations resulting in less evidence of damage when the exercise bout is repeated.   
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CHAPTER SIX 
 
 
 
 
The influence of the exercise-induced muscle damage repeated-
bout-effect upon heat strain during subsequent exercise in the 
heat 
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6.1. Abstract 
Exercise-induced muscle-damage (EIMD) has recently been shown to increase heat 
strain during exercise-heat-stress (HS), and thereby represents a risk factor for EHI.  We 
hypothesised that a repeated-bout of EIMD blunts the increase in rectal temperature (Tre) 
during subsequent endurance exercise in the heat. Sixteen non-heat-acclimated males 
were randomly allocated to EIMD (n=9) or control (CON, n=7).  EIMD performed a 
downhill running treatment at -10% gradient for 60 min at 65% V
.
O2max in 20°C, 40% RH.  
CON participants performed the same treatment but at +1% gradient.  Following 
treatment, participants rested for 30 min, and then performed HS (+1% gradient 
running for 40 min at 65% V
.
O2max in 33°C, 50% RH) during which thermoregulatory 
measures were assessed.  Both groups repeated the treatment and subsequent HS 14-
days later.  Isometric quadriceps strength was assessed at baseline, and 48-h post 
treatment. The decrease in leg strength 48-h post EIMD trial 1 (-7.5%), was absent 48-h 
post EIMD trial 2 (+2.9%) demonstrating a repeated-bout-effect.  Final Tre during HS 
was lower following EIMD trial 2 (39.25 ± 0.47 ºC) compared with EIMD trial 1 (39.59 ± 
0.49 ºC, P< 0.01), with CON showing no difference.  Thermal sensation and the Tre 
threshold for sweating onset were also lower during HS on EIMD trial 2. 
The repeated-bout-effect blunted the increase in heat strain during HS conducted after 
EIMD.  Incorporating a muscle-damaging bout into training could be a strategy to reduce 
the risk of EHI and improve endurance performance in individuals undertaking heavy 
exercise with an eccentric component in the heat.  
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6.2. Introduction 
Exercising in hot conditions poses one of the greatest challenges to homeostasis of the 
human body (Armstrong et al., 2007; Sawka et al., 2011). If heat production during 
exercise is not effectively dissipated, core body temperature can rise to dangerous levels, 
thereby placing the individual at risk of developing EHI (Armstrong et al., 2007) or the 
more serious and potentially fatal condition of EHS (Casa et al., 2012; Sawka et al., 
2011). In addition to exercising in hot and humid environments, a number of risk factors 
for EHI/EHS have been identified, including: inappropriate clothing, inadequate heat-
acclimation, high body mass index, poor physical fitness, dehydration, and underlying 
medical conditions (Armstrong et al., 2007; Epstein et al., 1999; Rav-Acha et al., 2004; 
Sawka et al., 2011).  Other potential risk factors, which are less well supported include 
disruption of sleep, and the circulating inflammatory response (Bouchama, 1995; Lim 
and Mackinnon, 2006; Moore et al., 2013; Shephard and Shek, 1999). Highly motivated, 
well trained athletes, who may ignore normal thermoregulatory behavioural cues, and 
military personnel, in whom evaporative cooling is limited due to their occupational 
clothing, and where exercise intensity is often externally regulated, are two groups who 
may be at particular risk of EHI/EHS (DeMartini et al., 2014). A number of deaths in 
athletes and military personnel each year are attributed to EHS (Carter et al., 2005; 
Casa et al., 2012; Rav-Acha et al., 2004). These groups regularly perform multiple bouts 
of heavy exercise, often within a short time span and in hot environmental conditions, 
and often involving an eccentric component (e.g. walking downhill/jumping/lunging etc.).  
As discussed previously (Chapter 5), it has been recently shown by Fortes et al. (2013), 
and others (Montain et al., 2000), that prior exercise-induced muscle-damage (EIMD) 
increases heat strain during exercise-heat-stress conducted shortly after muscle damage.  
For example, final rectal temperature (Tre) was 0.53 °C higher during 40 min of 
moderate exercise-heat-stress conducted 30 min after 1-hour of EIMD, compared to 
identical exercise-heat-stress conducted 30 min after 1-hour of non-muscle-damaging 
control exercise (Fortes et al., 2013). This increased heat strain suggests that 
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performing exercise with an eccentric component may represent an additional risk factor 
for EHI. 
Clearly, it is of interest to investigate and adopt strategies that may reduce the risk of 
EHI.  It is plausible that reducing the degree of muscle damage encountered will lessen 
the degree of heat strain encountered.  One obvious, but unexplored avenue of 
investigation is the well-known repeated bout effect of muscle-damaging exercise, where 
a single session of eccentric exercise induces adaptations resulting in less evidence of 
damage when the exercise bout is repeated (Clarkson et al., 1992; Clarkson and Hubal, 
2002; McHugh et al., 1999).  The mechanism to explain this repeated bout effect is not 
fully understood, though likely involves neural, cellular and mechanical mechanisms 
(Clarkson et al., 1992; Clarkson and Hubal, 2002; McHugh et al., 1999).   In our 
previous study (Fortes et al., 2013), increased circulating interleukin (IL)-6 
concentration following EIMD was associated with increased heat strain during 
subsequent exercise heat stress, a pertinent finding due to a potential inflammatory role 
in the aetiology of EHI/EHS (Bouchama, 1995; Lim and Mackinnon, 2006; Shephard and 
Shek, 1999).  A dampening of the inflammatory response is one proposed explanation 
for the repeated bout effect (Pizza et al., 1996), and given that there is some evidence 
that circulating IL-6 concentration is reduced following a second, repeated bout of EIMD 
compared with the first bout (Smith et al., 2007) this may provide a mechanism for a 
potential beneficial repeated bout effect in reducing heat strain. Also, circulating 
extracellular (e)Hsp 72 was measured as concentrations have been shown to increase 
following EIMD (Peake et al., 2005). Additionally, eHsp72 itself may have direct 
pyrogenic effects (Pastukhov et al., 2003), and it provides another measure of the 
inflammatory response due to its immune-stimulating capability (Asea et al., 2000; 
Whitham and Fortes, 2008). 
With this in mind, the aim of this study was to investigate the influence of the EIMD 
repeated-bout-effect upon heat strain during subsequent exercise in the heat.  To this 
end, we had non-heat-acclimated participants perform muscle-damaging exercise using 
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a downhill running model, and then assessed heat strain during an exercise-heat-stress 
test conducted 30 min post EIMD to coincide with the circulating inflammatory response.  
This procedure was then repeated 14 days later.  We hypothesised that the second 
(repeated) bout of EIMD would blunt the increase in Tre during subsequent exercise-
heat-stress compared with the first EIMD trial.  In order to discount any potential 
temporary heat acclimation, or passage of time effects, a separate control group 
undertook all identical procedures, except that non-muscle-damaging exercise was 
performed instead of EIMD. 
 
6.3. Methods 
6.3.1. Participants 
Sixteen healthy, physically active males volunteered to participate in the study, giving 
fully-informed consent in writing. The study received local ethical approval and was 
conducted according to the standards required by the Declaration of Helsinki.  
Characteristics of the participants were as follows: (Mean ± standard deviation): age, 
21.9 ± 1.7 yr; nude body mass, 72.3 ± 7.5 kg; height, 176 ± 7 cm; body mass index, 
23.1 ± 1.9 kg·m-2; body surface area, 1.88 ± 0.12 m2, and maximal oxygen uptake 
(VO2max) 59 ± 5 mL·kg-1·min-1. Participants were excluded if they were heat-acclimated, 
or regularly undertook downhill running or eccentric exercise as part of their normal 
training.  Participants were non-smokers, and free from any known immune, 
cardiovascular or metabolic disease.  To further confirm participants were free from 
upper-respiratory tract infections, on each of the 14 days preceding both main trials, 
participants completed an illness-specific questionnaire (WURSS-44) (Barrett et al., 
2002).  No participants were taking any medication (e.g. non-steroidal anti-inflammatory 
drugs) or generic ergogenic supplementation.  Participants were asked to refrain from 
exercise 72 hours prior to, and from alcohol and caffeine 24 hours prior to all exercise 
bouts.   
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6.3.2. Study design 
Participants were randomised to one of two protocols, EIMD or CON.  Nine participants 
completed an exercise-heat-stress-test 30 min after a treatment of muscle-damaging 
exercise (EIMD: running downhill on -10% gradient) (trial 1). This protocol was repeated 
two weeks later (trial 2).  A separate control group (CON, n = 7) performed energy 
expenditure equivalent non-muscle-damaging exercise treatment (CON: running at +1% 
gradient), followed 30 min later by the exercise-heat-stress test, with the protocol 
repeated 14 days later.  Thermoregulatory measurements (Tre, skin temperature (Tsk), 
sweating rate), perceptual measures (thermal sensation, rating of perceived exertion), 
heart rate, and metabolic energy expenditure, were assessed throughout all heat stress 
tests.  Blood samples were collected at pre-treatment, pre, post and 1-hour post HS on 
all trials and assessed for circulating inflammatory markers IL-6, IL-10, and heat shock 
protein (Hsp) 72 concentration.  Circulating extracellular (e)Hsp72 was measured as 
concentrations have been shown to increase following EIMD (Peake et al., 2005). 
Additionally, eHsp72 itself may have direct pyrogenic effects (Pastukhov et al., 2003), 
and it provides an other measure of the inflammatory response due to its immune-
stimulating capability (Asea et al., 2000; Whitham and Fortes, 2008). Isometric leg 
strength of the quadriceps, and perceived muscle soreness were determined at baseline 
and 48-hours post trials to assess the degree of muscle damage.  There were no 
differences in anthropometric or fitness data between the groups.  An overview of the 
study design is presented in Figure. 15. 
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Fig. 15. Schematic of experimental procedures. EIMD, exercise-induced muscle damage; CON, energy 
expenditure equivalent control exercise; HS, exercise heat stress; RH, relative humidity. † denotes blood 
sampling time points. Isometric leg strength was assessed at baseline and 48-hours post HS. 
 
6.3.3. Preliminary testing and familiarisation 
The VO2max for each participant was determined by a continuous maximal incremental 
exercise test to exhaustion performed on a motorised treadmill (HP Cosmos Mercury 4.0, 
Nussdorf-Traunstein, Germany) (Fortes et al., 2013).  Expired gas was analysed by an 
on-line breath-by-breath system (Cortex Metalyser 3B, Biophysik, Leipzig, Germany).  
After this, the treadmill running speed, which elicited 65%, VO2max running at +1% 
gradient was obtained by interpolation of the running speed-VO2 relationship.  A running 
speed verification was then conducted and employed as the running speed for the 
treatment on the CON group, and for the heat stress test for both groups.  A subsequent 
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verification was also performed on downhill running at -10% gradient with expired gas 
analysed on a continuous basis, and with the running speed adjusted accordingly until 
65% VO2max was attained. This downhill running verification took no more than 6 
minutes, and the verified running speed was used during treatment on those assigned to 
muscle-damaging (EIMD) trials.  Expired gas data were averaged every ten seconds over 
a period of two minutes during this process of verification. All instrumentation and 
procedures used in the experimental trials were also presented to participants at this 
time.  Thirty minutes after this verification was completed, maximal isometric leg 
strength was measured to assess participants’ baseline quadriceps leg-strength within 7 
days of the first experimental trial.  Diet diaries were provided to record all food 
consumed during the 24 hours prior to, and during the first experimental trial, and 
participants were instructed to replicate this before and during the second trial 14 days 
later. 
6.3.4. Experimental trials 
On the day of each experimental trial participants reported to the laboratory (ambient 
temperature 20 °C and relative humidity (RH) 40%) at 07:10 am having fasted 
overnight. Participants were provided fluids to consume (40 mL·kg-1·NBM·d-1) in the prior 
24-hour period to ensure they began exercise euhydrated. This was verified by checking 
that urine-specific gravity (Atago Uricon-Ne refractometer, Atago Co., Ltd. Tokyo, Japan.) 
upon arrival was less than 1.028 (Armstrong et al., 2010). Participants’ fasted condition 
was verified by a finger-prick blood sample analysed for glucose and ensuring the 
reading was <6 mg·dl-1 (ACCU-CHECK Aviva, Roche, Basel, Switzerland). Participants’ 
nude body mass (NBM) was then measured on a digital platform scale accurate to the 
nearest 50 g (model 705, Seca, Hamburg, Germany). A cereal bar equivalent to 8.4 
kJ·kg-1 NBM and water (5 ml·kg-1 NBM) was subsequently provided to participants based 
on this body mass. At 08:15am, baseline NBM was measured, and a resting blood 
sample was taken before the participant fitted a rectal thermistor and heart rate monitor 
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(Polar Electro, Kempele, Finland).  The participants also rated their perceived muscle 
soreness at this stage.  
6.3.5. Exercise trial treatment 
The exercise trial treatment (EIMD or CON) started at 08:30 am, with standardised 
clothes worn by participants (e.g. running shorts, socks and shoes). Participants ran for 
60 min at the individualised predetermined speed that reflected 65% VO2max on either 
+1 % gradient (CON) or -10% gradient (EIMD). Rectal core temperature and heart rate 
(HR) were assessed every 10 min, and 60 s expired gas samples were collected by 
Douglas bag method at 20 and 40 min of exercise, and analysed for VO2. Water (2 
mL·kg-1NBM) was provided throughout treatment every 15 min. 
6.3.6. Exercise heat stress 
After the treatment, participants sat for 30 min in a temperature-controlled environment 
(20 °C) during which skin thermistors were applied (Grant EUS-U, Cambridge, UK). 
Participants were provided with a standardised amount of fluids (2.5 mL·kg-1NBM) during 
this time. A blood sample was collected and pre-heat stress NBM was determined just 
before the participant entered an environmental chamber (Delta Environmental System, 
Chester, UK) which was kept at a dry bulb temperature of 33 °C, 50% RH, and 0.2 m·s-1 
face-on wind velocity. Immediately upon entering the chamber, a ventilated capsule was 
fastened to the forearm (for local sweating rate). Participants then began exercise-heat-
stress (HS) by running without fluids, on a motorised treadmill at +1% gradient for 40 
min at the predetermined set running speed that reflected 65% VO2max. Throughout HS, 
the following measurements were taken: local forearm sweating rate, HR, Tre, 
physiological strain index (Moran et al., 1998) and skin temperature (Tsk) continuously; 
rating of perceived exertion (RPE, Borg 6-20 scale (Borg, 1982)) and thermal sensation 
(McGinnis 0-13 points (Hollies and Goldman, 1977)) every 5 min; and 60 s expired gas 
samples by Douglas bag method (VO2) every 10 min of exercise. Immediately after HS, 
participants were removed from the chamber, seated, and a blood sample was taken 
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after a standardised period of 3 min (post HS). Post HS NBM (following towelled drying) 
was also determined at this time. Water was provided to replace sweat losses 
encountered during HS. A further blood sample was taken 1-h post HS. Participants were 
then provided with a standardised meal (3290 kJ), and fluids to consume until they 
came back to the laboratory 48-h later for assessment of leg strength and perceived 
muscle soreness. Participants were required to refrain from any exercise, or ingesting 
caffeine or alcohol in this 48-h intervening period. The participant left the laboratory and 
returned 14 days later to repeat the trial (trial 2). 
6.3.7. Assessment of muscle damage  
Isometric right-leg quadriceps strength was assessed on a dynamometer (HUMAC norm, 
CSMi, Stoughton, MA, USA).  Participants were sat upright and strapped in on their 
upper extremities to limit excess motion. The chair was adjusted so that the pivot was 
located on the lateral epicondyle of their right leg.  A lever was applied to the right leg 
and adjusted so that the pad was located on the inferior part of the tibialis anterior.  This 
lever was locked in at an angle of 70 ° leg extension. A warm-up protocol consisted of 
six sub-maximal repetitions (two repetitions at 25%, 50% and 75% of perceived effort) 
with a 30 s recovery between each repetition.  Following a 2 min rest period, participants 
were required to exert maximal isometric force against the lever pad.  Verbal 
encouragement was given throughout each repetition. Isometric leg strength of the 
quadriceps was determined by the peak torque elicited from four maximal 5s 
contractions (with a 90 s recovery between each). A separate pilot study conducted 
within our laboratory showed that there was no learning effect for this test, and that 
peak torque determined from this test has a day-to-day co-efficient variation of 5.5%.  
Perceived leg muscle soreness was self-rated by participants on a seven-point validated 
Likert scale (Vickers, 2001), whilst walking up and down the laboratory. The participant 
was blinded to the scores they had previously reported. 
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6.3.8. Body temperatures 
Rectal core temperature was assessed using a standard flexible, sterile, disposable 
thermistor (Henleys Medical Supplies Ltd, Herts, UK) inserted 12 cm beyond the anal 
sphincter, with temperature recorded using a data logger (YSI model 4000A, YSI, 
Dayton, USA). In both repeated trials participants used the same thermistor.  Insulated 
thermistors (Grant EUS-U, Cambridge, UK) were attached to the skin via surgical tape 
which conducted heat and allowed evaporation (Hypafix, BSN medical GmbH, Hamburg, 
Germany), and were used to measure Tsk at four sites on the left side of the body (on 
the chest at a point equi-distant to the acromion process and the nipple, the anterior 
mid-bicep, the anterior mid-thigh, and the lateral calf). The amount of tape used was 
standardised both between and within participants. Temperature data were registered 
using a portable data logger (Grant SQ2020, Cambridge, UK). Mean Tsk was calculated 
using a four-site weighted equation (Ramanathan, 1964).  
6.3.9. Sweating responses 
Whole-body sweating rate was estimated from nude body mass losses during HS.  Local 
forearm sweating rate was measured by dew-point hygrometry. Anhydrous compressed 
nitrogen was passed through a 5 cm2 capsule placed on the lower arm ventral surface 
(half-way between the antecubital fossa and carpus), and connected to a hygrometry 
system (DS2000, Alpha Moisture System, UK). Local forearm sweating rate was 
calculated using the difference in water content between effluent and influent air and the 
flow rate (1 L·min-1), and normalised for the skin surface area under the capsule 
(expressed in mg·cm-2·min-1). Sweating threshold and sensitivity were calculated by 
plotting the individual relationship between local forearm sweating rate and Tre values.  A 
simple linear regression equation for the first 6 min of exercise was calculated, with the 
threshold Tre for active thermoregulatory sweating defined as the Tre at which local 
forearm sweating rate = 0.06 mg·cm-2·min-1 (Buettner, 1959). Sweating sensitivity 
during the exercise transient phase was calculated as the slope of this linear regression 
line. 
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6.3.10. Rate of metabolic energy expenditure (Ṁ) 
Oxygen consumption (VO2) was calculated from 60 s expired air samples collected into a 
Douglas bag and analysed for O2 and CO2 concentrations by a paramagnetic and infrared 
gas analyser (Servomex 5200 Multipurpose, Crowborough, UK), and volume (Harvard 
Apparatus, Edenbridge, UK). Respiratory exchange ratio (RER) was calculated, and Ṁ  
was determined using VO2 (L·min-1) and RER in the following equation (Nishi, 1981): 
Ṁ (W) = VO2 (21166 [0.23 (RER) + 0.77])/60. 
6.3.11. Blood collection, handling and analysis 
Whole blood samples were collected by venepuncture from an antecubital fossa vein and 
gathered into two K2EDTA and one lithium-heparin vacutainer tubes (BD, Oxford, UK).  
Haematocrit (capillary method in triplicate) using a micro-haematocrit reader (Hawksley 
& Sons Ltd., Lancing, UK) and haemoglobin concentration using a photometer 
(Haemocue, Sheffield, UK) were both analysed immediately on heparinised whole blood 
in triplicate with plasma volume change calculated (Dill and Costill, 1974).  The 
remaining whole blood was spun in a refrigerated centrifuge at 1500 g for 10 min, with 
the plasma aspirated, aliquoted into reaction tubes, and frozen at -80 °C for subsequent 
analysis.  Circulating IL-6 and IL-10 concentrations were assessed on EDTA derived 
plasma using commercially available high-sensitivity ELISAs (Quantikine® HS IL-6, 
HS600B; Quantikine® HS IL-10, HS100C, R&D Systems Europe, Abingdon, UK).  
Circulating eHsp72 concentration was also assessed by commercially available ELISA 
(Hsp72 EIA kit, ADI-EKS-700B, Enzo Life Sciences LTD, Farmingdale, USA).  Intra-assay 
co-efficient of variation for circulating IL-6, IL-10 and eHsp72 concentration was 3.2 %, 
5 %, and 3 % respectively.  For all biochemical analyses, all participants’ samples were 
always assayed on the same plate. 
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6.3.12. Statistical analysis 
A sample size calculation was performed (G*Power, 3.1.5) using mean and standard 
deviation Tre data from our previous study (Fortes et al., 2013). For a two-tailed test 
with alpha level set at 0.05, and power set at 0.8, it was deemed appropriate to recruit a 
minimum of 7 participants in each group to detect a meaningful difference in final Tre 
during subsequent exercise in the heat. Due to recruitment randomisation, 9 participants 
were recruited into the EIMD group, and 7 into CON.  All data were checked for 
normality and sphericity.  Data were analysed within condition (i.e. EIMD trial 1 vs trial 
2), using two way repeated measures ANOVA or paired t-tests as appropriate. 
Bonferroni-adjusted paired t-test post-hoc procedures were used to determine within-
subject differences. Pearson product moment correlation was also performed to assess 
the relationship between change in leg strength 48h after EIMD with change in Tre during 
HS.  All data were analysed using SPSS version 20 software (IBM, NY, USA).  Data are 
presented as means ± SD.  Statistical significance was accepted as P < 0.05. 
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6.4. Results 
6.4.1. Treatment responses 
The experimental model was successful in demonstrating a repeated bout effect of 
muscle damage, since the decrease in isometric leg strength 48h following EIMD trial 1 
(-7.5 % vs baseline), was absent 48 h post EIMD 2 (+2.9 % vs baseline) (P < 0.01 
versus trial 1, Fig. 16A), and the increase in perceived muscle soreness 48-h post EIMD 
in trial 1, was blunted in trial 2 (P < 0.05, Fig. 16C).  The control group did not 
demonstrate any differences in leg strength (P = 0.37, Fig. 16B) or muscle soreness (P 
= 0.60, Fig. 16D) between trial 1 and trial 2.   There were no differences between trials 
1 and 2 in either EIMD or CON for ΔTre during treatment (EIMD trial 1, 1.84 ± 0.35, trial 
2 = 1.77 ± 0.43 °C, P = 0.53; CON trial 1 = 1.36 ± 0.49, trial 2 = 1.48 ± 0.43 °C, P = 
0.42).   
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Fig. 16. Markers of muscle damage (leg strength peak torque  (a and b) and muscle soreness (c and d)) 
assessed 48-h after either 60 min exercise-induced muscle damage (-10% gradient running at 65% VO2max, 
EIMD, triangles, n = 9, a and c) or 60 min of control exercise (+1% gradient running at 65% VO2max, CON, 
circles, n = 7, b and d).  Trial 1 represents the first bout, trial 2 represents the repeated bout performed 14 
days later. Individual responses are shown, with mean data shown as solid black squares.  # P < 0.05, ##P < 
0.01 vs trial 1.  
 
6.4.2. Exercise heat stress responses 
Rectal temperature, skin temperature and physiological strain index 
Rectal core and Tsk responses to HS are presented in Fig. 17. There were no significant 
differences in Tre and Tsk responses to HS between CON trial 1 and CON trial 2 (Figs. 
17B, 17D, 17F), confirming that there was no temporary heat acclimation effect of the 
first HS test on the second HS test or time effect on heat strain responses to HS.  All 
participants on EIMD had a lower final Tre during HS on EIMD trial 2 (39.25 ± 0.47 ˚C) 
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compared with EIMD trial 1 (39.59 ± 0.49 ˚C, P < 0.01, Fig. 17A), with only two 
participants showing evidence of mild hyperthermia during HS on EIMD trial 2 (final Tre > 
39.5 ˚C) compared with seven on EIMD trial 1. Physiological strain index was lower 
during HS on EIMD trial 2 (6.8 ± 2.8) compared with EIMD trial 1 (7.3 ± 3.1, P < 0.01). 
There was no significant difference in starting Tre between EIMD trials 1 and 2 before HS, 
but Tre was significantly lower on EIMD trial 2 compared with EIMD trial 1 throughout HS 
(main effect of trial, F = 22.2, P < 0.01), with a trend for an interaction (F = 2.9, P = 
0.09, Fig. 17C).  The ΔTre during HS was also lower after EIMD trial 2 (1.61±0.33 ˚C) 
than trial 1 (1.81±0.40 ˚C, P<0.05) and the ΔTre during HS correlated moderately with 
leg strength loss 48-h post EIMD (r = 0.46, P = 0.05).  There was no repeated bout 
effect on mean Tsk during HS following EIMD (P = 0.32), Fig. 17E). 
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Fig. 17. Final rectal temperature (Tre, a and b), absolute rectal temperature (Tre, c and d) and mean skin 
temperature (Tsk, e and f) responses during exercise-heat-stress tests which involved running for 40 min at 
65% VO2max in 33°C, 50% RH conducted 30 min after treatment which involved either exercise-induced muscle 
damage (-10% gradient running, EIMD, triangles, n = 9) or control exercise (+1% gradient running, CON, 
circles, n = 7). Note: due to individual skin thermistors becoming detached during HS, Tsk data (figs. E and F) 
are presented in those with a full data set (n = 7 EIMD, n = 6 CON).  Individual responses are shown for final 
Tre (a and b), with mean data shown as solid black squares (## P < 0.01 versus trial 1).  For panels c-f, mean 
± SD data are shown, with trial 1 representing the first bout (filled symbols), and trial 2 representing the 
repeated bout performed 14d later (open symbols). § Trial 2 significantly lower than trial 1 (main effect of trial, 
P < 0.05).	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6.4.3. Sweating rate and plasma volume change 
Whole body sweating rate was not different between the EIMD trials during HS (EIMD 
trial 1 = 23.3 ± 5.0, EIMD trial 2 = 23.0 ± 7.6 mL·min-1, P = 0.89), but there was a 
tendency for a higher forearm local sweating rate on EIMD trial 2 (F = 2.6, P = 0.08) 
during HS on EIMD trials (Fig. 18A).  Although there was no difference in sweating 
sensitivity between EIMD trials during the initial transient exercise phase (P = 0.17), the 
threshold temperature for sweating onset was significantly lower on EIMD trial 2 than 
EIMD trial 1 (EIMD trial 1 = 37.74 ± 0.16 ˚C, EIMD trial 2 = 37.58 ± 0.24 ˚C, P < 0.05; 
Fig. 18B).  No differences were observed during HS for sweating rate, sweating onset, 
or sweating sensitivity between CON trial 1 and 2. There was no effect on plasma 
volume change following HS on EIMD or CON trials. 
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Fig. 18. Local forearm sweating rate reported as a function of time (a), and as a function of rectal temperature 
(Tre, b) during exercise-heat-stress tests which involved running for 40 min at 65% VO2max in 33 °C, 50% RH 
conducted 30 min after exercise-induced muscle damage (-10% gradient running, n = 9).  Trial 1 represents 
the first bout (filled triangles), trial 2 represents the repeated bout performed 14d later (open triangles). 
Values are means (±SD in fig A). # Significantly different Tre for sweating onset (P < 0.05).	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6.4.4. Rate of metabolic energy expenditure, RER and HR  
There were no between-trial differences on EIMD for mean Ṁ (trial 1 =1045 ± 115, trial 
2 =1030 ± 128 W, P=0.21), indicating no improvement in running economy between 
trials.  These metabolic rates equated to 75% ± 5% and 74% ± 6% VO2max for EIMD 
trial 1 and trial 2 respectively, during HS.  No difference was observed in mean RER or 
HR between EIMD trial 1 and EIMD trial 2 during HS (RER: EIMD trial 1 = 0.88 ± 0.03, 
EIMD trial 2 = 0.88 ± 0.04, P = 0.80, HR EIMD trial 1 = 176 ± 14 beats·min-1, EIMD trial 
2 = 175 ± 12 beats·min-1, P = 0.54). No differences were observed during treatment for 
mean Ṁ between CON trial 1 and 2. 
6.4.5. RPE and thermal sensation 
Thermal sensation and RPE data for EIMD are presented in Fig. 19. Participants rated 
their thermal sensation lower throughout HS following EIMD trial 2 compared with trial 1 
(main effect of trial, F = 6.5, P < 0.05, Fig. 19A).  There was a trend (main effect of 
trial, F = 3.7, P = 0.09) for participants to rate their perceived exertion lower during HS 
following EIMD trial 2 compared with EIMD 1 (Fig. 19B).  No differences were observed 
during HS for RPE or thermal sensation between CON trial 1 and 2. 
156	  
	  
 
Fig. 19. Thermal sensation (a), and rating of perceived exertion (RPE, b) during exercise-heat-stress tests 
which involved running for 40 min at 65% VO2max in 33 °C, 50% RH conducted 30 min after exercise-induced 
muscle damage (-10% gradient running, n = 9). Trial 1 represents the first bout (filled triangles), trial 2 
represents the repeated bout performed 14d later (open triangles). § Trial 2 significantly lower than trial 1 
(main effect of trial, P < 0.05). Data are mean ± SD. 
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6.4.6. Plasma IL-6 and IL-10, and eHsp72 
Circulating concentrations of IL-6, IL-10 and eHsp72 responses to EIMD are depicted in 
Fig. 20.  There was no EIMD repeated bout effect on the inflammatory response 
between trial 1 and 2 for IL-6 (F = 2.3, P = 0.11), IL-10 (F = 0.7, P = 0.45), or eHsp72 
concentrations (F = 0.8, P = 0.45).  Similarly, there were no between trial effects on 
CON for IL-6 (F = 0.9, P = 0.44), IL-10 (F = 0.2, P = 0.73), or eHsp72 concentration (F 
= 2.2, P = 0.15). 
 
158	  
	  
 
Fig. 20. Plasma interleukin (IL)-6 (a), plasma IL-10 (b), and extracellular heat shock protein (Hsp) 72 (c) 
concentrations at baseline, pre, post and 1h-post exercise-heat stress (HS), which involved running for 40 min 
at 65% VO2max in 33°C, 50% RH, conducted 30 min after exercise-induced muscle damage (-10% gradient 
running, n = 9). Trial 1 represents the first bout (filled triangles), trial 2 represents the repeated bout 
performed 14d later (open triangles). No significant effects. Data are mean ± SD. 
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6.5. Discussion 
We have recently shown that an acute bout of EIMD increases heat strain during 
subsequent exercise heat stress (HS), and thus, EIMD likely poses a risk factor for EHI 
(Fortes et al., 2013). The aim of the present study was to investigate if the well-known 
repeated bout effect for EIMD (Clarkson et al., 1992; McHugh et al., 1999) would blunt 
the increase in heat strain during subsequent exercise-heat-stress. In line with our 
hypothesis, heat strain was reduced (0.34 °C lower final Tre) during HS following the 
second EIMD bout, compared with the first bout. Furthermore, 7 of 9 participants 
showed evidence of mild hyperthermia (final Tre > 39.5 °C) during HS on EIMD trial 1 
compared with only 2 of 9 participants during HS following EIMD trial 2.  In addition, we 
observed a lower temperature threshold for sweating onset, a lower thermal sensation 
and a lower physiological strain index during HS after the second EIMD bout.  This 
lessened heat strain during HS on the repeated EIMD trial was not due to temporary 
heat acclimation as a consequence of the first HS bout, nor due to passage of time 
effects, since no difference in heat strain was observed in the control group.  By blunting 
the increase in thermal strain during exercise-heat-stress, incorporating a muscle-
damaging bout into training could be used as a practical strategy to reduce the risk of 
EHI, and improve exercise performance, in individuals undertaking subsequent heavy 
exercise bouts with an eccentric component in the heat. 
Unaccustomed and/or heavy eccentric exercise is known to result in EIMD, and is 
characterised by decreased muscle strength, and increased muscle soreness in the days 
following EIMD (Clarkson et al., 1992; Clarkson and Hubal, 2002).  We utilised a 
downhill running model to evoke moderate, realistic muscle damage, evidenced by 
significant decreases in leg strength (-7.5%), and increases in muscle soreness 48-h 
post EIMD trial 1.  This degree of muscle damage is equivalent to experiencing ‘a light 
pain when walking’ (Vickers, 2001) and therefore likely reflects the degree of muscle 
damage that may be encountered by soldiers and athletes undergoing unaccustomed 
exercise with an eccentric component.  Research has consistently shown, that a prior 
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muscle-damaging bout produces a protective adaptation that results in lesser symptoms 
of EIMD when the muscle-damaging bout is repeated (e.g. blunted losses of leg strength, 
and reductions in muscle soreness)	  (Byrnes et al., 1985; Clarkson et al., 1992; McHugh 
et al., 1999).  The success of the repeated bout effect was demonstrated herein, since 
leg strength was restored to baseline levels, and muscle soreness was significantly 
reduced 48-h following the repeated bout of EIMD.   
Heat strain during HS was reduced following the second, repeated bout of EIMD 
compared with the first, with the ΔTre, and final Tre reduced 0.2 °C and 0.34 °C 
respectively during HS on EIMD trial 2 compared with trial 1.  The final Tre on EIMD trial 
2 was similar to the final Tre observed in the control group during HS on both CON trials 
(Fig. 17 c and d), although we acknowledge that these groups were composed of 
different individuals, so are not directly comparable.  In our previous study (Fortes et al., 
2013), final Tre was 0.53 °C higher during HS following EIMD compared to control non-
muscle-damaging exercise in a repeated measures design, whilst Montain et al. (2000), 
also demonstrated ~0.3 °C greater body temperature during HS following muscle-
damaging exercise compared to control exercise.  It therefore appears that a prior bout 
of EIMD provides a significant degree of protection against the increased heat strain that 
EIMD elicits during subsequent exercise-heat-stress. It is acknowledged the limitation 
that it has not been established a performance benefit due to the reduced heat strain but 
anticipate a delay in reaching a critical core temperature (purported to be ~40 °C 
(Gonzalez-Alonso et al., 1999)) after repeated EIMD.  Further research should 
investigate whether the observed reduction in thermal strain with repeated EIMD 
translates into a meaningful performance improvement. In this regard, its noteworthy 
that a similar reduction in final exercising Tre (-0.3 °C) during exercise-heat-stress after 
5 d heat acclimation brought about a 14% improvement in endurance performance 
during exercise in the heat (Garrett et al., 2009). Additional confidence in our findings 
could be added, since a particular strength of the current study is that a comparable 
control group was used in order to discount confounding heat acclimation or passage of 
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time effects.  Previous research has also shown no effect of a single prior heat stress 
bout on subsequent thermoregulatory responses during exercise heat stress conducted 
14 days later (Barnett and Maughan, 1993).  
The circulating IL-6 response to muscle-damaging exercise has been shown to be higher 
compared with non-muscle-damaging exercise (Bruunsgaard et al., 1997), a finding 
supported by our previous study (Fortes et al., 2013) where the elevated circulating IL-6 
concentration following EIMD correlated with the final Tre attained during subsequent HS.  
An elevated circulating IL-6 prior to heat stress is significant, given potential 
involvement of the acute inflammatory response in the aetiology of EHI (Bouchama, 
1995; Lim and Mackinnon, 2006; Shephard and Shek, 1999; Walsh et al., 2011).  A 
“dampening” of the inflammatory response is one proposed explanation for the repeated 
bout effect (Pizza et al., 1996).  Indeed, a previous study has shown reduced pyrogenic 
cytokines (IL-6), and increased anti-inflammatory cytokines (IL-10) in the 12 hours 
following a repeated bout of muscle damage evoked by downhill running (Smith et al., 
2007), although this finding is not supported by studies that have used different models 
of muscle damage (e.g. isokinetic knee extensor exercise (Croisier et al., 1999; 
Willoughby et al., 2003)). Therefore, it was of intereste in whether the hypothesised 
reduction in heat strain could be accounted for by an altered circulating inflammatory 
response following EIMD.  However, it was not observed any difference in pyrogenic IL-6 
or anti-inflammatory IL-10 response either prior to, or after heat stress between the two 
EIMD bouts.  It should be noted that in the study by Smith et al. (2007), cytokine 
concentrations were averaged over the 12 hour period following EIMD, thereby not 
providing useful information on the kinetics of the early inflammatory response 
immediately following EIMD. eHsp72 concentration was also assesed, which has been 
shown to be elevated following downhill running (Peake et al., 2005), and is known to 
act as a “danger signal” activating the immune system (Horowitz and Robinson, 2007; 
Whitham and Fortes, 2008) including IL-6 (Asea et al., 2000).  Furthermore, eHsp72 
itself may have direct pyrogenic effects (Pastukhov et al., 2003). Nevertheless, we did 
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not observe a difference in circulating eHsp72 concentration between EIMD trials.  It is 
noteworthy, however, that the circulating IL-6 and eHsp72 responses prior to HS during 
EIMD trial 1 were modest when compared with more metabolically challenging activities 
such as marathon running (Fehrenbach et al., 2005; Nieman et al., 2001), and therefore 
provided little margin for dampened responses.   
Muscle-damaging exercise increases steady state exercising VO2 following downhill 
running (Braun and Dutto, 2003), and rodent models have shown decreased contraction 
economy in damaged muscle fibres (Warren, III et al., 1996).  One might therefore 
anticipate improved running economy during HS on the second EIMD trial.  However, 
this was not the case, since Ṁ during HS was similar on both EIMD trials.  EIMD has also 
been shown to inhibit glycogen resynthesis (O'Reilly et al., 1987), yet altered 
metabolism is also an unlikely mechanism since RER was not different between EIMD 
trials.  Whilst there was no effect on Tsk, we did observe a lower temperature threshold 
for sweating onset, and a lower thermal sensation during HS on the second EIMD bout.  
The mechanism(s) for how a muscle-damaging bout of exercise 14 d earlier decreased 
the threshold Tre for sweating onset during HS following a repeated-bout of EIMD 
remains unclear. There may be shared pathways with the concept of cross-tolerance, 
where adaptations to one stressor confer protection via molecular, cellular and neural 
interactions to other forms of stressor (Horowitz, 2014; Horowitz and Robinson, 2007).  
This process is thought to be mediated, in part, by intra-cellular Hsp’s, and it has been 
suggested that acquired thermotolerance (the accumulation of protective Hsp’s within 
cells following heat exposure), and systemic adaptations to heat acclimation share a 
common pathway (Kuennen et al., 2011).  This may be pertinent since EIMD has been 
shown to increase Hsp72 and Hsp27 expression within muscle cells following EIMD 
(Paulsen et al., 2009; Thompson et al., 2001), and that the changes we observed during 
HS on EIMD trial 2, reflect similar adaptations to those observed during heat acclimation 
(reduced exercising Tre, earlier sweating onset, reduced thermal sensation).  
Furthermore, a smaller intracellular heat shock response is shown in heat-intolerant 
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military personnel (Moran et al., 2006). It is acknowledged a limitation of the current 
study is that it has not been assessed intra-cellular Hsp’s.  It is possible that increases in 
Hsp’s within muscle cells following the first EIMD bout confer some degree of heat 
acclimation evident 14 d later but future work is required to investigate this.  It remains 
to be shown whether muscle-damaging exercise provides cross-tolerance against other 
novel stressors.  
Non-heat-acclimated individuals undertaking heavy training bouts with an eccentric 
component in the heat are likely at increased risk of developing EHI (Fortes et al., 2013; 
Montain et al., 2000) e.g. athletes performing unaccustomed exercise, or soldiers 
running or walking across mountainous terrain. Considered alongside our present 
findings this work might help to explain why EHS in athletes, soldiers and labourers 
typically occurs in the first four days of unaccustomed heavy exertion in the heat 
(Armstrong et al., 2007; Cluver, 1932). The present findings indicate that this risk can 
be mitigated by incorporating a bout of muscle-damaging exercise into the training 
regimen, prior to travel/deployment to hot environments, but this requires further 
investigation. Further research should also investigate the duration of the demonstrated 
protective effect and confirm whether other models of eliciting EIMD, e.g. drop-jumps, 
have a comparable protective effect to that shown here with downhill treadmill running, 
with the added practical benefit of allowing a large number of individuals to be treated at 
once.   
In conclusion, the repeated-bout-effect blunted the increase in heat strain during 
exercise-heat-stress conducted after EIMD, as shown by reduced exercising Tre, reduced 
thermal sensation, and earlier sweating onset.  Incorporating a muscle-damaging bout 
into training could be a strategy to reduce the risk of EHI and improve endurance 
performance in individuals undertaking heavy exercise with an eccentric component in 
the heat. 
 
 
164	  
	  
 
 
 
CHAPTER SEVEN 
 
 
 
 
General Discussion 
 
 
 
 
 
 
 
 
 
 
 
165	  
	  
7.1. Background 
Extreme temperature exposure or single-day, multiple strenuous exercise bouts (singly 
or in any combination) are common in active populations (e.g. military personnel, 
athletes, outdoor enthusiasts). These individuals can resultantly have an increased 
susceptibility to URTI or be predisposed to EHI and EHS.  
Anecdotal evidence points towards cold exposure increasing one’s susceptibility to 
infections. Evidence to support such a link between cold exposure and an increased 
infection incidence is notably lacking in available human studies (Castellani and Rhind, 
2002). The few human studies to investigate the effect of cold exposure on immune 
function report conflicting information that is dependent on the degree of hypothermia, 
the health of the individual, and the immune parameters studied (Lackovic et al., 1988; 
Brenner et al., 1999; Wenisch et al., 1996; Costa et al., 2010). Collectively, these 
studies suggest that lowering core temperature (core body temperature decrease > 1 °C) 
can disrupt circulating immune function, which may partly explain the increased URTI 
reported after cold exposure. Limitations of previous research are that they included 
unhealthy populations (e.g. patients undergoing surgery) and they did not perform a 
thermoneutral control trial (Wenisch et al., 1996; Beilin et al., 1998). Therefore it is 
unclear whether surgery, anaesthesia, existing comorbidity and diurnal variation have 
independent effects for the altered immune function reported. It therefore remained to 
be shown in healthy humans whether immune function is impaired when core 
temperature is reduced (e.g. core temperature decrease of 1–2 °C).  
Oppositely, active populations such as athletes and soldiers taking part in heavy training 
are also expected to perform multiple bouts of strenuous exercise in hot environments, 
which may predispose them to EHI or the more severe form, and EHS. Conventionally 
classified risk factors for EHI and EHS include hot and humid environmental conditions, 
unsuitable clothing, sleep disruption, absence of heat acclimation, high exercise intensity, 
poor physical fitness levels (or obesity) and undiagnosed medical conditions (Armstrong 
et al., 2007;	  Epstein et al., 1999; Rav-Acha et al., 2004). These conventional risk factors 
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do not however explain all EHI events, this begs the question: “Which lesser known risk 
factors or pathways might play important roles in many cases of EHI?” (Sawka et al., 
2011)  
One further pathway was suggested for EHI progression; this relates to a systemic 
inflammatory reaction with an incremental increase in pyrogenic cytokines [e.g., 
interleukin (IL)-1β, IL-6, and TNF -α] (Bouchama, 1995; Lambert et al., 2001; Shephard 
and Shek, 1999). This may result in quicker progression toward EHI and/or EHS (Walsh 
et al., 2011). If firm evidence of a pyrogenic cytokines role in the development of EHI is 
uncovered, it would be of great interest to investigate, and develop strategies of 
avoiding or managing EHI.   
Reducing the amount of muscle damage and inflammation would plausibly decrease heat 
strain. Indeed, evidence showed that over 80% of all EHI casualties reported during 
Marine recruits’ training occurred in the first 3 days of unaccustomed exercise in the heat 
(Kark et al., 1996). This is also supported by data collected during Operation TELIC in 
the summer of 2003 where a heat illness rate of 50/1000 was recorded during the first 
10-14 days of deployment  among troops that were performing arduous physical activity 
prior the commencement of this doctorate (Bolton et al., 2006).  One obvious, but as yet 
un-investigated avenue is the well-known repeated bout effect in muscle-damaging 
exercise, where a single session of eccentric exercise causes adaptations which in-turn 
result in decreased damage from subsequent training (Clarkson et al. 1992; Clarkson 
and Hubal 2002; McHugh et al. 1999).   
This thesis, therefore aimed to investigate: 
1. The effect of mild hypothermia and prolonged cold exposure on healthy humans 
using measures of immune function. 
2. Whether exercise-induced muscle damage (EIMD) exacerbates heat strain during 
subsequent exercise-heat-stress, which may in due course increase the subject’s 
risk of exertional heat illness.  
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3. Whether a repeated-bout of EIMD lower the increase in rectal temperature (Tre) 
experienced during subsequent endurance exercise under determined heat 
conditions.	  	  
7.2. Summary of main findings 
Firstly, during mild hypothermia we observed a decreased antigen-stimulated whole-
blood culture IFN-ϒ production and an increase in circulating leukocytes, and plasma 
cortisol, adrenaline and noradrenaline levels in healthy humans. Conversely, neutrophil 
degranulation (bacterially stimulated elastase release per neutrophil), plasma elastase 
concentration and production of antigen stimulated IL-4 were unchanged. Despite 
rewarming and feeding the adaptive immunity was suppresed  for at leat 3-hours 
(Chapter 4). To the best of our knowledge, for the first time it has been showed that 
cold exposure and mild-hypothermia do not alter neutrophil degranulation, or antigen-
stimulated IL-4 production but did lower antigen-stimulated IFN-ϒ production. In 
addition, despite rewarming and feeding, IFN-γ production did not return to control 
values within the 3-hour recovery period. Collectively, these findings might therefore, at 
least in part, explain the increased susceptibility to upper respiratory tract infections 
reported after cold exposure. Future research should confirm present findings and should 
investigate strategies to blunt the immune suppression following cold exposure and mild 
hypothermia in order to decrease the risk of infections for those involved in activities in 
cold environments. 
Secondly, we found evidence that, in non–heat-acclimated males, the ∆Tre increased 
during exercise heat stress when performed 30 min after moderate muscle-damaging 
exercise (timed to match the early inflammatory phase). This resulted in a ~0.5 °C rise 
in final Tre during 40 min of moderate exercise heat stress (HS1) for the muscle 
damaged participants (final Tre ~39.5 °C). 
It was also found that the preceding EIMD evoked an increase in plasma IL-6 
concentration which was associated (r = 0.67) with increased heat strain during HS1.  
It was also observed a meaningful, albeit small, increase in ∆Tre when exercise heat 
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stress was timed to coincide with deferred muscle inflammatory phase (24 h after 
moderate muscle-damaging exercise (Chapter 5). Data presented here, therefore show 
that a bout of EIMD, brought about by downhill running, increases heat strain during 
successive endurance exercise in the heat conducted 30 min after and, to a much lesser 
extent, 24 h after muscle damage. In line with previous literature, EIMD evoked 
increases in the circulating pyrogen IL-6 were associated with increased heat strain 
during exercise heat stress conducted 30 min after EIMD. These results have practical 
relevance, particularly for non–heat-acclimated athletes and soldiers undertaking either 
multiple, or prolonged bouts of heavy exercise with an eccentric component in the heat. 
Consequently, it has been of interest to investigate, and provide strategies that could 
reduce the risk of EHI following EIMD.  Quite naturally, it has been thought that reducing 
the degree of muscle damage encountered could be a countermeasure to lessen the 
degree of heat strain encountered. One unexplored avenue of investigation was the well-
known repeated bout effect of muscle-damaging exercise, where a single session of 
eccentric exercise induces adaptations resulting in less evidence of damage when the 
exercise bout is repeated.  
We recorded reduced heat strain (0.34 °C lower final Tre) during HS post a second EIMD 
bout, compared to after the initial bout. Other observations include a lower temperature 
threshold for sweating onset, decreased thermal sensation and a decreased physiological 
strain index during HS after the second EIMD bout.  No difference in pro-inflammatory 
IL-6 or anti-inflammatory IL-10 response was observed either prior to or after heat 
stress between EIMD bouts. In addition, an assessment of eHsp72 concentration showed 
it to be elevated following downhill running (Peake et al., 2005). Nevertheless, no 
difference was observed between EIMD trials in the concentration of circulating eHsp72 
(Chapter 6). As showed by this data the repeated-bout-effect blunted the increase in 
heat strain during exercise-heat-stress conducted after EIMD, as shown by reduced 
exercising Tre, reduced thermal sensation, and earlier sweating onset.  Therefore, 
incorporating a muscle-damaging bout into training could be a strategy to reduce the 
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risk of EHI and improve endurance performance in individuals undertaking heavy 
exercise with an eccentric component in the heat. 
Future research should investigate where improved acclimation protocols or cross-
acclimation adaptations would further improve safety for those at risk of EHI. 
7.3. Effect of cold exposure and mild hypothermia on circulating leukocyte 
counts and their function 
Circulating leukocytes were increased by 50% immediately following cold exposure and 
were higher than in the thermo-neutral control group throughout the recovery phase. 
This rather modest leucocytosis could possibly be explained by neutrophil demargination 
from the vascular endothelium, a consequence of shearing and increased concentrations 
of neuro-hormones (Brenner et al., 1998; Malpica et al., 2002; Ramel, 2003; Ramel and 
Peake, 2004; Ortega et al., 2005; Bote et al., 2008; Laing et al., 2008; Zhang et al., 
2011). 
The circulating leukocytes increase was primarily due to a 93% neutrophil increase. This 
significant neutrophilia has been reported previously (Fedor and Fisher, 1959; Villalobos 
et al., 1955; Blair et al., 1969). Indeed, Blair and colleagues (1969) reported a 
circulating neutrophil increase in septic patients when they were cooled to 34°C. On the 
contrary, in an animal study Biggar et al. (1983) found hypothermia to be associated 
with a notable reduction in mature and immature neutrophil release into circulation from 
the bone marrow.   
We measured neutrophil function by bacterially stimulating neutrophil degranulation. 
This increased after cold exposure, however no differences were observed between trials. 
This observation is inconsistent with previous findings, where these had shown that a 
modest cooling of the whole body (Tre 35.9 °C) has lead to decreased neutrophil 
degranulation (Costa et al., 2011). This discrepancy underlines how unclear the 
neutrophilia mediators and cold responsive decrease in neutrophil degranulation are: 
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they are simply not as defined as had previously been thought and this requires further 
research. 
A lymphocyte decline (-13%) was observed both during and after exposure to cold air 
with a return to control values after 3 hours. Previous studies reported that T cell 
population changes are proportional to stress duration and intensity, and that this is to a 
lesser extent true of changes in B cell populations (Gleeson et al., 2005). T cells are 
fundamental to the orchestration and regulation of cell-mediated immune responses to 
pathogens (Shephard and Shek, 1999). One important consequence of deficient T cell 
function is increased viral infections incidence (Fabbri et al., 2003). The  lymphocyte 
decrease might contribute to the increased URTI susceptibility  widely reported during 
winter. It is yet to be seen whether this decline is merely due to cold exposure or if it 
stems from shivering and involuntary tonic contractions, which count as acute physical 
exercise (Rhind et al., 2001). 
The monocyte count showed a short initial increase as mild hypothermia set in, but 
beyond this it was unaltered by cold air exposure. One explanation of this rise could be 
the thermogenic activity, which is  regarded to be exercise-stress. Indeed, transient 
monocytosis has been reported during physical exercise. The most likely cause  is the 
shifting of monocytes into the circualtion pool (Rhind et al., 2001).  
7.4. Effect of cold exposure and mild hypothermia on circulating citokines 
Antigen-stimulated whole-blood culture IFN-γ production decreased immediately after 
cold exposure and remained 69% lower than the thermo-neutral control trial throughout 
the 3-hours recovery. Antigen-stimulated IL-4 production was unaltered by cold 
exposure. Th1 cells mediated the release of cytokines (such as interferons) and they are 
important to defence against intracellular pathogens (D’Elios et al., 2007). Prolonged 
moderate-intensity exercise has been found to depress Th1 cell production (Gleeson et 
al., 2005). This was the first study to report that other stress factors (e.g. cold) might 
adversely affect interferon production. Present results might indicate that a cold 
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exposure-induced decrease in adaptive immunity capability might increase the likelihood 
pathogen susceptibility, even during recovery. This is due to the fact that the adaptive 
immunity response follows an initiation process. The antigen is presented to T helper 
lymphocytes at the peptide binding groove on major histocompatibility complex class II 
molecules on antigen-presenting CD4+ T cells. This is key to the cell-mediated immune 
response, since they direct and orchestrate the adaptive immune response to viruses 
and bacteria. Decreased IFN- ϒ production might result in suppressed cellular immune 
system response to invading micro-organisms, since they act with immunostimulatory 
and immunomodulatory effects and directly inhibit viral replication (Gleeson et al., 
2011).   
As mentioned above, IL-4 productions remained unaltered by cold exposure and this is in 
line with literature evidence that IL-4 can be produced in response to prolonged, 
moderate intensity exercise (Gleeson et al., 2005). The steady concentration of this 
cytokine could be indicating that leukocyte function was unaffected during cold exposure. 
It is known that monocytes, lymphocytes and B cells have roles in IL-4 production, and 
that a combination of this and IL-10 can interrupt Type-1 T-cell cytokine production 
(Steensberg, 2003). On study showed that strenuous exercise decreases circulating 
type-1 T-cells, whereas the percentage of Type-2 T-cells was unaffected. Cortisol and 
adrenaline both decrease Type-1 T-cell cytokine production, whereas IL-6 stimulates 
Type-2 T cell cytokine production (Chapter 4).  
The role played by IL-4 and IL-6 in a hypothermic scenario is as yet not well established. 
What is known is that it activates B cells and T cell proliferation and regulates adaptive 
immunity responses (Paul et al., 1997). This is usually coupled with IL-10, another anti-
inflammatory cytokine. There is evidence that IL-10 production from microglia, on the 
contrary, decreases proportionally to the decrease in body core temperature (Matsui et 
al., 2004). This decrease is beneficial, since excessive levels of IL-10 are detrimental to 
the central nervous system. 
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7.5. Effect of cold exposure and mild hypothermia on neurotransmitters 
Innate immunity is affected by adrenaline, noradrenaline and cortisol as outlined above. 
Plasma noradrenaline increase upon exposure to cold due to SAM axis stimulation. This 
promotes shivering thermogenesis, vasoconstriction and endogenous substrate 
breakdown (Castellani et al., 2002). 
Neurotransmitters are also known to regulate both innate immune cell function and 
leucocytosis by bone marrow release and demargination (Ortega, 2003). In this context, 
the main effectors of the quick rise in circulating neutrophils seem to be catecholamines 
since they are rapidly released into the blood, and stimulate an immediate immune cells 
response (Brenner et al., 1998). The modest increase observed in plasma cortisol 
(~12 %) from cold exposure is not thought likely to account for the observed changes in 
leukocyte trafficking considering the time required for cortisol to affect immune 
responses (Goldstein-Golaire et al., 1970; Jefferies, 1991). Supporting this is the fact 
that a few hours after cold exposure there was no delayed blood leukocytes increase due 
to cortisol-induced release of neutrophils from the bone marrow (Gagnon et al., 2014). 
That the second increase in leukocyte trafficking elicited by cortisol is dependent upon 
exercise intensity and duration has been shown (Fragala et al., 2011) and high-intensity 
exercise results in significant cortisol elevation (200% from Jacks et al., 2002), although 
this is unlikely to be the case in the present study. Additionally, any significant cortisol 
effects tend to be reported once the plasma cortisol concentration exceeds the capacity 
of the corticosteroid-binding globulin (550 nmol l-1) and the free cortisol concentration 
increases (Costa et al., 2011). This is not the case in the present study where the 
highest concentration of plasma cortisol recorded was 498 ± 158 nmol l-1 during mild-
hypothermia. This additionally supports the idea that cortisol did not play a main role in 
the observed changes in leukocyte trafficking. 
The present study directly compared the rise in adrenaline and noradrenaline. The 
increase in neurotransmitters, induced by exercise can be replicated using data provided 
by Galbo in 1975 (Galbo et al., 1975). The observed catecholamines rise is similar to 
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that observed in response to a short bout of running (10 mins) at 75 % VO2Max intensity 
or to repeated bouts of running at 75 % VO2Max intensity for prolonged time periods. This 
suggests that the innate immunity changes observed might be, in part, explained by the 
body initiating thermoregulatory activity which counteracts mild-hypothermia. That 
would help to explain why neutrophil function was unaffected by cold exposure even if 
neutrophilia had occurred. Notably, catecholamines have a direct effect on cardiac output 
and the shear effect derived, and this might explains the observed changes in white 
blood cell numbers.  
In addition, increased circulating adrenaline might account for the lymphopenia during 
recovery from cold exposure which is possibly via alterations in the adhesion molecules 
and surface receptors on the lymphocytes (Kruger and Mooren, 2007; Costa et al., 
2011). Adrenaline is now thought to play a key role in regulating lymphocyte trafficking 
during environmental stress (Costa et al., 2010).  Furthermore, adrenaline and 
noradrenaline sympathetically mediate influences on cardiac output indirectly, which this 
alters the subsequent increase in enhanced blood flow associated shear stress. 
7.6. Similarities between immune response following cold exposure and after 
physical exercise 
An indirect method was used to calculate the energy cost of thermoregulatory responses 
during cold exposure as suggested by the Compendium of Physical Activities (Ainsworth 
et al., 2011). Indeed,  using Metabolic Equivalent of Task (MET) (MET = 3.5 mL 
oxygen·kg-1 body weight·min-1), described as the ratio of the metabolic rate for an 
activity divided by a standardized expression of the rest metabolic rate, showed that 
thermogenic activity during cold exposure can be equated with prolonged bouts of 
moderate exercise (5.6 (2.0) MET) (Chapter 4). 
This explains why some innate immune marker changes are similar to those from 
exercise. Under these conditions exercise can be looked upon as the thermogenic activity 
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the body counteracts a cold environment with (Walsh et al., 2006).  It is reasonable to 
expect immune markers to mimic an exercise response (Young et al., 2000).  
Lymphocytosis was observed during and after cold exposure. The number of cells during 
recovery fell below pre-exercise levels (Chapter 4). It has previously been reported that 
T cell population changes are proportional to stress intensity and duration, although the 
intensity of effect is more marked B cell populations (Gleeson et al., 2005). Research 
showed the T cell population decreased by 50 % after a 2.5 h of treadmill running at 75 
% VO2Max (control value: resting values. Gleeson et al., 2005). The lymphocyte count 
acted in a similar fashion to the response to prolonged exercise, although the decrease 
observed was smaller during our trials. The T cell number regained baseline levels after 
3 h, which mirrors lymphocytic responses to prolonged exercise (Robson et al., 1999). 
Cold air exposure failed to alter monocyte count above a small initial increase associated 
with mild hypothermia. One plausible explanation for this rise could be shivering and 
involuntary tonic contractions. Young et al. (2001), looked on this as acute physical 
exercise, and others have reported it as resulting in transient monocytosis.  That would 
most likely represent the migration of monocytes from the marginated to the circulation 
pool. This could be the result of, singly or in combination, a haemodynamic and/or 
cortisol or catecholamine-induced release at the vascular endothelium (Walsh et al., 
2011). This is supported by a research study which asserted that administering the beta-
blocker propranolol resulted in lessened exercise-induced monocytosis (Walsh et al., 
2011). Beyond this, reports show that stressors can affect monocyte phenotype, 
cytokine expression and cell surface proteins (Freidenreich and Volek, 2012). For 
example, there is a preferrance for the use of inflammatory monocytes following accute 
exercise (CD4+/CD16+) (Freidenreich and Volek, 2012). It is conceivable, therefore, 
that marginated cells exhibit a more mature inflammatory function for entry into tissues 
and are seperated from the endothelium by exercise. It is interesting to note that the 
percentage of these CD14+/CD16+ cells reduces during recovery which may indicate 
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remarginalization or tissue recruitment. Acute exercise also reduces the inflammatory 
monocyte’s expression of TLRs 1,2 and 4 (Gleeson et al., 2011). 
Antigen-stimulated whole-blood culture IFN-ϒ production was lower throughout cold 
exposure and did not recover to baseline levels after 3 hours despite participants having 
been fed and rewarmed (see Chapter 4). This mirrored the rise seen after 2.5 h of 
cycling at 65 % VO2Max (Lancaster et al., 2005). The release of IFN-ϒ (as with other 
cytokines ) is mediated by Th1 cells.  They are important in intracellular pathogen 
defence (e.g. against viruses. see: D’Elios et al., 2007). Prolonged moderate-intensity 
exercise has been found to decrease Th1 cells (Gleeson et al., 2005), which might 
explain a decreased IFN-ϒ production. 
7.7. Study limitations and future directions (Chapter 4) 
While we have provided some novel and thought-provoking preliminary findings on 
immune responses to mild-hypothermic state and cold exposure (Chapter 4), further 
research is still needed to clarify the nature and extent of the immune mechanisms 
involved. It is specifically suggested that an extended number of adaptive immunity 
markers would be measured. This would provide more compelling evidence on how, and 
for how long, adaptive immunity is suppresed post induced hypothermia. Further to this, 
the role of thermo-genic activity on innate immune markers during cold exposure needs 
clarification. Indeed, most of the measured markers responded similarly to moderate 
intensity, prolonged exercise. Some evidence suggests that increased metabolic 
response to cold exposure is equal to prolonged exercise performance. An in vitro 
investigation, or another study design that could measure or exclude the effects of 
thermogenic-activity on innate immune markers, should be conducted to clarify the 
effect of cold on human immune markers. 
 
 
176	  
	  
7.8. The effect of muscle-damaging exercise on heat strain during subsequent 
exercise heat stress (Chapter 5) 
In agreement with our hypothesis, we showed that in non–heat-acclimated males ∆Tre is 
increased during exercise heat stress performed 30 min after moderate muscle-
damaging exercise timed to coincide with the early inflammatory phase. This resulted in 
a ~0.5 °C greater final Tre during HS1 in muscle damaged participants (final Tre ~39.5 °C) 
after just 40 min of moderate exercise heat stress. 
These results might have real-world applicability, particularly for non–heat-acclimated 
athletes and soldiers who undertake repeated and/or prolonged heavy training bouts 
with an eccentric component in hot environmental conditions. Actions that can decrease 
EIMD associated inflammation may mitigate the risk of EHI. 
Downhill running is often used in studies to evoke muscle damage (Braun and Dutto, 
2003; Paulsen et al., 2012; Peake et al., 2005), and the aim of the model used here was 
to evoke moderate, realistic muscle damage that would not impair the participants ability 
to complete subsequent exercise heat stress bouts. 
7.9. Effect of muscle-damaging exercise on cytokines plasmatic concentrations 
and their subsequent effect on heat strain during exercise heat stress 
We identified circulating IL-6 concentration to be a marker for acute inflammation, and 
assessed this for changes.  We hypothesized that EIMD-evoked increases in circulating 
IL-6 and that this would be associated with increased heat strain during consecutive 
exercise heat stress (30 min after muscle-damaging exercise). 
As expected, EIMD significantly increased circulating IL-6 relative to CON prior to the 
first exercise-heat-stress bout. Importantly the circulating level of IL-6 after EIMD was 
relatively modest compared to the level usually observed following prolonged, 
metabolically demanding endurance exercise (Nieman et al., 2001). As such, the post 
EIMD IL-6 increase showed wide variability (Chapter 5). Nonetheless, we noted a 
moderate correlation between the circulating concentration of IL-6 after treatment and 
the subsequent change in Tre during HS1 in EIMD trial (r = 0.67). The sequential nature 
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of this relationship is noteworthy; an early, modest inflammatory response was 
associated with subsequent increases in Tre during exercise heat stress. Furthermore, 
these associations did not follow the second exercise-heat-stress bout, when pre-HS2 IL-
6 concentrations had returned to baseline values, with no difference between trials. 
Since IL-6 is known to be a pyrogen (Dinarello et al., 1991), acute increases in 
circulating IL-6 after muscle damage might plausibly act on the cycloxygenase 2–
mediated PGE2 pathway, resulting in in an incremental change to the thermoregulatory 
set point  (Rummel et al., 2006; Bradford et al., 2007) and heat strain during exercise 
heat stress. All things considered, we recognize the augmentation in the circulating IL-6 
response after EIMD to be relatively moderate and understand that the mooted concept 
of a thermoregulatory set point is controversial (Romanovsky, 2007). 
We showed an association, albeit moderate, between prior acute circulating inflammation 
and a subsequent exercise heat strain. Accordingly, a logical line of exploration would be 
to identify strategies that could diminish inflammation which may, in turn, mitigate rising 
Tre figures and lower EHI risk during exercise heat stress (Chapter 6).  
Muscle-damaging exercise has previously been shown to cause a higher circulating IL-6 
response, compared to non-muscle-damaging exercise (Bruunsgaard et al., 1997), and 
that finding was supported by our previous study (Fortes et al., 2013 – Chapter 5). 
Therefore the elevated circulating IL-6 concentration following EIM correlated to the final 
Tre attained during a subsequent HS.  Elevated circulating IL-6 before heat stress is 
significant as it is potentially involved in an acute inflammatory response in the aetiology 
of EHI (Bouchama, 1995; Shephard and Shek, 1999; Lim and Mackinnon, 2006; Walsh 
et al., 2011).  A “dampening” of the inflammation response has been proposed as one 
explanation for the repeated bout effect (Pizza et al., 1996). Although our study did not 
observe any differences to the pro-inflammatory IL-6 response between the two EIMD 
bouts either before or after heat stress.  Notably, Smith and colleagues reported that 
cytokine concentrations were averaged over the 12 hour period following EIMD. 
Therefore this figure could not be expected to garner closely time-referenced information 
on the kinetics of early inflammatory response following EIMD (Smith et al., 2007).  
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The concentration of circulating IL-10 exhibited no EIMD repeated bout effect. The chief 
role of IL-10 is to oppose inflammatory responses in order to down-regulate adaptive 
immune effector responses and to minimise tissue damage under microbial challenges. 
Additionally, IL-10 inhibits several pro-inflammatory cytokines and other soluble 
mediators. A previous study conducted during marathon competition in 1997 found that 
the dramatic increase in the inflammation responsive cytokine IL-6 was balanced by the 
release of the anti-inflammatory cytokine IL-10 (Ostrowski et al., 1999). Indeed, IL-6 
appears to be responsible for subsequent rises in the circulating levels of anti-
inflammatory cytokines (IL-10 and IL-1ra) and that it also stimulates the cortisol release 
from the adrenal glands (Steensberg, 2003). In this context, regulatory T cells, Th2 cells, 
monocytes, CD8+ T cells, macrophages and Th1 cells are the principle parties in IL-10 
production.  In our study, we observed a modest rise in IL-6 which might explain the 
lack of changes of IL-10 concentration between trials (Chapters 5 and 6). In effect, a 
substantial increase in IL-6 plasmatic concentration might be needed to trigger the 
subsequent rise of anti-inflammatory cytokines but further research is needed to clarify 
this process. 
7.10. Heat Shock Protein 72 (Hsp 72) 
We assessed eHsp72 concentration, which was shown by Peake et al. (2005) to be 
elevated following downhill running. It is also known to act as a “danger signal”, 
activating the immune system and IL-6 (Horowitz and Robinson, 2007; Whitham and 
Fortes, 2008; Asea et al., 2000).  Furthermore, eHsp72 has been suggested to have 
direct pyrogenic effects (Pastukhov et al., 2003).  Regardless, our study did not observe 
a difference in circulating eHsp72 concentration between EIMD trials.  Yet it should be 
kept in mind that during EIMD trial 1 the circulating IL-6 and eHsp72 responses prior to 
HS were modest when compared with marathon running or other more metabolically 
challenging activities (Nieman et al., 2001; Fehrenbach et al., 2005). The slight margin 
for dampened responses is clear when viewed in this light.   
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7.11. Exercise-induced muscle damage and the repeated bout effect (Chapter 6) 
Our downhill running model evoked moderate, realistic muscle damage. Indeed, 
significant decreases in leg strength (-7.5 %), and increases in muscle soreness 48-h 
post EIMD trial 1 were seen.  This muscle damage is equivalent to ‘a light pain when 
walking’ (Vickers, 2001) and therefore reflects that reportedly encountered by soldiers 
and athletes subjected to unaccustomed exercise with an eccentric component.  
Research has consistently shown that a prior muscle-damaging bout produces a 
protective adaptation, and results in lesser symptoms of EIMD when the muscle-
damaging bout is repeated (e.g. diminished leg strength losses and reductions in muscle 
tenderness) (Byrnes et al., 1985; Clarkson et al., 1992; McHugh et al., 1999).  The 
repeated bout effect was successfully demonstrated here, as leg strength regained 
baseline levels and muscle soreness was significantly reduced 48-h after the repeated 
bout of EIMD.  The decrease in leg strength observed seems to support the theory which 
states that the repeated bout effect is due to fragile muscle fibres loss during the first 
bout of exercise and their subsequent replacement with less damage-susceptible fibres 
during recovery. Indeed, when the muscle-damaging exercise was repeated during EIMD 
trial 2 no further leg-strength decrease was observed. Conversely, if this fibre loss 
continued during EIMD trial 2 a significant decline in muscle strength would have 
occurred.  Therefore, a plausible explanation is that damaged fragile fibres were repaired 
over time and that these repaired fibres are enhanced and less susceptible to damage. 
In conclusion, these findings do not fully explain the process behind the repeated bout 
effect but provided evidence that the first bout of damage produced an adaptation that 
lasted for at least 14 days, time that has occurred between trials during our study. 
7.12. Studies limitations (Chapters 5 and 6) 
Future studies need to examine the contribution of pyrogenic pathways after muscle 
damage upon exercise heat strain in more depth. Whether or not the greater proportion 
of circulating IL-6 response after EIMD (Chapters 5 and 6) come from leukocytes, 
muscle cells, or other cells remains to be shown (Montain et al., 2000; Braun and Dutto, 
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2003; Paulsen et al., 2012). However, our study did not observe any difference in the 
responses of either pyrogenic IL-6 or anti-inflammatory IL-10 prior to, or following heat 
stress between the two EIMD bouts (Chapter 6).  
A previous study has shown reduced pyrogenic cytokines (IL-6), and increased anti-
inflammatory cytokines (IL-10) in the 12 h following a repeated bout of muscle damage 
evoked by downhill running (Smith et al., 2007), although this finding is not supported 
by studies that have used different models of muscle damage (e.g. isokinetic knee 
extensor exercise (Croisier et al., 1999; Willoughby et al., 2003)).  This hypothesised 
reduction in heat strain could be accounted for by an altered circulating inflammatory 
response following EIMD, as a “dampening” of the inflammatory response is one 
proposed explanation for the repeated bout effect (Pizza et al., 1996). Our findings do 
not, support this explanation for the repeated bout effect but we acknowledge that 
further research with an extended post-exercise time-frame (48 h-120 h post) is 
required (Chapter 5). Indeed, many of the criterion measures may peak 48-72 h post 
exercise. Data of this breadth would confirm whether or not the criterion measures rose, 
peaked or fell, and whether muscle function was altered.  
We did not assess intra-cellular HSPs (Chapter 6).  It is possible that increased muscle 
cell HSPs following the first EIMD bout would confer some degree of heat acclimation and 
this would be evident up to 14 d later. Indeed, EIMD has been previously showed to 
increase HSP72 and HSP27 expression within muscle cells (Paulsen et al., 2009; 
Thompson et al., 2001), and a smaller intracellular heat shock response is shown in 
heat-intolerant military personnel (Moran et al., 2006). During our study (Chapter 6), 
we did observe a lower thermal sensation during HS on the second EIMD bout and a 
lower temperature threshold for sweating onset which might open-up to the idea that 
muscle-damaging exercise provided cross-tolerance against other novel stressors 
(Horowitz, 2007). Another good question is whether, and if so how, the mechanism(s) 
for a muscle-damaging bout of exercise 14 d earlier would decrease the threshold Tre for 
sweating onset during HS following a repeated-bout of EIMD.  Some pathways may 
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share responsibility with the cross-tolerance, i.e. adaptations to one stressor might 
confer protection to other forms of stressor via molecular, cellular and neural 
interactions (Horowitz, 2014; Horowitz and Robinson 2007).  In this context, previous 
evidence suggested that acquired thermo-tolerance (post heat exposure cellular HSP 
accumulation) and systemic heat acclimation adaptations share a common pathway 
(Kuennen et al., 2011) and this process is expected to be mediated (at least in part) by 
intra-cellular Hsp.  The changes we observed during HS on EIMD trial 2, reflect similar 
adaptations to those observed in heat acclimation (reduced exercising Tre, earlier 
sweating onset, reduced thermal sensation).  Therefore, we strongly recommend that 
studies will be performed to identify the changes induced by muscle-damaging exercise 
on HSPs concentration at intracellular level and the subsequent effect on 
thermoregulation. If novel research on cross-tolerance will be inspired by the 
suggestions here presented new strategies to protect from EHI and EHS those involved 
in physical activity in hot environments may be developed. Also, heat-acclimation is 
currently known to require repeated exposures to heat over a considerable duration 
(Armstrong et al., 1991; Pandolf et al., 1998). Our findings suggest that one bout of 
EIMD could be a strategy to induce cross-tolerance and by reducing the amount of time 
and training required for acclimatization. This might be greatly beneficial to athletes and 
soldiers taking part in activities in hot environments.  
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7.13. Conclusions 
 
The major conclusions drawn from this thesis are: 
 
1. Cold exposure and mild-hypothermia did not alter neutrophil degranulation 
bacterially stimulated elastase release per neutrophil, or antigen-stimulated 
production of IL-4. 
2. A leucocytosis, mainly caused by a neutrophil increases, has been observed 
during and following cold exposure, which was probably in response to 
neurotransmitters increase. 
3. The increased release of noradrenaline and adrenaline might respond to increased 
metabolic needs. 
4. However, lowered IFN-ϒ production was noted in the hours following the cold 
exposure presenting “open window” in the immune  systems ability to respond to 
bacterial challenges. The prolonged period of adaptive immunity suppresion 
continued despite rewarming and feeding. This might partially explain the 
increased upper respiratory tract infection susceptibility aneqdotely reported by 
outdoor enthusiast during cold weather. 
5. A bout of EIMD increases heat strain during successive endurance exercise in the 
heat conducted 30 min after muscle damage was confirmed by the data. This is 
also true, although to a much lesser extent, 24 h after the EIMD. 
6. EIMD also evoked increases in circulating pyrogenic cytokine IL-6. This was 
associated with an increased severity of heat strain during exercise heat stress 
trials conducted 30 min after the EIMD. 
7. Repeated-bout-effect lessened the onset of heat strain during exercise-heat-
stress conducted after EIMD. This was shown by a reduced exercising Tre, reduced 
thermal perception, and an earlier onset of sweating during HS 2. Training 
programs that incorporate a muscle-damaging bout could be an effective strategy 
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in reducing EHI risk. This could also improve endurance performance in hot 
conditions when individuals undertake heavy exercise with an eccentric 
component.	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APPENDIX A: 
Bangor University 
School of Sport, Health and Exercise Sciences 
Subject Information Sheet 
Project Title: An Experimental Study of Practical Field Methods for Cold Casualty 
Protection and Treatment during Prolonged Cold Exposure  
Research Co-ordinators: Dr Sam Oliver and Dr Neil Walsh  
Tel: 01248 383965                       Email:s.j.oliver@bangor.ac.uk 
Additional Investigators: Dr Matt Fortes, Dr Gavin Lawrence, Jenny Brierley, Alberto 
Dolci, Phil Heritage, Aaron Burdett, Robin Wilson, Beth Palmer and James Firman 
Invitation to take part 
You are being invited to take part in a research study. Before you decide to take part it 
is important for you to understand why the research is being conducted and what will be 
required of you should you agree to be involved. Please take time to read the following 
information carefully and discuss it with the investigators. Ask us if there is anything that 
is not clear or if you would like more information. 
Do I have to take part? 
This is entirely your decision. If you decide to take part you will be given this information 
sheet to keep and be asked to sign a consent form. If you decide to take part you 
are still free to withdraw at any time without giving a reason. If you decide not to 
participate or withdraw during the study, your decision will not affect your relationship 
with the School of Sport, Health and Exercise Sciences, or any of the investigators 
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involved in the study. All information collected during the study will be treated 
confidentially and if you choose to withdraw then your data will be deleted from our 
records.   
Background 
Prolonged cold exposure and becoming mildly cold is associated with impaired health and 
performance. Accidents in cold and wet environments can lead to hypothermia. This is 
especially the case when casualties remain stationary or are suffering from trauma with 
blood loss (for example, mountaineering or car accident). In the UK average mountain 
rescue times are typically at least 2 hours. It is therefore important that easily 
administrable and transportable cold protection methods are developed which can be 
used whilst casualties wait for emergency services rescue. Ultimately, mortality rates will 
be decreased if cold protection methods can be developed and shown to reduce or 
maintain a casualty’s core temperature. Current field cold protection methods have been 
shown to be relatively ineffective (e.g. polythene survival bag), or their effectiveness is 
presently unknown (e.g. hot drinks and Blizzard Survival bags). Therefore the present 
investigation aims to determine the effectiveness of polythene survival bags with hot 
drinks and Blizzard survival bags with and without heat pads. 
Objective 
To assess which field method offers optimal protection for casualties in a cold 
environment. 
What will be expected of you? 
If you decide to take part in this study there will be a number of constraints placed upon 
you.       During the day prior to completing a trial you will be expected: 
• To avoid drinking alcohol or caffeinated drinks (i.e. coffee, tea, coke and diet 
coke). 
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Visit	  One	  
	  
Project	  
Briefing	  
	  
• To avoid participating in moderate to high intensity exercise. 
Whilst completing the experimental trials in the laboratory you will be expected: 
• To spend one whole day in the laboratory on four separate occasions. 
• To eat and drink only what is prescribed to you. 
• Arrive to the laboratory after an overnight fast (10-12 hours) 
• To follow the study’s timetable. 
• To be weighed nude (behind screens to maintain privacy). 
• To have four blood samples taken during each one day trial (~65 ml) totaling 16 
blood samples during the 4 week study period (~260 ml). 
• To provide saliva and urine samples. 
• To perform four cold water immersions (~13°C for a maximum of 60 minutes). 
• To perform four 3 hour cold air tests in 0°C. 
• To complete a health log 2 weeks prior, during and 2 weeks following the last 
trial. 
You will be excluded if you are a smoker, asthmatic, diabetic, have a pacemaker or any 
heart condition or you are currently taking specific types of medication or supplements. 
IN TOTAL, THE STUDY WILL REQUIRE YOU TO GIVE UP 34 HOURS OF YOUR 
TIME. 
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Visit One: Project briefing and familiarisation (1 hour) 
At this meeting you will be fully briefed about the requirements of the project. You will 
be talked through the subject information sheet by an investigator and given the 
opportunity to ask any questions. You will then leave with the information sheet so as to 
allow you time to discuss your possible involvement in the study with significant others. 
This will also allow you additional time to think of questions.  
You will be asked to refrain from exercise and alcohol and caffeine consumption for 24 
hours prior to each visit. At this visit you will be familiarised with the procedures for 
collection of saliva and venous blood. All blood samples will be collected by a qualified 
member of staff from a forearm vein using a small needle (~16 ml of blood at each 
collection). A saliva sample will be obtained by asking you to dribble into a plastic 
container for 5 minutes. You will also be familiarised with the cognitive function tests and 
also the health log which you will be asked to complete at the end of each day. 
Visit Two: Question and answer session (optional) 
Visit two is provided as an additional opportunity for you to ask questions. Once you are 
fully satisfied with the information and on agreement to take part in the study you will 
be asked to complete an informed consent form, a medical questionnaire and make 
arrangements for the following visits. 
Experimental trials: 
You will be required to complete four experimental trials in a random order each 
separated by 7 days. Each experimental trial will consist of an 8 hour period where you 
will be in the laboratory under treatment conditions (Visit three, four, five and six). 
Including the briefing meeting, familiarisation visit and all four experimental 
trials you will be required to visit the laboratory on seven occasions for a total 
of ~34 hours. 
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Visit Three, Four, Five and Six: (8 hours) 
Prior to arriving at the laboratory 
You will be instructed to consume your normal daily food intake and keep a food diary of 
what you ate the day before the trial. We will also provide you with your daily water 
requirements (approximately 2.5 L for a 70 kg person), which will help to ensure that 
you are hydrated prior to each trial. We ask that you arrive at the physiology laboratory 
with the appropriate clothing (i.e. swim shorts, a second pair of dry shorts and a towel) 
following an overnight fast at 07:00 hours.  
Experimental procedures 
On arrival to the laboratory and after completely emptying your bladder and bowels, 
your body composition will be estimated by a non-invasive bio-electrical impedance 
analysis; which requires you to stand on a set of weighing scales. On arrival at the 
laboratory you will be given a rectal probe to fit, and a universal container with which to 
collect a urine sample. The rectal probe will be used to monitor rectal core temperature. 
You will also be asked to wear a chest strap so that we can monitor your heart rate. You 
will then sit quietly for 30 minutes in the laboratory (ambient temperature ~20°C) after 
which blood and saliva samples will be obtained and you will complete the cognitive 
function tests. You will then enter the cold water bath (~13°C) and be immersed up to 
your shoulders until your core temperature has decreased to 36°C (~40 minutes). At 
this point you will be withdrawn from the water. After drying and putting on your dry 
shorts you will enter the environmental chamber (0°C) with one of the four survival bags. 
You will then be asked to sit on a chair whilst inside the survival bag. You will be 
randomly assigned at each trial to one of the four practical cold protection methods: 1. 
Polythene survival bag; 2. Polythene survival bag with hot drink; 3. Blizzard Survival bag 
and 4. Blizzard Survival Heat bag. After getting into the survival bag and at 1 and 2 
hours you will be provided with a flavoured drink. The quantity of this drink will depend 
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on your body weight but will be similar to a large mug of tea. On one trial (trial 2) this 
drink will be hot, i.e. similar to that temperature of regular tea or coffee. You will be 
asked to consume these drinks within 15 min. Regular measurements of 
thermoregulation will be made and core temperature will be continually monitored. 
Cognitive function tests and saliva samples will be obtained at one hour intervals. The 
experimental trials will end and you will be removed from the chamber at 3 hours or if 
core temperature decreases to 35°C. Following removal from the environmental 
chamber (0°C), a blood and saliva sample will be obtained and you will be wrapped in 
blankets. You may be immersed in warm water to aid rewarming. One and two hours 
following the cold exposure we will obtain further blood and saliva samples during which 
time you will sit in a comfortable ambient temperature ~20°C with blankets or dressed 
in your normal clothes. During this time, your core temperature will be monitored and 
you will be supervised by experimenters. In the second hour of this recovery you will be 
provided with a large meal and warm drink. Following the final blood and saliva sample 
you will be allowed to eat and drink freely and you will be permitted to leave when your 
core temperature returns to with 0.5°C of your initial core temperature. Transport home 
will be provided if required.  
Advantages of taking part 
A benefit of taking part in this study is that you will receive comprehensive feedback, 
with full explanations, of your body composition (e.g. body fat %) and blood measures 
(e.g. immune function). This feedback should help you with planning and monitoring 
your athletic training program. The feedback you will receive regarding your body 
composition is similar to that which many testing facilities provide as a fee-paying 
service. Advantages for Undergraduates from within SSHES are that you will gain a 
valuable insight into the procedures and work involved in a 3rd year project. Additionally 
participation in this project can be used for skills units of the Undergraduate portfolio. 
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Disadvantages of taking part 
The disadvantages of taking part in this study, which you will probably be most 
concerned about, are: 1. cold exposure test 2. blood samples; and 3. time commitment.  
 
1. Cold exposure: Cold tests lasting two to three hours have been safely used to stress 
the body’s ability to maintain core body temperature by our research group and many 
others. During these cold air tests you will likely experience some peripheral numbness 
and mild discomfort in your hands and feet. To minimise this discomfort, we will provide 
you with thermal gloves and socks. 
A number of military studies have exposed individuals to freezing and/or wet conditions 
following periods of prolonged physical exercise, inadequate nutrition and sleep loss, and 
no medical complications were reported after rewarming in individuals whose core 
temperature decreased to 35°C). In these investigations no voluntary ‘drop out’ or 
medical withdrawal of subjects was reported. Additionally, in contrast to these previous 
investigations in which subjects sat uncovered, the provision of survival bags in the 
proposed study will provide insulation.  
In the current investigation you will be removed from the climate chamber if your core 
temperature decreases to 35°C. It is important to note that 35°C is considered the upper 
limit of mild hypothermia (35-32°C), and following the removal of cold stress your 
thermoregulatory mechanisms are likely to steadily recover normal core temperature 
(~37°C). For example, in a study using cold water immersion to reduce core 
temperature to 33°C participants left to shiver post immersion were able to recover core 
temperature to 36°C within 1 hour.  
Following removal from the chamber you will be wrapped in blankets. In addition, if your 
core temperature reduces below 35°C you will be immersed up to the axilla in a warm 
water bath (38-42°C). This technique has previously been used in a number of studies to 
rewarm participants in experiments where core temperature is decreased to between 33-
229	  
	  
34°C.  For your safety your core temperature will be monitored by a rectal probe every 
minute throughout the cold exposure protocol and during the first hour of recovery 
period or until your core temperature returns to within 0.5°C of their starting core 
temperature.  
The results of this study will ensure people can be better informed as to the most 
effective method of cold protection in extreme environmental conditions. 
2. Blood samples: The blood samples will be taken using a smaller needle than is 
typically used by doctors in your local surgery or hospital. Therefore you will likely 
experience only very mild discomfort i.e. like a scratch. The quantity of blood we are 
taking in each visit is small (i.e. approximately one tenth of that which would be 
obtained when you give blood). Additionally, qualified phlebotomists experienced at 
performing this procedure will collect blood samples. To ensure you are completely 
happy with giving blood samples, we will familiarise you with the blood sampling 
procedure on your first visit to the laboratory.  
3. Time commitment: To complete all aspects of the study we will require you to visit 
the laboratory on six occasions for a total of approximately 33 hours. Thus, participation 
in this project satisfies the requirement in hours for the Undergraduate portfolio skills 
unit. 
 At all times you will be closely supervised by an experimenter trained in First-Aid. 
Any further questions will be happily answered by Dr Sam Oliver or any of the additional 
investigators.  
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Invitation to take part 
You are being invited to take part in a research study.  Before you decide whether to 
participate, it is important for you to understand why the research is being done and 
what it will involve.  Please take time to read the following information carefully and 
discuss it with friends, family and your GP if you wish.  If there is anything that is not 
clear or if you would like more information, please do not hesitate to ask us.  Take time 
to decide whether or not you wish to take part. 
What is the purpose of this study? 
Military personnel are often expected to perform repeated bouts of arduous physical 
activity on the same day, often in hot environments which may increase their risk of 
exertional heat illness (EHI) or the more serious and potentially fatal condition termed 
exertional heat stroke (EHS).  Whilst a number of traditional risk factors have been 
identified that increase the risk of EHI and EHS in military personnel (for example, hot 
and humid environmental conditions, inappropriate clothing, inadequate acclimatisation, 
sleep disruption, high exercise intensity, high % body fat, and low physical fitness),  it 
has also been suggested that muscle damaging exercise similar to that encountered 
during unaccustomed exercises such as downhill walking and running may adversely 
affect an individual’s normal body temperature response to exercise in the heat. 
Additionally, alterations in immune function as a result of muscle damage may also pay 
a role in EHI and EHS.  It is the purpose of this study to investigate the influence of 
muscle damage evoked by downhill running on the ability of an individual to 
thermoregulate, and on their immune system during subsequent exercise bouts 
conducted in a hot but safe environment.    
Why have I been chosen? 
You have been chosen because you are a recreationally active male, aged between 18 
and 40 years of age, free from infection and, and not currently taking medication.  
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Do I have to take part? 
This is entirely your decision. If you decide to take part you will be asked to sign a 
consent form. You will be given a copy of this form to keep for your information. You will 
be free to withdraw at any time without giving a reason. If you decide not to participate, 
it will not affect your relationship with the School of Sport, Health and Exercise Sciences 
or any of the researchers. All the information collected will be treated confidentially. 
What will happen to me if I take part? 
The study will involve you making eight visits to the School of Sport, Health and Exercise 
Sciences.  The purpose and time commitment of each visit are outlined below: 
Visit 1) You will be talked through the protocol by an investigator and given the 
opportunity to ask any questions.  If you decide to take part, you will be asked to sign a 
consent form (visit length ~30 mins). 
Visit 2) During this visit you will be asked to perform an incremental exercise test on a 
treadmill, whilst wearing a mask, which will last approximately 20 minutes.  This test 
starts off easy (fast walking pace) and gets progressively harder until you cannot 
continue.  By the end, you will be running very quickly.  By measuring your expired air, 
we will be able to calculate your maximal oxygen uptake (a good indicator of your 
overall fitness) and to calculate the intensity at which you will exercise during the 
experimental trials.  Following this test, you will have a short recovery period (approx 10 
mins), and then you will be asked to run at a moderate speed on the treadmill for 
approximately 20 minutes in order for us to verify the correct exercise intensity for the 
subsequent experimental trials.  We will ask you to run on a flat gradient, and then on a 
downhill gradient.  Since you may not be used to running downhill, we will give you 
ample opportunity to practice, by starting off slowly and gradually increasing the running 
speed (visit length ~ 1 hour).  
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Visits 3- 8). There are 3 experimental trials, each one requiring 2 visits on consecutive 
days.  The 3 experimental trials consist of a muscle damage trial (MD), control trial (CON) 
and a carbohydrate trial (CHO);   
MD trial 
You will be asked to report to the laboratory at 07:15h having not eaten that morning.  
We will provide you with a snack and a set amount of fluids.  At 08.00h you will be asked 
to provide a urine sample, and to weigh yourself nude behind screens (for your privacy) 
for a body mass measurement.  You will then be prepared for the exercise bout i.e. you 
will be asked to fit a rectal thermistor so that we can monitor your core temperature, 
and we will fit 4 skin thermistors that measure your skin temperature, and a heart rate 
monitor.  You will then provide a blood sample which will be taken by venepuncture of a 
forearm vein by a qualified phlebotomist.  You will be provided with a small amount of 
water before performing the first exercise bout. This exercise bout will be run on a 
motorized treadmill at a moderate exercise intensity (65% maximal oxygen uptake) with 
the gradient set at -10% downhill in order to induce muscle damage.  You will be 
provided with small amounts of fluid during this exercise bout which will last for 1-hour. 
Additionally, you will be asked to breathe into a bag at 2 time points during this bout so 
that we can determine your exercise intensity.  Upon completion, you will be asked to sit 
quietly in the laboratory for 30 mins during which time you will weigh yourself nude and 
another blood and urine sample will be collected. After this 30 min period, you will enter 
an environmental chamber set to hot conditions (33ºC and 50% relative humidity).  You 
will run on the treadmill at a moderate intensity (65% maximal oxygen uptake) at a 
level gradient for 40 minutes, during which time you will not be allowed to consume 
fluids.  During this exercise bout, you will be asked to breathe into a bag every 10 
minutes, and to rate your perceived exertion and how hot you feel every 5 minutes.  
Once you have completed this second exercise bout, further nude body mass measures 
will be made, and a blood and urine sample will be collected.  You will then sit quietly for 
1-hour in the laboratory during which time your recovery core and skin temperatures will 
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be assessed continuously.  You will be provided with recovery fluids during this time.  A 
further blood and urine sample will be collected after this 1-hour recovery period. You 
will then be allowed to shower, and we will then provide you with a small lunch.   A final 
body mass, blood and urine sample will be collected 2 hours after you finished exercising.  
You will then be free to leave the department, but will be asked to return at 08:30h the 
following day to complete one further exercise bout in the environmental chamber at the 
same intensity and duration (40 mins) and under the same environmental conditions 
(33ºC and 50% relative humidity),with nude body mass measured, and blood and urine 
samples collected, pre, immediately post and 1 and 2-hours after the exercise bout.  You 
will also be asked to rate your muscle soreness.  In the 21-hour period between the two 
exercise heat bouts, we will ask you to record what you eat, and to replicate this on the 
other two experimental trials.  In total, this experimental trial will involve 2 visits – the 
first one ~5.5 hours, and the second one ~4 hours (~9.5 hours total). 
Control trial 
This experimental trial will follow exactly the same procedures and timings as the MD 
trial, except that the first exercise bout will be conducted on a level treadmill gradient 
(not downhill). (~9.5 hours total). 
Carbohydrate trial 
This experimental trial will follow the same procedures and timings of the MD trial, 
except that instead of consuming water prior and during the first exercise bout, you will 
consume a carbohydrate containing drink.  Additionally, the first exercise bout will be 
conducted on a level treadmill gradient (not downhill). (~9.5 hours total). 
These trials will be performed in a randomized order, and 14 days apart to allow you to 
recover.  In total the study will require you to give 27 blood samples, 27 nude body 
mass measurements, 27 urine samples, and will take up 30 hours of your time. 
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What do I have to do before each visit? 
We ask that you try to consume plenty of fluids in the 24 hours prior to visit 2, and we 
will provide you with a set amount of fluid to drink in the 24 hours prior to visits 3 -8.  
We also ask that in the 24 hours prior to visits 3-8 you do not perform any exercise, 
drink alcohol or consume any form of diuretics or tobacco.  We will also ask you to 
record what you eat on the day before visits 3 and 4, and to replicate these meals on the 
night before visit 5 - 8.  You may also wish to bring a towel and change of clothes for 
each visit. 
What are the possible disadvantages and risks of taking part? 
The disadvantages of taking part in this study are the discomfort associated with the use 
of temperature thermisters, blood sampling, muscle damage and exercising in a hot 
environment. For your safety your core temperature will be monitored by a rectal 
temperature probe inserted 10 cm beyond the anal sphincter. These probes are 
commonly used in thermoregulation research and most people do not notice them once 
they have started exercising.  Blood sampling will be performed by qualified 
phlebotomists using a disposable small needle.  We will collect 14ml of blood four times 
on each of the 6 exercise trial days.  Removing this amount of blood will not affect your 
performance or health in any way.  However, you may experience bruising of the area 
around the venepuncture site.  Any discomfort you experience will be short lived.  The 
muscle damaging protocol (downhill running) is routinely used in exercise physiology 
research and you will experience muscle soreness in the 1-3 days following this exercise 
bout.  This soreness will be comparable to the sort of soreness you might experience 
after performing a new type of exercise for the first time.  However, this soreness will 
pass in 3 – 5 days and will not leave any lasting damage.  There are standard risks 
associated with performing intense exercise in hot conditions.  Accordingly, all 
experimenters are trained in recognizing and treating signs and symptoms of exertional 
heat illness.  Additionally, persons trained in CPR and AED will be readily available or 
present at all exercise trials.  However, it should be noted that measures are in place to 
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minimize the risk of exertional heat illness, and accordingly the risk of this occurring is 
very small.   
What are the possible benefits of taking part? 
Taking part in this study will enable you to receive comprehensive feedback, with full 
explanations of your fitness level. The feedback you will receive regarding your fitness 
level is similar to that which many fitness testing centres provide as a fee-paying service.  
Advantages for undergraduates from within SSHES are that you will gain a valuable 
insight into the procedures and work involved in a 3rd year project. Additionally 
participation in this project can cover both the open and personal performance skills 
units of the undergraduate portfolio.  Finally, you will be paid £50 cash upon completion 
of all experimental procedures. 
What if something goes wrong? 
If you are harmed whilst taking part in this research project, there are no special 
compensation arrangements.  If you are harmed due to someone’s negligence, then you 
may have grounds for legal action but you may have to pay for it.  Regardless of this, if 
you wish to complain, or have any concerns about any aspect of the way you have been 
approached or treated during the course of this study you may contact the Head of the 
School of Sport, Health and Exercise Sciences, Professor Michael Khan.   
Will my taking part in this study be kept confidential? 
All information collected about you during the course of the study will be kept strictly 
confidential.  It will be anonymised so that only the following people will have access to 
your records:  
Dr Neil Walsh (University lecturer), Dr Matthew Fortes (Postdoctoral researcher), 
Umberto Di Felice (PhD student) and Alberto Dolci (PhD student). 
Your data will be stored on a password protected computer and in locked filing cabinets.  
This data will be destroyed 10 years after the conclusion of the study.  
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What will happen to the results of the research study? 
The results from this study may be published in a leading international physiology 
journal.  Your blood samples will be stored for a maximum period of six years and may 
be used in future investigations in this area of research.  Again, you will not be able to 
be identified from this.  A written report will be given to any participants who are 
interested in the results of the study. 
Who is organising and funding the research?  
This research is organised by the named investigators above, and funded by Bangor 
University.   
Who has reviewed the study? 
The study has been approved by the School of Sport, Health and Exercise Sciences 
ethics committee of Bangor University. 
Contact for further information 
If you require any further information about the study please contact any of the project 
investigators whose contact details are displayed below: 
  
Dr Matthew Fortes   01248 383687  m.fortes@bangor.ac.uk  
Dr Neil Walsh    01248 383480  n.walsh@bangor.ac.uk 
 
   
 
Thank you very much for taking the time to read this information sheet. 
 
If you choose to participate in this study you will be given a copy of the 
information sheet and a signed consent form to keep 
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Invitation to take part 
You are being invited to take part in a research study.  Before you decide whether to 
participate, it is important for you to understand why the research is being done and 
what it will involve.  Please take time to read the following information carefully and 
discuss it with friends, family and your GP if you wish.  If there is anything that is not 
clear or if you would like more information, please do not hesitate to ask us.  Take time 
to decide whether or not you wish to take part. 
What is the purpose of this study? 
Athletes and military personnel are often expected to perform repeated bouts of arduous 
physical activity on the same day, often in hot environments which may increase their 
risk of exertional heat illness (EHI).  A number of traditional risk factors have been 
identified that increase the risk of heat illness in athletes and military personnel (for 
example, hot and humid environmental conditions, wearing lots of clothing, lack of 
acclimatisation to hot conditions, poor sleep, high exercise intensity, high amount of 
body fat, and poor fitness).  We have recently shown that downhill running, which can 
damage the leg muscles resulting in soreness, makes people get hotter when they 
perform an exercise run in the heat 30 mins later.  This increase in body temperature 
may be due to alterations in the immune system, and could result in an increased risk of 
heat illness.  It is also known that performing one bout of this type of muscle damaging 
exercise can lessen the negative effects, and reduce soreness after further muscle 
damaging type exercise bouts.  It is the purpose of this current study to investigate if 
repeated muscle damage exercise (downhill running) results in people getting “less hot” 
whilst exercising in the heat.  To assess this, you will be expected to perform either 1) 
muscle damaging exercise (60 min running downhill), followed by a 40 min exercise run 
in the heat.  You will then repeat this 2 weeks later, and we will compare your body 
temperature responses between these two trials, or 2) non-muscle damaging exercise 
(60 min running on the flat), followed by a 40 min exercise run in the heat.  You will 
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then repeat this 2 weeks later, and we will compare your body temperature responses 
between these two trials 
Why have I been chosen? 
You have been chosen because you are a recreationally active male, aged between 18 
and 40 years of age, free from infection and, and not currently taking medication.  
Do I have to take part? 
This is entirely your decision. If you decide to take part you will be asked to sign a 
consent form. You will be given a copy of this form to keep for your information. You will 
be free to withdraw at any time without giving a reason. If you decide not to participate, 
it will not affect your relationship with the School of Sport, Health and Exercise Sciences 
or any of the researchers. All the information collected will be treated confidentially. 
What will happen to me if I take part? 
The study will involve you making ten visits to the School of Sport, Health and Exercise 
Sciences.  The purpose and time commitment of each visit are outlined below: 
Visit 1) You will be talked through the protocol by an investigator and given the 
opportunity to ask any questions.  If you decide to take part, you will be asked to sign a 
consent form. Then you will be randomly assigned to the control trial (CON) or to 
exercise-induced muscle damage trial (EIMD) (visit length ~30 mins). 
Visit 2) During this visit you will be asked to perform an incremental exercise test on a 
treadmill, whilst wearing a mask, which will last approximately 20 minutes.  This test 
starts off easy (fast walking pace) and gets progressively harder until you cannot 
continue.  By the end, you will be running very quickly.  By measuring your expired air, 
we will be able to calculate your maximal oxygen uptake (a good indicator of your 
overall fitness) and to calculate the intensity at which you will exercise during the 
experimental trials.  Following this test, you will have a short recovery period (approx 10 
mins), and then you will be asked to run at a moderate speed on the treadmill for 
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approximately 20 minutes in order for us to verify the correct exercise intensity for the 
subsequent experimental trials.  We will ask you to run on a flat gradient, and then 
depending on which group you have been assigned, on a downhill gradient.  Since you 
may not be used to running downhill, we will give you ample opportunity to practice, by 
starting off slowly and gradually increasing the running speed (visit length ~ 1½ hours).  
Visit 3) Using fitness machine similar to that found in a gym, we will assess your leg 
strength using 4 four maximal contractions after a warm-up consisting of six isometric 
contractions at 25%, 50% and 75% of intensity (visit length ~ 30 min).   
Visit 4) The day after visit 3, you will be asked to report to the laboratory at 07:15h 
having not eaten that morning.  We will provide you with a snack and a set amount of 
fluids.  At 08.00h you will be asked to provide a urine sample, and to weigh yourself 
nude behind screens (for your privacy) for a body mass measurement.  You will then be 
prepared for the exercise bout i.e. you will be asked to fit a rectal thermistor so that we 
can monitor your core temperature, and we will fit 4 skin thermistors that measure your 
skin temperature, and a heart rate monitor.  You will then provide a blood sample which 
will be taken by venepuncture of a forearm vein by a qualified phlebotomist.  You will be 
provided with a small amount of water before performing the first exercise bout. This 
exercise bout will be run on a motorized treadmill at a moderate exercise intensity (65% 
maximal oxygen uptake) with the gradient set at -10% downhill in order to induce 
muscle damage if you are on the EIMD trial or with the gradient set at +1% if you are on 
the CON trial.  You will be provided with small amounts of fluid during this exercise bout 
which will last for 1-hour. Additionally, you will be asked to breathe into a bag at 2 time 
points during this bout so that we can determine your exercise intensity.  Upon 
completion, you will be asked to sit quietly in the laboratory for 30 mins during which 
time you will weigh yourself nude and another blood sample will be collected. After this 
30 min period, you will enter an environmental chamber set to hot conditions (33ºC and 
50% relative humidity).  You will run on the treadmill at a moderate intensity (65% 
maximal oxygen uptake) at a level gradient for 40 minutes, during which time you will 
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not be allowed to consume fluids.  During this exercise bout, you will be asked to 
breathe into a bag every 10 minutes, and to rate your perceived exertion and how hot 
you feel every 5 minutes.  Once you have completed this second exercise bout, a further 
nude body mass measure will be made, and a blood sample will be collected.  You will 
then sit quietly for 1-hour in the laboratory during which time your recovery core and 
skin temperatures will be assessed continuously.  You will be provided with recovery 
fluids during this time.  A further blood sample will be collected after this 1-hour 
recovery period. You will then be allowed to shower, and we will then provide you with a 
small lunch, after which you will be free to leave the department. (visit length ~4.5 
hours total). 
Visit 5 and 6) These will be exactly the same as visit 3 (to assess your leg strength), 
and will be performed 24 hours, and 48 hours after visit 4 respectively. (visit length ~ 
30 min each). 
Visit 7, 8, 9, and 10) These visits will consist of exactly the same procedures and 
timings as per visits 3-6, but will be performed 2 weeks after the start of visit 3.  (visit 
lengths ~ 30 min, 4.5 hours, 30 min and 30min each respectively). 
In total the study will require you to give 8 blood samples, 8 nude body mass 
measurements, 2 urine samples, and will take up 14 hours of your time. 
What do I have to do before each visit? 
We ask that you try to consume plenty of fluids in the 24 hours prior to all visits, and we 
will provide you with a set amount of fluid to drink in the 24 hours prior to visits 4 and 8.  
We also ask that in the 24 hours prior to visits 4 and 8 you do not perform any exercise, 
drink alcohol or consume any form of diuretics or tobacco.  We will also ask you to 
record what you eat on the day before visits 4, and to replicate this meal on the night 
before visit 8.  You may also wish to bring a towel and change of clothes for each visit. 
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What are the possible disadvantages and risks of taking part? 
The disadvantages of taking part in this study are the discomfort associated with the use 
of temperature thermistors, blood sampling, muscle damage and exercising in a hot 
environment. For your safety your core temperature will be monitored by a rectal 
temperature probe inserted 12 cm beyond the anal sphincter. These probes are 
commonly used in thermoregulation research and most people do not notice them once 
they have started exercising.  Blood sampling will be performed by qualified 
phlebotomists using a disposable small needle.  We will collect 12ml of blood three times 
on each of the 2 exercise trial days (visits 4 and 8).  Removing this amount of blood will 
not affect your performance or health in any way.  However, you may experience 
bruising of the area around the venepuncture site.  Any discomfort you experience will 
be short lived.  The muscle damaging protocol (downhill running) is routinely used in 
exercise physiology research and you will experience muscle soreness in the 1-3 days 
following this exercise bout.  This soreness will be comparable to the sort of soreness 
you might experience after performing a new type of exercise for the first time.  
However, this soreness will pass in 3 – 5 days and will not leave any lasting damage.  
There are standard risks associated with performing intense exercise in hot conditions.  
Accordingly, all experimenters are trained in recognizing and treating signs and 
symptoms of exertional heat illness.  Additionally, persons trained in CPR and AED will 
be readily available or present at all exercise trials.  However, it should be noted that 
measures are in place to minimize the risk of exertional heat illness, and accordingly the 
risk of this occurring is very small.   
What are the possible benefits of taking part? 
Taking part in this study will enable you to receive comprehensive feedback, with full 
explanations of your fitness level. The feedback you will receive regarding your fitness 
level is similar to that which many fitness testing centers provide as a fee-paying service.  
Advantages for undergraduates from within SSHES are that you will gain a valuable 
insight into the procedures and work involved in a 3rd year project. Additionally 
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participation in this project can cover both the open and personal performance skills 
units of the undergraduate portfolio.   
What if something goes wrong? 
If you are harmed whilst taking part in this research project, there are no special 
compensation arrangements.  If you are harmed due to someone’s negligence, then you 
may have grounds for legal action but you may have to pay for it.  Regardless of this, if 
you wish to complain, or have any concerns about any aspect of the way you have been 
approached or treated during the course of this study you may contact the Head of the 
School of Sport, Health and Exercise Sciences, Dr Tim Woodman.   
Will my taking part in this study be kept confidential? 
All information collected about you during the course of the study will be kept strictly 
confidential.  It will be anonymised so that only the following people will have access to 
your records:  
Prof. Neil Walsh (University lecturer), Dr Matthew Fortes (Postdoctoral researcher), and 
Alberto Dolci (PhD student). 
Your data will be stored on a password protected computer and in locked filing cabinets.  
This data will be destroyed 10 years after the conclusion of the study.  
What will happen to the results of the research study? 
The results from this study may be published in a leading international physiology 
journal.  Your blood samples will be stored for a maximum period of six years and may 
be used in future investigations in this area of research.  Again, you will not be able to 
be identified from this.  A written report will be given to any participants who are 
interested in the results of the study. 
Who is organising and funding the research?  
This research is organised by the named investigators above, and funded by Bangor 
University.   
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Who has reviewed the study? 
The study has been approved by the School of Sport, Health and Exercise Sciences 
ethics committee of Bangor University. 
Contact for further information 
If you require any further information about the study please contact any of the project 
investigators whose contact details are displayed below: 
  
Alberto Dolci                   01248 388288  pepc2e@bangor.ac.uk 
Dr Matthew Fortes   01248 383687  m.fortes@bangor.ac.uk  
Prof. Neil Walsh   01248 383480  n.walsh@bangor.ac.uk 
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APPENDIX B: 
 
INFORMED CONSENT TO PARTICIPATE 
IN A RESEARCH PROJECT OR EXPERIMENT 
 
Title of Research Project:  
The influence of repeated bouts of muscle damaging exercise upon 
thermoregulation during exercise in the heat. 
  
The researcher conducting this project subscribes to the ethics conduct of research and 
to the protection at all times of the interests, comfort, and safety of participants.  This 
form and the information sheet have been given to you for your own protection and full 
understanding of the procedures.   Your signature on this form will signify that you have 
received information which describes the procedures, possible risks, and benefits of this 
research project, that you have received an adequate opportunity to consider the 
information, and that you voluntarily agree to participate in the project. 
Having been asked by Alberto Dolci of the School of Sport, Health and Exercise Sciences 
at Bangor University to participate in a research project experiment, I have received 
information regarding the procedures of the experiment. 
I understand the procedures to be used in this experiment and any possible personal 
risks to me in taking part. 
I understand that I may withdraw my participation in this experiment at any time. 
I also understand that I may register any complaint I might have about this experiment 
to Dr Tim Woodman, Head of the School of Sport Health and Exercise Sciences, and that 
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I will be offered the opportunity of providing feedback on the experiment using standard 
report forms. 
I may obtain copies of the results of this study, upon its completion, by contacting: 
AlbertoDolci     pepc2e@bangor.ac.uk               
 
I confirm that I have been given adequate opportunity to ask any questions   
and that these have been answered to my satisfaction. 
 
I have been informed that the research material will be held confidential 
by the researcher. 
 
I agree to participate in the study 
NAME (please type or print legibly): 
_______________________________________________ 
ADDRESS:
 (Optional)__________________________________________________________ 
 
PARTICIPANT’S SIGNATURE:  __________________________        DATE: 
 _________ 
 
RESEARCHER’S SIGNATURE:  __________________________        DATE: 
 _________ 
Two sheets should be completed - one for the participant and one for the researcher  
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APPENDIX C: 
Bangor University 
SCHOOL OF SPORT, HEALTH AND EXERCISE SCIENCES 
Name of Participant ……..………………………………………………………….. 
 
Age ………………………  
 
Are you in good health?      YES  NO 
 
If no, please explain 
How would you describe your present level of activity?  
Tick intensity level and indicate approximate duration. 
Vigorous  Moderate  Low intensity  
 
Duration (minutes)……………………………………………………………………. 
 
How often?  
< once per month   4-5  times per week  
once per month  > 5 times per week  
2-3 times per week    
 
Have you suffered from a serious illness or accident?    YES    NO 
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If yes, please give particulars: 
Do you suffer, or have you ever suffered from: 
 
 YES NO  YES NO 
Asthma   Epilepsy   
Diabetes   High blood pressure    
Bronchitis      
 
Are you currently taking medication?       YES  NO 
    
If yes, please give particulars: 
Are you currently attending your GP for any condition or have you consulted your doctor 
in the last three months?     YES  NO  
If yes, please give particulars: 
Have you, or are you presently taking part in any other laboratory experiment? 
         YES  NO 
      
 
 
PLEASE READ THE FOLLOWING CAREFULLY 
 
Persons will be considered unfit to do the experimental exercise task if they: 
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• have a fever, cough or cold, or suffer from fainting spells or dizziness; 
• have suspended training due to a joint or muscle injury; 
• have a known history of medical disorders, i.e. high blood pressure, heart or lung 
disease; 
• have had hyper/hypothermia, heat exhaustion, or any other heat or cold disorder; 
• have anaphylactic shock symptoms to needles, probes or other medical-type equipment; 
• have chronic or acute symptoms of gastrointestinal bacterial infections (e.g. Dysentery, 
Salmonella); 
• have a history of infectious diseases (e.g. HIV, Hepatitis B); and if appropriate to the 
study design, have a known history of rectal bleeding, anal fissures, haemorrhoids, or 
any other condition of the rectum. 
 
DECLARATION 
I agree that I have none of the above conditions and I hereby volunteer to be a 
participant in experiments/investigations during the period of …………………20…… 
My replies to the above questions are correct to the best of my belief and I understand 
that they will be treated with the strictest confidence.  The experimenter has explained 
to my satisfaction the purpose of the experiment and possible risks involved. 
I understand that I may withdraw from the experiment at any time and that I am under 
no obligation to give reasons for withdrawal or to attend again for experimentation. 
Furthermore, if I am a student, I am aware that taking part or not taking part in this 
experiment, will neither be detrimental to, or further, my position as a student. 
I undertake to obey the laboratory/study regulations and the instructions of the 
experimenter regarding safety, subject only to my right to withdraw declared above. 
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Signature (participant) ……………………………..………….  Date …………………….. 
 
Print name …………………………………………………….. 
 
Signature (experimenter) ………………….………………….  Date …………………….. 
 
Print name ………………………………………………………. 
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APPENDIX D:  
 
The reproducibility of the Isometric right-leg extension strength test 
 
Purpose. To assess the reproducibility of  the Isometric right-leg extension strength test 
Methods. Nine males (mean ± SD: age, 22 ± 2 years; height, 175 ± 8 cm; BM, 72 ± 7.2 
kg; VO
2max 
59.4 ± 5.1 mL· kg
-1
·min
-1
) performed three  Isometric right-leg extension 
strength test spaced over a three days period. Within-subject variation was minimised by 
testing at a similar time of day. In addition, on the day prior to each test, participants 
refrained from exercise and consumed a similar diet and water equal to 40 mL·kg
-1 
of 
BM. All Isometric right-leg extension strength test were performed as previously 
described in Chapter 6. Typical error of the measurement, expressed as an absolute 
value (standard error of the measurement) and CV, were obtained as described 
elsewhere (Hopkins, 2000).  
Results. Participants completed 317 ± 57.3, 329.3 ± 92.5 and 312.3 ± 66.9 Nm on trials 
1, 2 and 3 respectively. The standard error of the measurement between trials 1-2 and 
2-3 were 12.3 and -8.0 Nm. A CV of 5.8% was noted between trials, highlighting the 
importance of allowing participants a single familiarisation session. In addition, no order 
or learning effect was identified as ANOVA revealed no significant differences between 
trials 1, 2 and 3 (P > 0.05).  
Conclusion. The CV of 5.8% is much smaller than the CV reported by results included in 
Chapter 6.  
